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ABSTRACT OF THE DISSERTATION 
 
Establishing a foundation for physiological fMRI:  
How do we noninvasively quantify the human brain at work? 
 
by 
 
Eulanca Yuka Liu 
 
Doctor of Philosophy in Neurosciences with a Specialization in Multi-Scale Biology 
 
University of California San Diego, 2019 
 
Professor Richard B. Buxton, Chair 
 
The development of functional magnetic resonance imaging (fMRI) caused a paradigm 
shift in the study of neuroscience. However, despite the boom in research, fMRI has had a 
much smaller impact in the clinical setting. This is due to the complexity of the blood-
oxygenation level dependent (BOLD) signal and its lack of inherent physiological meaning. 
Instead, cerebral blood flow (CBF) and cerebral metabolism of oxygen (CMRO2) have been 
proposed as physiological indicators of neural activity, and noninvasive measurement of these 
parameters could lead to improved applicability to clinical problems. While arterial spin labeling 
		 xiv 
(ASL) techniques are well-established for measuring baseline CBF and fractional changes in 
CBF to a stimulus, measurements of CMRO2 are more controversial. Some methods to estimate 
CMRO2 involve contrast injection or administration of special gases, which could potentially 
prevent their use in certain patient populations.  
Here, the feasibility for quantitative measurements reflective of neural physiology is 
established. This is accomplished through a suite of tools to estimate specific physiological 
metrics that reflect baseline CBF and CMRO2 and their responses to a standard stimulus, 
without encumbering the patient. The techniques utilized are Velocity Selective Excitation and 
Arterial Nulling (VSEAN) to measure oxygen extraction fraction (OEF), which leads to the 
calculation of baseline CMRO2, and FLuid Attenuated Inversion Recovery-Gradient Echo 
Sampling of Spin Echo (FLAIR-GESSE) to calibrate baseline deoxyhemoglobin through R2¢, 
leading to fractional CMRO2 estimates. These, in combination with the latest BOLD/ASL 
acquisitions, form a toolbox that allows for full physiological quantification. Initial results 
demonstrate values of baseline CMRO2 that match previously reported results, as well as a 
close relationship between R2¢ data and widely-used gas method results. The toolbox is then 
applied to detecting changes in brain state induced by caffeine administration. Measurements in 
the pre- and post-caffeine states illustrate the ability of the toolbox to 1) reproduce known 
physiological changes due to caffeine and 2) significantly distinguish the change in brain state 
due to this intervention. These results demonstrate the use of physiological fMRI in providing a 
more detailed and reproducible picture of the human brain at work, paving the way for future 
clinical applications. 
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INTRODUCTION 
 
The potential of quantitative physiological fMRI 
 The human brain at work: What does it look like? How can we tell it is working? Can we 
open a window to peer into the primary motor cortex as someone taps their fingers? The 
seemingly inaccessible dream of visualizing an individual’s brain at work without an invasive 
procedure became a reality with the advent of functional magnetic resonance imaging (fMRI) in 
the early 1990s (Kwong et al., 1992; Ogawa et al., 1992). The method utilized the Blood-
Oxygenation Level Dependent (BOLD) signal in human subjects to map the functional anatomy 
of the brain. Since then, the field has evolved quickly, with BOLD fMRI being used to map areas 
associated with a wide range of tasks and functions in healthy brains, from eloquent speech 
centers to memory networks, as well as in better understanding which regions are affected by 
certain disease processes.  
 The technique was translated from research applications to clinical applications, such as 
in neurosurgical planning. Cognitive, sensory, or motor stimuli are used to localize the functional 
areas that should be spared during resection (Matthews et al., 2006). While mapping out 
functional neuroanatomy is now regularly performed in pre-surgical planning, BOLD fMRI has 
not found wider acceptance in clinical applications beyond localization of functional regions. 
This is in part due to the complexity of the BOLD response and its lack of inherent physiological 
meaning. Increase in BOLD contrast is based on an increase in cerebral blood flow (CBF) to the 
region and a relatively smaller increase in cerebral metabolism of oxygen (CMRO2), both 
thought to be driven by an increase in local neuronal signaling. The relatively larger increase in 
CBF relative to CMRO2 means that more oxygen is delivered to that region than is being 
extracted, and thus the concentration of deoxyhemoglobin decreases locally. On the scale of a 
voxel, which can be thought of as a 3D box that is the basic unit of the “window” used to image 
	 2 
the brain, the decrease in deoxyhemoglobin leads to a decrease in the rate of transverse signal 
relaxation (R2*), which leads to an increase in signal intensity if an R2*-weighted image is 
acquired. This is then the area that “lights up” when that region of the brain is active.  
 However, BOLD is not only dependent on CBF and CMRO2 changes. The models 
relating BOLD to CBF and CMRO2, such as the widely used Davis model (Davis et al., 1998), 
also depend on a baseline scaling factor M, which reflects the amount of deoxyhemoglobin in 
the baseline state, as well as the relationship between CBF and cerebral blood volume (CBV), 
through the factor a. The scaling factor M is important because, for the same change in CBF 
and CMRO2, the BOLD response will be larger when M is larger. Essentially, if there is more 
deoxyhemoglobin present in the baseline state, the change in deoxyhemoglobin will be larger 
for a given change in CBF or CMRO2, and so the BOLD response will be larger. In short, while 
we might expect the physiological changes in CBF and CMRO2 to reflect changes in neural 
activity, the BOLD response may vary across subjects, or with development, or with disease 
even when the underlying physiological changes in CBF and CMRO2 are the same.  
 In addition, the changes in the BOLD response to a stimulus or task are hard to compare 
across scan sessions, and thus offer little information to care providers who wish to track and 
quantify progression of a disease or effects of an intervention. A fundamental problem with 
using the BOLD response to a stimulus in the clinical setting is that it only reflects a change 
between two dynamic states, often called the baseline and activation states. However, it tells us 
nothing about the baseline state itself, which in the case of disease could involve chronic 
alterations of CBF and CMRO2. For neurosurgery planning, simply detecting where a BOLD 
response is happening is sufficient information to guide the surgery. But for most disease 
applications, the change in the magnitude of the BOLD response to a standard stimulus may be 
intrinsically variable, and may only indirectly reflect the more specific chronic effects of the 
disease on flow and metabolism in the baseline state. For example, the oxygen extraction 
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fraction (OEF) is a key physiological parameter that affects the BOLD signal, because the 
deoxyhemoglonin content of venous blood increases when OEF increases. The basic BOLD 
effect—the increase of the MR signal with brain activation—is due to a dynamic decrease of 
OEF in the activation state. In addition, though, the OEF in the baseline state indirectly affects 
the magnitude of the dynamic BOLD response because the OEF determines the baseline 
deoxyhemoglobin content and thus affects the BOLD scaling factor M. As a result, the BOLD 
signal itself is difficult to interpret, potentially depending on both acute and chronic effects of the 
disease, and thus characterization of physiological factors—CBF and CMRO2, as well as the 
coupling of the two parameters, l=dCMRO2/dCBF—may be better for understanding underlying 
neural activity and for potential clinical applications.  
 Arterial spin labeling (ASL) techniques have been well established for measuring both 
baseline and fractional change in CBF in the research and clinical settings. However, measuring 
oxygen metabolism is more challenging. Measurements of metabolism can be done using PET 
studies, but quantitative fMRI methods offer the potential of an alternative that does not require 
ionizing radiation exposure, is less expensive, and is more widely available. In contrast to ASL, 
which can measure both the fractional change to a stimulus dCBF as well as the absolute 
baseline value of CBF, the corresponding measurements for CMRO2 of fractional change and 
absolute baseline value are done with two separate experiments. To calculate dCMRO2, the 
dynamic change in CMRO2 in response to a stimulus, the calibration factor M must be 
measured through the calibrated BOLD method (Davis et al., 1998). Knowing the value of M, 
the fractional change in CMRO2 to the stimulus can be calculated from measurements of the 
BOLD and CBF responses. Essentially, knowing M allows us to untangle the complexity of the 
BOLD response and measure the underlying CMRO2 change. A current challenge of this 
methodology, though, is that the classic calibration method requires the subject to breathe a 
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special gas mixture with elevated carbon dioxide. The setup of these gas experiments is 
complicated and may be too burdensome in most clinical scenarios (Merola et al., 2018; Wise et 
al., 2013). Additionally, while the calibrated BOLD approach can measure the fractional change 
in CMRO2 to a stimulus, it cannot tell us what CMRO2 is in the baseline state. Characterization 
of baseline CMRO2 requires a separate measurement, often of baseline oxygen extraction 
fraction (OEF). With OEF measured, baseline CMRO2 is calculated through the relationship !"#$% = !'(	 ∙ $+(	 ∙ !,$%. Here CaO2 is the arterial oxygen content. Quantitative fMRI 
techniques for measuring OEF have been developed based on measuring the BOLD response 
to inhalation of a gas enriched with O2; in combination with hypercapnia administration for 
estimating M, this is called dual-calibrated fMRI (Merola et al., 2018, 2017). In addition, though, 
techniques have been developed that measure the relaxation rate of venous blood (Bolar et al., 
2011; Guo and Wong, 2012; Lu et al., 2012), and do not require the subject to breathe special 
gas mixtures.  
 To best translate measurements of CBF and CMRO2 to the clinic, non-gas, noninvasive 
techniques are the most promising for widespread application. ASL has already proven to be 
useful on various patient populations, but the two techniques to measure baseline and fractional 
CMRO2 must still be tested. Specifically, for a non-gas implementation, we need to be able to 
estimate M without a hypercapnia experiment, and measure OEF without a hyperoxia 
experiment. Recent developments have yielded methods for a signal reflecting baseline 
deoxyhemoglobin by measuring tissue R2¢, the component of the transverse magnetization 
relaxation that can be reversed with a spin echo. The rationale behind this is that signal decay 
(relaxation of the transverse magnetization) happens because spins that experience different 
magnetic fields precess at different rates and get out of phase with one another, so the net 
signal decreases over time. The magnetic field at the location of a particular spin depends on 
large scale static field variations and also on fluctuating fields due primarily to other spins (e.g., 
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the second hydrogen nucleus in a water molecule creates a fluctuating magnetic field at the 
location of the first hydrogen nucleus as the water molecule tumbles). A spin echo experiment 
refocuses the part of the decay due to the static field offsets, and the remaining relaxation rate 
due to just the fluctuating fields is R2. In a typical fMRI experiment using a gradient echo 
acquisition, the decay rate R2* includes the effects of both fluctuating fields (R2) and static field 
offsets, and the approximate relationship is R2* = R2¢ + R2.  The basis of using R2¢ as a 
surrogate for deoxyhemoglobin content is the idea that the dominant source of R2¢ in tissue is 
the effect of deoxyhemglobin in blood vessels. Importantly, though, any other sources of broad 
field inhomogeneity also contribute to R2¢, and these must be corrected. If this correction is 
effective, the factor R2¢ can be thought of as a substitute for M, and thus allows for calculation of 
fractional CMRO2 to a stimulus, because both are proportional to the baseline deoxyhemoglobin 
content.  
 Baseline OEF also can be measured through relaxation effects, but in this case, it is the 
R2 of venous blood that is the important parameter. Again, the key rationale for this method is 
that the concentration of deoxyhemoglobin in blood is the primary determinant of R2. For venous 
blood, the hemoglobin-O2 saturation is directly related to the OEF, because most of the O2 in 
blood is bound to hemoglobin, with O2 as dissolved gas only about 2% of total O2. With an 
appropriate calibration curve relating R2 to hemoglobin-O2 saturation, the OEF can be 
calculated. The key challenge here is that the signal of venous blood must be isolated in the 
experiment so that R2 can be measured with a spin-echo method.  
 These techniques can all be explored in combination to create a full quantitative 
physiological picture of CBF and CMRO2 in the baseline state and in response to a stimulus or 
task. This combination of non-gas methods for fully quantifying the physiology has not been 
tested before, and my goal here is to evaluate this suite of techniques. If successful, these 
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methods could not only be used for measuring CMRO2 responses to particular stimuli, but 
potentially to measure ongoing CMRO2 fluctuations not driven by an applied stimulus or task. If 
this is possible, these methods could be useful for understanding the activity of fluctuating 
resting state networks. However, for this application there is a basic physiology question that 
needs to be resolved regarding the blood volume changes that accompany changes in blood 
flow: are these tightly coupled, or are they uncoupled during transitions between activity levels? 
For example, it has been proposed that the BOLD post-stimulus undershoot could arise if blood 
volume recovers from the stimulus more slowly than blood flow. In our modeling of the BOLD 
signal to derive CMRO2, fluctuations we need to assume that blood volume and blood flow vary 
together, and if this is not true, slow variations in blood volume could be mistaken for slow 
variations in CMRO2. Answering this physiological question will open the possibility of fully 
measuring the dynamics of CMRO2.  
My research interests lie in the potential clinical use of noninvasive fMRI sequences to 
detect changes in brain state, such as in following the effects of a drug. In the lab of my doctoral 
advisor, Dr. Richard Buxton, I aimed to establish and fine tune a suite of tools to measure 
specific physiological metrics that reflect baseline CBF and CMRO2 and their responses to a 
standard stimulus, without encumbering the patient or inducing a state of discomfort. This 
toolbox ought to be sensitive and specific in quantifying change in brain state in the individual. I 
utilized this suite of new techniques to evaluate changes in brain state with administration of a 
drug, caffeine, in single subjects to test the sensitivity of the quantitative methods for detecting 
altered global neural state. I determined which measurements were the best at distinguishing a 
pre-caffeinated state from a post-caffeinated state, and which were the most specific to the 
changes induced by caffeine. This has laid a foundation for future clinical applications by testing 
the ability of our methodology to characterize brain function in healthy human subjects.  
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Overview of the dissertation 
To reach the end goal of developing quantitative techniques to measure changes in 
cerebral blood flow and metabolism of oxygen with neural activation, the following questions 
needed to be answered first: 
1) Physiology: Do the dynamics of blood volume changes present a significant obstacle 
to measuring metabolism? 
2) Methodology: Can we measure both the fractional change in CMRO2 and baseline 
CMRO2 without the use of special gases? 
3) Applications: Can we make meaningful quantitative measurements in individual 
subjects at baseline after an intervention, as a precursor to clinical applications? Can we 
distinguish two distinct states using these acquired parameters? Which measurements, or 
combination of measurements, are the most discriminatory? 
 
Aim 1: Do the dynamics of blood volume changes present a significant obstacle to measuring 
metabolism?  
One key component of measuring changes in brain state is understanding how oxygen 
metabolism responds to shifts in neural activity. Current methodology for probing this variability 
of CMRO2 is very limited (Buxton, 2010). While oxygen-15 based positron emission tomography 
(PET) methods are capable of only a few repeated steady state measurements, simultaneous 
dynamic measurements of CBF and BOLD signals with calibration offer the potential for 
previously impossible dynamic CMRO2 measurements (Mintun et al., 1984, 2002). However, 
since the BOLD effect depends on both venous hemoglobin saturation and deoxygenated 
cerebral blood volume (CBVdHb) as the primary determinants of total deoxyhemoglobin (dHb), 
dynamic measurements of CBF and BOLD alone are insufficient for estimating CMRO2 (Griffeth 
and Buxton, 2011). CBVdHb dynamics must first be addressed. This basic physiological question 
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is the focus of Aim 1, as reported in Chapter 1: do CBVdHb dynamics differ strongly from CBF 
dynamics? Recent studies from the Buxton lab of the effect of hyperoxia on the BOLD signal 
suggest a novel method specifically sensitive to CBVdHb (Blockley et al., 2013), which is a dHb-
weighted average over all vascular volumes, dominated by venous vessels, but also including 
capillaries and some contribution from partially deoxygenated arterioles. Using this approach in 
imaging human primary visual cortex, we can assess whether the dynamics of CBVdHb hinder 
measurement of CMRO2. From there, we will expand current steady state models of the BOLD 
signal that do not fully capture its complexities into a detailed model that incorporates 
appropriate CMRO2, CBF, and CBVdHb dynamics, thus quantifying underlying neurovascular 
activity with more accuracy.  
Test case: What is driving the BOLD post-stimulus undershoot? The experiments done 
to address Aim 1 will also allow us to answer the question of the origins of the BOLD post-
stimulus undershoot, a phenomenon seen since the advent of BOLD imaging but heretofore 
unexplained (Jean J. Chen and Pike, 2009). Our measurements of BOLD, CMRO2, CBF, and 
CBVdHb dynamics during and after a stimulus will allow us to determine which of these drivers of 
the BOLD response directly produces the undershoot.   
Recent studies indicate that increasing the arterial pO2 leads to a change in the tissue 
relaxation rate R2* that is proportional to the deoxygenated blood volume (Blockley et al., 2012). 
In the context of a detailed framework for the BOLD response developed by Griffeth et al. 
(Griffeth and Buxton, 2011), a new interpretation of the R2* change with hyperoxia as a direct 
reflection of deoxygenated CBV was developed by Blockley and colleagues (Blockley et al., 
2013; Blockley et al., 2012). The essential idea is that the added arterial concentration of O2 as 
dissolved gas diffuses quickly into tissue, offsetting the amount of oxygen needed to be 
removed from hemoglobin. This raises hemoglobin saturation in all blood compartments that 
contain deoxyhemoglobin in the normoxic state. This change in saturation, however, does not 
	 9 
depend on resting OEF or hematocrit. The R2* difference for a particular state in hyperoxia 
versus normoxia is then directly proportional to CBVdhb, with a proportionality constant that 
depends on the global change in arterial pO2 (Blockley et al., 2013). The hyperoxia approach 
thus offers a way to test CBVdhb dynamics, and specifically to test whether it remains elevated 
during the BOLD post-stimulus undershoot.  
We measured responses to a visual stimulus in both normoxia and hyperoxia in 19 
healthy subjects and calculated the change in R2* (R2*hyperoxia – R2*normoxia) at each time point in 
the baseline, stimulus, and post-stimulus periods. Ideally, this R2* change should be 
proportional to CBVdHb at each time point. However, other confounding factors may lead to an 
overall shift of R2* between normoxia and hyperoxia. To minimize such effects, we focused on 
the difference between the R2* change during the stimulus (or during the undershoot) and the 
R2* change for the baseline state. If CBVdHb increases during the stimulus, we expect the 
measured difference to be positive. The Balloon Model, with a prediction of elevated CBVdHb 
during the undershoot, predicts that measured difference to remain positive (Buxton et al., 
1998).  
BOLD and ASL data collected with a visual stimulus task administered in normoxia and 
hyperoxia, scaled using data from a calibrated BOLD hypercapnia experiment at baseline, 
provided a look at both stimulus activation and post-stimulus undershoot phases to elucidate 
how much dHb-weighted volume changes during activation, and whether it is elevated in the 
undershoot. To control for signal drift, a corrected normalized effective BOLD signal 
representing fractional ∆BOLD was calculated from the measured ∆R2*.  
Our statistically significant primary findings show a measured difference that was 
positive during the stimulus, consistent with increased CBVdHb, but negative during the 
undershoot, consistent with a reduction of CBVdHb rather than sustained elevation. Combined 
with previous results finding a decrease of CBF during the post-stimulus undershoot (J. Jean 
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Chen and Pike, 2009; Griffeth and Buxton, 2011; Mullinger et al., 2017), these results support 
the idea that CBV follows CBF, and that the effect of volume is weak with stimulation and takes 
a long time develop. A slow CBVdHb increase is consistent with small animal measurements that 
suggest a slow increase in venous volume. Drew et al. (Drew et al., 2011), using two-photon 
laser-scanning microscopy to measure changes in flow and volume in mice to spontaneous and 
sensory evoked activity, saw venules only dilate in response to prolonged stimulation (30 
second repetitive stimulation, vs 0.5-2 sec required for normal decision making in mice). 
Magnetization transfer-varied BOLD and contrast-agent fMRI techniques performed on 
anesthetized cats presented with a 40-second visual stimulation showed slow venous dilation 
compared to rapid arterial vasodilation an order of magnitude faster (Kim and Kim, 2011). 
Recent work in the lab by Dr. Aaron Simon modeled CMRO2 and CBVdHb responses in humans 
to an oscillating flickering checkboard. The findings show that BOLD and CBF dynamics are 
most consistent with tight coupling between CBF and CMRO2, and a CBVdHb response slower 
than either CBF or CMRO2 by an order of magnitude (Simon et al., 2016). Taken together with 
our results, these findings imply that the contribution of CBVdHb changes to BOLD is insignificant 
for short stimulation periods. Thus, moving forward, using short stimuli in subsequent 
experiments allows us to assume that CBVdHb dynamics follow CBF, making it possible to 
accurately estimate the dynamics of CMRO2. This work is now published (Liu et al., 2019). 
 
Aim 2: Can we measure both the fractional change in CMRO2 and baseline CMRO2 without the 
use of special gases? 
Current methods for quantitative fMRI. Quantitative and noninvasive measurements of 
CBF using arterial spin labeling (ASL) methods are now well established (Alsop et al., 2015), 
but the measurement of CMRO2 is much more challenging. Much of the previous work in the 
Buxton lab and in my previous work has used an imaging method that provides simultaneous 
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measurements of the time course of both CBF and the BOLD signal (Wong et al., 1998). 
However, this is still not enough information to measure CMRO2. An additional calibration 
experiment is needed to determine a scaling parameter M in the model of the BOLD signal that 
essentially depends on the amount of deoxyhemoglobin in the baseline state, and because it 
depends on the subject’s baseline state can vary across subjects and across brain regions 
within a subject (Davis et al., 1998; Griffeth and Buxton, 2011). In the classic calibrated-BOLD 
method, M is calculated on a voxel-wise basis from measured CBF and BOLD responses to a 
hypercapnia challenge (Davis et al., 1998). This provides enough information to measure the 
fractional change in CMRO2 in response to a stimulus, but not the absolute CMRO2 value. A full 
quantitative fMRI approach, characterizing absolute CMRO2 values in both the baseline and 
activated states (as is possible for CBF with ASL) requires an additional measurement to 
measure baseline CMRO2. A method being developed by several groups involves measurement 
of CBF and BOLD responses to an additional gas-based challenge, hyperoxia (Blockley et al., 
2012; Gauthier et al., 2012; Wise et al., 2013).  
Quantitative fMRI without the gases. In the approach above, the need for measurements 
while the subject breathes controlled gas mixtures makes quantitative fMRI a complicated 
procedure, and cannot be used on sick patients for whom wearing gas masks or breathing 
higher concentrations of CO2 and O2 would not be possible. To eliminate this barrier to entry 
into clinical applications, I substituted these widely-accepted techniques with new methods 
aimed at measuring CMRO2 that do not require the use of gases and so could be more widely 
performed. The method I propose to evaluate uses two noninvasive imaging methods to 
substitute for the altered gas measurements and is described in Chapter 2. The baseline 
CMRO2 measurement is done with a technique called VSEAN (Velocity-Selective Excitation and 
Arterial Nulling) that isolates the signal of local venous blood and measures its relaxation rate R2 
(Guo and Wong, 2012). Because R2 depends primarily on the O2 saturation of hemoglobin, this 
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provides a measurement of the local O2 extraction fraction (OEF), and together with a baseline 
CBF measurement with ASL this provides a measurement of baseline CMRO2. The VSEAN 
method was developed at UCSD, and is an example of a class of methods under development 
at multiple sites that measure the R2 of venous blood to estimate OEF (Krishnamurthy et al., 
2013; Lu et al., 2003; Lu and Ge, 2008; Rodgers et al., 2015).  
The measurement of fractional CMRO2 is dependent upon a calculation of the scaling 
parameter M. The calibration information to estimate M is based on measurement of R2¢, 
essentially the component of transverse magnetization relaxation that can be reversed with a 
spin echo. This approach, termed FLAIR-GESSE (Simon et al., 2016) (FLuid Attenuated 
Inversion Recovery-Gradient Echo Sampling of Spin Echo sequence) has an extensive 
literature building on early work of Yablonskiy and Haacke (Yablonskiy and Haacke, 1997). R2¢ 
can be utilized in two ways. The first is by performing calibrated BOLD using hypercapnia and 
FLAIR-GESSE on the same subjects in the baseline state to calibrate R2¢; this is necessary 
because R2¢ depends on BOLD effects around small vessels that are harder to model. M is 
derived from the simple BOLD model (Griffeth et al., 2013) using the calibrated BOLD 
measurements; using the relationship M@M¢, with M¢ = R2¢ • TE, M¢ can be substituted into the 
BOLD model. A scaling conversion factor c converting R2¢ to M with the relationship " = .+	•	#%/ 	•	0 , in which c enumerates the relationship of M to R2¢ using this particular model, 
is also explored. Using this conversion factor c, we can then continue using the model for 
analysis of activation data. Another approach to utilizing R2¢ is a Bayesian approach, undertaken 
in previous work by Simon et al. (Simon et al., 2016). The calibration data from either R2¢ or CO2 
responses is used with a more detailed BOLD model to estimate CMRO2. This work provides 
support for the accuracy of substitution of CO2 acquisitions with R2¢.   
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Our results demonstrate successful implementation of VSEAN to measure OEF and 
baseline CMRO2. The experiments also utilized empirical data from a CO2 calibrated BOLD 
experiment and a FLAIR-GESSE acquisition and found a close relationship between dCMRO2 
calculated using the two methods. The estimate of OEF and thus baseline CMRO2 from VSEAN 
agrees with previous studies using PET imaging (Mintun et al., 1984) providing support for this 
noninvasive technique in humans. The estimate of dCMRO2 using the M from R2¢ is consistent 
and physiologically feasible for such a visual stimulus (Ances et al., 2009; Griffeth et al., 2013; 
Griffeth and Buxton, 2011). This data is thus critical for establishing the empirical connection 
between the R2¢ and M from CO2 for use with the simple BOLD models. A manuscript of this 
work is in submission for publication. 
 
Aim 3. Can we make meaningful quantitative measurements in individual subjects, as a 
precursor to clinical applications? 
After establishing the successful implementation of gas-free measurements of absolute 
CMRO2, I investigated the extent to which we can use the previously described methods to 
detect a change in a subject’s brain state, such as before and after the administration of a drug. 
Evaluating the sensitivity and specificity of these parameters for detecting such changes will 
allow for better application of BOLD in gleaning information on the current state of a patient’s 
brain.  
Caffeine as an intervention. Caffeine is a global adenosine receptor antagonist. Caffeine 
removes adenosinergic tonus, and thus induces opposite effects to that of adenosine activation 
(Ribeiro and Sebastio, 2010). Adenosine itself is a neuromodulator that couples to both 
inhibitory (A1, A3) or stimulatory (A2A, A2B) G-proteins, leading to complex downstream effects in 
the brain. Here, specifically, we see the effects of adenosine antagonism on inhibitory 
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adenosine A1 and stimulatory A2A receptors. A2A receptors have been established as potent 
vasodilators, and thus caffeine antagonism of these leads to vasoconstriction (Fredholm et al., 
1999). Inhibitory A1 receptors, on the other hand, has amongst its many properties an 
“anticonvulsant effect,” in that these receptors restrain excessive neuronal activity (Barraco et 
al., 1984). Administration of caffeine in this case can be thought of as removing this inhibition of 
neuronal activity, and perhaps setting the brain at a more excitable state. While there are many 
other effects of adenosine and its receptors throughout the brain and the rest of the body, these 
particular characteristics are most relevant to using caffeine as a probe. 
We tested the sensitivity of the quantitative techniques for detecting changes due to 
caffeine with a motor-visual stimulus in individual subjects. Prior work has shown that this drug 
is a useful test for inducing a modest change in brain state and for delineating vascular and 
metabolic effects (Griffeth et al., 2011). However, important to note is that the goal of these 
studies was not to characterize caffeine itself nor its effects on the brain, but rather to use it as a 
probe for how well the suite of tools can separate two distinct conditions. In addition, caffeine 
allows us to test the basic ideas underlying these non-gas methods. Specifically, prior studies 
found that caffeine reduces CBF without a corresponding decrease in CMRO2. We thus expect 
baseline OEF to increase post-caffeine. From the theory behind our methods, we predict that 
our VSEAN method based on R2 of venous blood will show an increased OEF, and we further 
predict that R2¢ will increase as baseline deoxyhemoglobin increases through the increase in 
OEF. By performing our two baseline measurements both pre- and post-caffeine, we were able 
to test these predictions. Finally, even though our goal was not primarily to characterize the 
effects of caffeine on CBF and CMRO2, these studies did provide some interesting findings in 
that regard. 
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Baseline changes after caffeine administration. CBF, OEF, and R2¢ were measured 
using the suite of a BOLD/ASL acquisition (background-suppressed pseudo-continuous ASL), 
FLAIR-GESSE, and VSEAN while the subject was at rest, both in a pre-caffeinated state and 
after administration of a 200mg caffeine tablet, as detailed in Chapter 3. The baseline values of 
CBF, OEF, R2¢ and CMRO2 were then compared between the two conditions. This first part of 
the analysis focused on the predictions of our non-gas baseline methods. Basic behavior of R2¢ 
and OEF were analyzed; both OEF and R2¢ in gray matter were increased with caffeine 
administration as predicted by the theory underlying the VSEAN and R2¢ measurements. CBF, 
as has been shown in previous studies, decreased after caffeine, but the drop was consistent 
with a fixed absolute decrease across subjects, rather than a fixed percentage change of that 
subject’s baseline CBF. This was an interesting finding not previously predicted. CMRO2, on the 
other hand, did not change significantly; however, an analysis of the relationship between the 
degree of change and the baseline value suggests a more complex picture involving individual 
responses to caffeine: post-caffeine the variance of the CMRO2 values across subjects 
increased substantially, even though the mean value did not change. These findings in a resting 
state led to the next study that incorporated a more complex task.     
Functional and baseline changes: the full picture. In Chapter 4, the three techniques 
were then used to measure baseline and fractional changes to a functional task/stimulus to 
answer the question: can we detect a change in brain state using one or several of these 
parameters? Using a motor-visual task to target a motor ROI and a visual ROI, eight values 
were evaluated: 1) baseline CBF, 2) baseline OEF, 3) baseline R2¢, 4) baseline CMRO2, 5) 
fractional BOLD change (dBOLD) to task/stimulus, 6) fractional CBF (dCBF) change to 
task/stimulus, 7) fractional CMRO2 change (dCMRO2), 8) coupling ratio l ( dCMRO2/dCBF) to 
task/stimulus. This was done in 4 conditions: 1) pre-caffeine motor ROI, 2) pre-caffeine visual 
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ROI, 3) post-caffeine motor ROI, 4) pre-caffeine visual ROI. For each ROI, the pre-caffeine 
value was subtracted from the post-caffeine value to calculate the difference (∆) in each 
parameter due to caffeine. The pre- and post-caffeine means were compared using a matched 
pairs T-test with the null hypothesis that post-caffeine – pre-caffeine = 0; in other words, ∆=0. 
This allowed us to compare the parameters to determine which could be best at predicting 
which state the subject is in. Our results revealed that scaled dBOLD (dBOLD/R2¢), baseline 
CBF, and coupling ratio l (dCMRO2/dCBF) were the most sensitive parameters for separating 
pre-caffeine from post-caffeine states. In this particular example of caffeine, the methods that 
were most useful were BOLD/ASL and FLAIR-GESSE, but that may not be the case with other 
drugs or interventions. It is thus important to retain the full suite of tools, yielding measurements 
for all parameters, in order to paint a full picture of what is changing with the change in brain 
state. Interestingly, the scaled dBOLD difference was not specific to a caffeine intervention; a 
repeat of the pre-caffeine acquisition and comparison of the two sets of pre-caffeine showed 
that the BOLD change was present, and thus not limited to only the caffeine-induced state. As a 
result, the coupling ratio l and baseline CBF were better metrics for distinguishing the states. In 
short, specific responses (BOLD, CBF or CMRO2) may simply be more variable across different 
repeated stimulations than the relationships between these responses, such as the coupling 
parameter l.  
A key point to emphasize is that while not all the measured parameters were useful for 
distinguishing pre- and post-caffeine states, these other measurements may be applicable in the 
context of other drugs or interventions. It is thus important to collect the entire suite of 
measurements to best determine the most discriminating value or combination of values.  
The results of our studies have demonstrated the use of physiological fMRI—
quantification of cerebral blood flow and metabolism of oxygen as surrogates for neural 
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activity—in providing a more detailed and reproducible picture of what the brain is doing. These 
measurements have real physiological implications and can thus be potentially compared 
across different sessions or days, and compared with normative data for a healthy population. 
They could also lead to meaningful information on an individual basis, which is vital for use in a 
clinical setting. This work therefore provides the foundation for clinical applications of our 
metrics to evaluate, monitor and quantify clinical changes in brain state, such as the effects of a 
drug, progression of a disease, or response to therapy in individual patients. These very 
tangible applications will soon follow as I lay out my plans for future studies.  
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CHAPTER 1: Cerebral blood volume changes during the BOLD post-stimulus undershoot 
measured with a combined normoxia/hyperoxia method 
 
 
Abstract  
Cerebral blood flow (CBF) and blood oxygenation level dependent (BOLD) signal 
measurements make it possible to estimate steady-state changes in the cerebral metabolic rate 
of oxygen (CMRO2) with a calibrated BOLD method. However, extending this approach to 
measure the dynamics of CMRO2 requires an additional assumption: that deoxygenated 
cerebral blood volume (CBVdHb) follows CBF in a predictable way. A test-case for this 
assumption is the BOLD post-stimulus undershoot, for which one proposed explanation is a 
strong uncoupling of flow and blood volume with an elevated level of CBVdHb during the post-
stimulus period compared to baseline due to slow blood volume recovery (Balloon Model). A 
challenge in testing this model is that CBVdHb differs from total blood volume, which can be 
measured with other techniques. In this study, the basic hypothesis of elevated CBVdHb during 
the undershoot was tested, based on the idea that the BOLD signal change when a subject 
switches from breathing a normoxic gas to breathing a hyperoxic gas is proportional to the 
absolute CBVdHb. In 19 subjects (8F), dual-echo BOLD responses were measured in primary 
visual cortex during a flickering radial checkerboard stimulus in normoxia, and the identical 
experiment was repeated in hyperoxia (50% O2/balance N2). The BOLD signal differences 
between normoxia and hyperoxia for the pre-stimulus/baseline, stimulus, and post-stimulus 
periods were compared using an equivalent BOLD signal calculated from measured R2* 
changes to eliminate signal drifts. Relative to the pre-stimulus baseline, the average BOLD 
signal change from normoxia to hyperoxia was negative during the undershoot period 
(p=0.0251), consistent with a reduction of CBVdHb, and contrary to the prediction of the Balloon 
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Model. Based on these results, the BOLD post-stimulus undershoot does not represent a case 
of strong uncoupling of CBVdHb and CBF, supporting the extension of current calibrated BOLD 
methods to estimate the dynamics of CMRO2. 
 
1. Introduction 
Functional magnetic resonance imaging (fMRI) based on measurement of the blood-
oxygenation level dependent (BOLD) signal is widely used for mapping patterns of activation in 
the human brain. However, interpretation of the BOLD response in terms of the underlying 
physiological changes is challenging due to the complexity of the signal. The BOLD signal is 
primarily due to a change in total deoxyhemoglobin (Buxton, 2013), determined by changes in 
cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2), and cerebral blood 
volume (CBV).  
Although the physiological ambiguity of the BOLD signal is a major challenge for 
interpreting BOLD data alone, it offers the potential for a deeper probe of the physiology when 
combined with an additional independent measurement of CBF using an arterial spin labeling 
(ASL) method. The CBF and BOLD measurements, combined with an appropriate calibration 
measurement, make it possible to estimate CMRO2 changes (Davis et al., 1998). 
Measurements of CMRO2 are challenging with any methodology, and this calibrated BOLD 
approach is now a leading tool for probing oxygen metabolism in the human brain (Pike, 2012). 
However, a confounding effect for measuring CMRO2 changes is a change in CBV, which also 
affects the BOLD signal. Typically, calibrated BOLD studies measure changes between two 
steady-states, with the assumption that the CBV can be assumed to follow CBF in a steady-
state relationship based on previous measurements; this is usually modeled as a power law 
relationship (Grubb et al., 1974). Extending the calibrated BOLD approach to measure the 
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dynamics of CMRO2 involves a key question: does CBV dynamically follow CBF, so that the 
dynamics of CBV can be taken into account in the analysis? 
The BOLD post-stimulus undershoot has been a prime example of the ambiguity of 
separating CMRO2 and CBV effects in the BOLD response. The undershoot is a reduction, 
relative to the baseline, of the BOLD signal after the end of the stimulus that may persist for tens 
of seconds before the signal returns to baseline. The phenomenon has been observed since the 
beginning of fMRI (Kwong et al., 1992), and yet there is still no consensus in the field on the 
physiological origin of the undershoot (van Zijl et al., 2012). Possible interpretations include a 
slow recovery of CBV (Buxton et al., 1998; Mandeville et al., 1999), a slow recovery of CMRO2 
(Frahm et al., 2008; van Zijl et al., 2012), or a CBF undershoot (Jean J. Chen and Pike, 2009). 
For extending calibrated BOLD methods to measuring the dynamics of CMRO2, two of these 
possibilities are not a problem because different dynamics of CBF and CMRO2 could potentially 
be untangled with simultaneous measurements of CBF and BOLD dynamics. The problem is 
the first hypothesis, an uncoupling of CBV and CBF, with CBV recovering to baseline more 
slowly than CBF and CMRO2. The BOLD post-stimulus undershoot thus presents an important 
test case: if the undershoot is due to a mechanism such as delayed CBV recovery—an 
extended transient uncoupling of CBF and CBV—then dynamic measurements of CMRO2 are 
problematic. 
Experimentally testing for a transient uncoupling of CBF and CBV has its own 
challenges; specifically, exactly what is meant by blood volume? The BOLD response is 
determined by how deoxyhemoglobin (dHb) leads to relaxation of the net signal. The relevant 
blood volume is a dHb-weighted average over all vascular volumes (CBVdHb), dominated by 
venous vessels, but also including capillaries and some contribution from partially deoxygenated 
arterioles. In simple models of the BOLD effect, CBVdHb is often taken as the venous blood 
volume, where the blood is most deoxygenated, but other blood compartments also contribute. 
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Averaging over blood compartments is further complicated by the effects of diffusion near the 
smallest vessels, where a given amount of deoxyhemoglobin in a capillary will have less of an 
effect on relaxation than it would if it were in a larger vein (Buxton, 2013). For this reason, the 
correspondence between CBVdHb and standard anatomical vascular compartments is somewhat 
complicated. Measurements of total CBV may be a poor reflection of CBVdHb, and while 
measurements of venous CBV should capture the dominant contribution to CBVdHb, some 
contributions will be missed. Nevertheless, most of our current understanding of CBV dynamics 
is based on measurements of anatomical vascular compartments (Buxton et al., 1998; Drew et 
al., 2011; Kim and Kim, 2011; Mandeville et al., 1998). 
Here, we report results using a promising approach for a more definitive test of CBVdHb 
dynamics based on the effects of hyperoxia (Blockley et al., 2013, 2012). This approach exploits 
the idea that increasing the arterial pO2 leads to a decrease in the tissue relaxation rate R2*  
—a hyperoxia-BOLD effect—that is proportional to the deoxygenated blood volume. In the 
context of a detailed framework for the BOLD response developed by Griffeth et al. (Griffeth and 
Buxton, 2011), a new interpretation of the R2* change with hyperoxia as a direct reflection of 
CBVdHb was developed by Blockley and colleagues (Blockley et al., 2015, 2013, 2012). The 
essential idea is that the added arterial concentration of O2 as dissolved gas diffuses quickly into 
tissue, offsetting the amount of oxygen needed to be removed from hemoglobin. This raises 
hemoglobin saturation in all blood compartments that contain deoxyhemoglobin in the normoxic 
state. This change in saturation, however, only weakly depends on resting OEF or hematocrit 
(Blockley et al., 2013). The R2* difference for a particular state in hyperoxia versus normoxia is 
then directly proportional to CBVdHb, with a proportionality constant that depends on the global 
change in arterial pO2 (Blockley et al., 2013). The hyperoxia approach offers a way to test 
CBVdHb dynamics by measuring the response to a stimulus in both normoxia and hyperoxia, and 
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comparing the BOLD signal difference between hyperoxia and normoxia at different time points 
in the response.  
We measured responses to a visual stimulus in both normoxia and hyperoxia and 
calculated the hyperoxia-BOLD effect, the change in R2* (∆R2*) between hyperoxia and 
normoxia (∆R2* = R2*hyperoxia – R2*normoxia), at each time point in the baseline, stimulus, and post-
stimulus periods. Ideally, ∆R2* should be proportional to absolute CBVdHb at each time point. 
However, other confounding factors associated with hyperoxia, such as additional changes in 
R2* related to gas delivery or physiological changes in CBF and CMRO2, may lead to an overall 
shift of R2* between normoxia and hyperoxia. To minimize such effects, we focused on the 
difference between ∆R2* during the undershoot (or during the stimulus) and ∆R2* for the 
baseline state, reflecting the absolute volume change ∆CBVdHb from baseline. The prediction of 
the Balloon Model is that CBVdHb is elevated compared to baseline during the undershoot, which 
in turn predicts that ∆R2* should be larger in the undershoot state than the baseline state. Our 
primary finding was the opposite pattern, arguing against an elevated blood volume. However, 
the cost of dealing with a measurement sensitive to CBVdHb rather than anatomical vascular 
compartments is that the signal changes are small, and hyperoxia may produce additional 
effects that could alter the measurements. To aid in the interpretation of this result we also 
include modeling to define the predicted measurements and explore different potential 
confounding effects.  
 
2. Methods 
The primary experiment involved measuring stimulus responses under conditions of 
hyperoxia and normoxia. In addition, the study included a hypercapnia measurement as part of 
the protocol to perform a calibrated BOLD experiment (Davis et al., 1998) needed for the 
modeling aspects of the study.   
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2.1 Subjects 
Twenty-one healthy adults were recruited for the study. Two subjects were eliminated 
from the analyses because inspired and end-tidal O2 and CO2 measurements revealed leaks in 
the tubing or non-rebreathing facemask. Thus, the study sample included 19 subjects (8 female, 
mean age=24.9 years, range 20-31 years). The study was approved by the Human Research 
Protections Program of the University of California, San Diego; written informed consent was 
obtained from all subjects. Subjects were remunerated for their participation. 
  
2.2 Gas administration 
Inspired and end-tidal O2 and CO2 were monitored for all subjects throughout the run 
using a Perkin Elmer 1100 medical gas spectrometer (Perkin Elmer, Waltham, MA). Subjects 
were equipped with a non-rebreathing facemask (Hans Rudolph, KS, USA). The inspiratory port 
of the mask was connected to large gas-tight balloons (VacuMed, CA, USA), pre-filled with the 
appropriate gas mixtures. Gas mixtures were purchased pre-mixed (Airgas-West, CA, USA); the 
hyperoxic condition utilized 50% O2, balance N2, while hypercapnia was 5% CO2, 21% O2, 
balance N2. The tubing (VacuMed, CA, USA) was disconnected to allow the subject to breathe 
normal room air in the normoxic condition.  
 
2.3 Imaging 
A dual-echo spiral PICORE QUIPSS II ASL acquisition (Wong et al., 1998) was used to 
acquire simultaneous BOLD and ASL dynamic images on a General Electric (GE) Discovery 
MR750 3.0T scanner. The acquisition prescription consisted of 7 axial slices (5 mm thick/1 mm 
gap) covering the occipital cortex, centered around the calcarine sulcus, with TR=2500ms, 
TI1=700ms, TI2=1750ms, TE=3.3/30ms, 90° flip angle, FOV 256mm, and matrix 64x64. A field 
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map was acquired using the same slice prescription to correct distortions in the spiral 
acquisition due to magnetic field inhomogeneity (Noll et al., 2005). Physiological monitoring was 
performed throughout the scan session using a pulse oximeter for cardiac cycle monitoring and 
respiratory bellows for respiratory dynamics (GE MR750 built-in). A cerebral spinal fluid (CSF) 
reference was obtained for CBF quantification (Chalela et al., 2000; Liu et al., 2004; Perthen et 
al., 2008) using a single-shot EPI acquisition (TE = 3.3ms, TR = 4000ms); a minimum contrast 
scan (eight-shot spiral acquisition, TE=11ms, TR=2000ms) was acquired to map and correct for 
transmit and receiver coil inhomogeneities (Wang et al., 2005). These latter acquisitions used 
the same prescription as the ASL acquisition. A high resolution T1-weighted anatomical scan 
(FSPGR) was acquired for each subject for image registration. 
 
2.4 Stimulus paradigm   
The task used to elicit neural activity in the occipital lobe (V1) was a black and white 
flickering radial checkerboard presented using MATLAB (2014a, The MathWorks, MA, USA) 
with the Psychophysics Toolbox extensions (Brainard, 1997; Pelli, 1997). The checkerboard 
contrast and luminance were as described in previous work (Simon et al., 2016); the central 
region, with visual angle ~1.5°, was maintained at iso-luminant gray, with 6 Hz light-dark 
reversal frequency. The subject could view the stimulus, projected onto a screen, through a 
mirror set atop the head coil.   
The study consisted of an 18-min run during which both BOLD and CBF-weighted 
images were acquired. The run was composed of a 3-min functional localizer, a 
normoxia/normocapnia (room air) block, a hypercapnia block, and a hyperoxia block. See 
Figure 1.1A for a representation of the run design. Throughout the run, subjects fixated on a 
cross projected in the center of the screen, on top of which single digit numbers were 
superimposed for a 1-back task. Subjects performed the task (Kirchner, 1958) continuously 
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throughout the run. The 1-back task consisted of random single digit numbers displayed at 1-
sec intervals; subjects were instructed to press a button on a response box each time they 
observed the same digit displayed sequentially. The 1-back task was used solely to help the 
subjects maintain fixation and wakefulness, and was not treated as an activation task in any of 
the analyses. The 3-min functional localizer consisted of three 30-sec ON/30-sec OFF blocks of 
the visual stimulus to strongly activate the visual cortex. Following the localizer and a 1-min 
baseline, the 4-min normoxia block was presented that consisted of two 1-min ON/1-min OFF 
blocks of the visual stimulus while the subject breathed room air. Next, a 3-min hypercapnia 
challenge was conducted, with the subject breathing the hypercapnia mixture in the baseline 
state. After hypercapnia administration, subjects were switched to breathing the hyperoxia 
mixture. Two minutes were allowed for gas equilibration. The final segment was a 1-min 
baseline and 4 minutes of 1-min ON/1-min OFF blocks of the visual stimulus in hyperoxia. 
 
2.5 Data Analysis 
2.5.1 Constructing separate CBF and BOLD images: Raw ASL images were first 
distortion corrected using the field map acquisition to account for inhomogeneity in the magnetic 
field (Noll et al., 2005). The time series data were motion corrected and registered to one image 
in the 18-min run using AFNI software (Cox, 1996). The first four images of the run were 
discarded to allow the signal to reach steady state. Minimum contrast images were used to 
correct ASL data for coil sensitivity inhomogeneity (Wang et al., 2005). Applying surround-
subtraction to the raw first-echo ASL images produced CBF-weighted images with minimal 
contamination from BOLD (Liu and Wong, 2005).  BOLD-weighted images were constructed for 
both echoes with a surround average of the ASL time series, designed to minimize CBF-
weighting (Liu and Wong, 2005). 
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2.5.2 Region of interest (ROI) responses: ROIs were generated using the CBF-weighted 
images and the second echo BOLD responses to the 3-min functional localizer. A general linear 
model approach, described by Perthen et al. (Perthen et al., 2008), was used for ROI selection. 
The pattern of the stimulus was convolved with a gamma density function to produce a stimulus 
regressor (Boynton et al., 1996). A constant and a linear term were used as nuisance 
regressors. A gray matter mask was generated from the average CBF with a cut-off of 2 times 
the mean of the average CBF across all slices. ROI selection was also restricted to the posterior 
third of the brain. Voxels exhibiting both CBF and BOLD were selected using an overall 
significance threshold of p=0.05 and minimum cluster size of 4. In this way, an active visual ROI 
defined solely from voxels activated by the functional localizer was identified for each subject 
based on exhibiting both CBF and BOLD activation independently. ROI-averaged CBF-weighted 
and first and second echo BOLD-weighted time series were generated for each subject. Due to 
the long duration of the run, we removed a linear baseline from the data calculated as a fit to the 
baseline periods, defined as the mean of the 15 seconds of rest before the first normoxia visual 
stimulus (at the 4-min mark), the 15 seconds of rest before the second normoxia visual stimulus 
(at the 6-min mark), and the 15 seconds of rest before the CO2 stimulus onset (at the 8-min 
mark). Each time series was normalized to the average baseline value after the correction for 
linear drift. These normalized values were used for all subsequent analyses. For the CBF data, 
we expected there to be an artifactual lowering of the ASL signal due to the T1 shortening effect 
of hyperoxia. Based on the work of Bulte and colleagues (Bulte et al., 2007), we took estimates 
of the T1 of blood as 1.66 sec for air and 1.50 sec for the FiO2=0.5 of our experiment. In our 
pulsed ASL method we expect the ASL signal to be attenuated approximately by an exponential 
in TI2/T1 (Wong et al., 1998), giving an estimated correction factor of 1.12 between breathing air 
and breathing the hyperoxic mixture. The apparent CBF values were multiplied by this factor 
beginning with data points at the 11-min mark, when hyperoxia was administered. 
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2.5.3 Quantitative R2* measurements: For the ROI, a time series of R2* was calculated 
from the first and second echo BOLD time series as: !"∗ $ = &'( ) *+,) *+" /(/02 − /01)&, where 
S(TE1) and S(TE2) are the signals at the first and second echoes at time t during the run. One 
advantage of working with R2* is that it removes systematic effects of drift that scale both echo 
intensities in the same way. The average value over the defined baseline periods was 
calculated and subtracted to form a time series !R2*(t). For some of the subsequent analyses 
we converted !R2*(t) back to an equivalent “cleaned” BOLD signal without the drift effects 
as:&56 $ ≅ −/02 ∙ 5!"∗ $ . 
2.5.4 Hyperoxia-BOLD response ("BOLDh-n). Here we define the hyperoxia-BOLD 
response for a given state ∆R2*h-n as the difference between !R2* measured during hyperoxia 
and !R2* measured during normoxia. These values ∆R2*h-n were converted to equivalent 
hyperoxia-BOLD responses ("BOLDh-n). For each gas condition the two visual stimulus blocks 
were averaged. The resulting data are a 2.5-min time course consisting of a 30-sec baseline, 1-
min visual stimulus, and 1-min undershoot period and return to baseline. We focused on the 
average change for three states: Baseline, defined as the mean of the 30-sec window before 
onset of the visual stimulus and the last 15 seconds of the 1-min rest window after stimulus 
termination; Activation, defined as the last 30 seconds of the stimulus block; and Undershoot, 
defined as starting 10 seconds after the end of the stimulus and continuing for 30 seconds. For 
each period, the average "BOLDh-n was calculated. Based on the modeling of the effects of 
hyperoxia (Blockley et al., 2013), for the ideal experiment each of these "BOLDh-n values should 
be proportional to the absolute CBVdHb in that state. In practice, we expect that additional effects 
of administering hyperoxia may lead to an additional shift of R2* (Pilkinton et al., 2011). To 
minimize this effect we focused on the difference of "BOLDh-n values between the baseline and 
the activation and undershoot states.  
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2.5.5 CO2 responses. For each subject the ROI-averaged BOLD and CBF responses to 
hypercapnia were calculated from the mean of the baseline period, taken as the 30-sec window 
prior to administration of CO2, and from the mean of the CO2 period, taken as the 2-min window 
at the end of the CO2 inhalation block (one minute after onset of CO2 administration).  
 
3. Results 
3.1 Experimental results 
Subject inhalation of the hyperoxic gas mixture produced a measured difference in end-
tidal pO2 of +189 +/- 15 mmHg compared to normoxia. The average CBF and R2* time courses 
are shown in Figure 1.1. In the baseline state the mean R2* in the selected ROI was 21.2 +/- 
0.04 s-1, and decreased by 0.13 +/- 0.1 s-1 following inhalation of the hyperoxic gas. The mean 
dynamic R2* curve across subjects is plotted in the top panel of Figure 1.1B, presented as the 
negative of R2* (-R2*) to visually resemble the BOLD response.  
The mean ASL signal in the baseline state decreased by approximately 22% between 
normoxia and hyperoxia. This decrease is likely to be due to a combination of a reduction of the 
T1 of blood due to the added O2 and a reduction of CBF associated with the hyperoxia 
experiment. After the estimated correction for T1 changes was applied, the CBF was still 
reduced in hyperoxia compared with baseline by 13% +/- 5%. There was a significant difference 
(p=0.0009) between the end-tidal CO2 levels of the hyperoxia and normoxia conditions. The 
reduction (3.6%) could be causing the reduced CBF during hyperoxia since decreased CO2 
causes vasoconstriction. 
After converting the R2* measurements to a clean BOLD signal, the average data for the 
activation responses in normoxic and hyperoxic states, and the responses to hypercapnia data, 
are shown in Figure 1.2 as averages across the subjects. Plotted in Figure 1.2A are the 
fractional changes in CBF and BOLD signal (!CBF and !BOLD) from the baseline state during 
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the activation and undershoot periods in each of the normoxic and hyperoxic gas conditions. In 
Figure 1.2A, the shifted axes for the hyperoxia plot (red dashed lines) indicates the change in 
CBF and BOLD induced purely by administering hyperoxia. Baseline shifts for CBF and BOLD 
from normoxia to hyperoxia were -0.13 and 0.0059, respectively, expressed as a fractional 
change from their respective baselines in normoxia (blue dashed lines). Fractional !CBF and 
!BOLD were calculated from the respective gas-state baselines to the stimulus state (activation 
or undershoot).  Table 1.1 summarizes these fractional changes in each gas state and the 
measured CO2 responses.  Figure 1.2B plots the average measured CO2 responses with the 
normoxic responses only (both activation and undershoot) for comparison, with reference lines 
showing various CMRO2 and CBF coupling ratios (n = CMRO2/CBF). 
Dynamics of BOLD and CBF responses in normoxia and hyperoxia are illustrated in 
Figure 1.3. BOLD changes to the visual stimulus (Figure 1.3B, Table 1.1) clearly depict a 
significant undershoot after the stimulus ends in both hyperoxia and normoxia. The hyperoxia-
BOLD effect, the difference between R2* in the hyperoxic and normoxic conditions, is shown in 
(Fig. 1.3C). The change ∆BOLDh-n is significantly negative (Table 1.1) in the undershoot window 
(p=0.0251), and in the activation period there was a strong trend for a positive value that did not 
reach statistical significance (p=0.0509). We also tested these data in a different way, motivated 
by the idea that the Balloon Model predicts that the difference between the activation value and 
the undershoot value should be smaller than the difference between the activation value and the 
baseline value, corresponding to elevated CBVdHb during the undershoot. Calculating this 
difference on an individual subject basis, the activation/undershoot difference was significantly 
larger than the activation/baseline difference (p<0.00001).   
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The CBF in normoxia showed a modest but statistically significant undershoot from 
baseline (p=0.041, Fig. 3A, Table 1.1). There was no significant CBF undershoot in the 
hyperoxia data (p=0.221). 
 
3.2 Modeling results 
To aid with the interpretation of the data, we modeled the BOLD signal change to 
estimate the predicted experimental effects under different scenarios, working with the average 
experimental responses described above. Our primary goal was to address the basic 
hypothesis of the Balloon Model: is the deoxyhemoglobin (dHb)-weighted blood volume 
elevated above baseline in the BOLD post-stimulus undershoot period? 
3.2.1 Modeling the BOLD signal: We used the classic Davis model to estimate the size 
of effects predicted for these experiments (Buxton, 2013; Davis et al., 1998).The BOLD signal is 
modeled as a function of the venous blood volume V and the magnetic susceptibility difference 
between the intravascular and extravascular spaces. This susceptibility difference is assumed to 
be zero when there is no dHb in the vessel, and to increase linearly with the venous dHb 
concentration C. The BOLD signal, the fractional change in signal from a baseline state 
(subscript “0”) and an active state, is modeled as: 56 = −9 :;< − :=;=< ! [1] 
where k is a scaling factor that depends on magnetic field and echo time, and the exponent # is 
meant to capture the average nonlinearity of the effect of deoxyhemoglobin on the measured 
signal. We assume that Eq. [1] can be applied to each of the average signals during the three 
epochs of our experiment (baseline, primary activation, and post-stimulus undershoot) with 
appropriate average values of V and C during those windows. This assumes that the post-
stimulus undershoot is long enough to be treated in a quasi-static way. In normoxia, the O2 
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extraction fraction E can be well-approximated by the change in O2 bound to hemoglobin, so 
that C/C0 = E/E0. The first equation can then be rewritten as: 
56 = > 1 − ::= 00= < !  [2] 
with > = 9:=;=<. For the calibrated BOLD experiment, the volume change V is assumed to be 
proportional to the blood flow F as (Davis et al., 1998; Grubb et al., 1974): ::= = ??= @!  [3] 
Writing the ratio of blood flow in the active and baseline states as f=F/F0, and taking r as the 
ratio of CMRO2 in the two states, the ratio of extraction fractions is E/E0 = r/f. The BOLD signal 
is then: 56 = > 1 − A@B<C< ! [4] 
 
3.2.2 Calibrated BOLD extrapolations: The hypercapnia experiment can be analyzed 
with Eq. [4] and the usual assumption that CO2 inhalation increases CBF but has a negligible 
effect on CMRO2 (r=1). Applying the calibrated BOLD approach, we first tested whether the 
data were of sufficient quality to conclude anything definite about metabolism in the undershoot 
period. That is, if we assume that there is no balloon effect, so that blood volume is always 
coupled to blood flow, are the BOLD and CBF changes in the undershoot more consistent with 
the CBF/CMRO2 coupling in the activation experiment or the CO2 experiment? For the CO2 
experiment, the CBF/CMRO2 coupling ratio n, defined as the ratio of fractional change in CBF to 
fractional change in CMRO2, or (f-1)/(r-1), is assumed to be infinite. From the CO2 experimental 
data, M was calculated from Eq. [4] and assumed values $=0.2 and #=1.3 (J. Jean Chen and 
Pike, 2009; Mark et al., 2011), yielding M = 0.1355; and for assumed values $=0.2 and #=1 
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(Blockley et al., 2015; Griffeth et al., 2013), yielding M = 0.1802. The CBF/CMRO2 coupling ratio 
n=2.25 ($=0.2 and #=1.3) and n=2.41 ($=0.2 and #=1) were calculated from the normoxia 
visual activation data. Assuming that the coupling ratios remain constant for different amplitude 
responses, the expected curves in the BOLD/CBF plane were extrapolated to the undershoot 
region with Eq. [4], shown in Figure 1.2B for assumed values of $=0.2 and #=1. Both curves 
pass through the uncertainty ellipse of the undershoot measurements, so we cannot draw any 
conclusions about CBF/CMRO2 coupling in the undershoot period. The remainder of the 
modeling focused on estimates related to the tests of the Balloon Model prediction of elevated 
blood volume as the source of the BOLD undershoot, based on Eqs. [1-4]. 
3.2.3 Estimating the size of the volume change needed to explain the BOLD undershoot: 
Qualitatively, a negative BOLD response, as in the post-stimulus undershoot, is thought to be 
due to increased dHb relative to the baseline state. The “balloon” aspect of the Balloon Model is 
the prediction that the excess dHb is due to a slowly recovering venous blood volume while CBF 
and CMRO2 have returned to baseline values, so that the extraction fraction E also has returned 
to its baseline value E0. The fractional increase in venous blood volume, V/V0, needed to explain 
the observed BOLD undershoot can be estimated from Eq. [2], once M is determined from the 
BOLD and CBF responses to hypercapnia using Eq. [3] with assumed values for $ and #. 
Figure 1.4A and 1.4B show the results of applying this approach to the observed data for 
several combinations of the assumed values of $ and #. Each scenario used the average 
measured CBF and BOLD responses to hypercapnia and the average BOLD undershoot in 
normoxia as the fixed data. Note that the blood volume change during the stimulus (Activation) 
depends on the choice of $, but the blood volume change needed to explain the BOLD 
undershoot is only weakly sensitive to the choice of $ and #. 
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3.2.4 Modeling the hyperoxia effect on venous dHb: The effect of hyperoxia is to provide 
extra O2 as dissolved gas in plasma that offsets the amount of O2 removed from hemoglobin, 
decreasing dHb in the venous blood. An arterial blood gas measurement was not done, but we 
can estimate the effect of the change in pO2 with plausible assumptions. Assuming arterial 
pO2=100 mmHg with 98% arterial oxygen saturation in normoxia that increased to 100% in 
hyperoxia, a hemoglobin content in arterial blood of 9.3 milliequivalents of O2 per L of blood 
(Davenport, 1974), and a solubility of 0.00135 mM/mmHg of dissolved O2 in arterial blood 
(Valabrègue et al., 2003), the hyperoxia condition produced an average increase of about 0.43 
mM in arterial O2 concentration, or about 4.6%. For comparison, using the same assumptions 
with a normoxic saturation of 98% and a typical baseline O2 extraction fraction of 40%, the 
venous deoxyhemoglobin concentration in normoxia is about 3.7 mM. The added O2 with 
hyperoxia then is expected to produce a decrease of venous deoxyhemoglobin concentration of 
about 12%.  
3.2.5 Modeling the hyperoxia-BOLD effect: We assume that the effect of hyperoxia is to 
lower the venous dHb concentration by a small amount w (Blockley et al., 2013), so that C = C0 
- w, with w estimated above to be about 12% of C0 for these experiments. For the ideal 
hyperoxia experiment there is no change in blood volume due to hyperoxia itself, so that V = V0. 
Then we can apply Eq. [1] to estimate the hyperoxia-BOLD response: 56D" = 9:= ;=< − (;= − E)< ≈ 9:=GE ∙ ;=<B,! [5] 
where the linear approximation applies for w<<C0. For our estimate of w/C0 = 0.12, the 
difference in the estimate of !bO2 differs by only about 2% using the linear approximation 
compared to the full expression in Eq. [5]. Note that because k is a physical constant, and not 
dependent on the particular physiological state, the hyperoxia-BOLD response depends 
primarily on the absolute blood volume V0 in that state and the absolute change of venous dHb 
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concentration w produced by the hyperoxia. This primary effect of blood volume on the 
hyperoxia-BOLD response is the motivation for the current experiments. In practice, though, this 
model predicts there will be an additional weak dependence on the normoxic venous dHb 
concentration C0 through the second term in Eq. [5], and the potential confounding effects of 
this are considered below.  
3.2.6 Estimating the expected hyperoxia-BOLD response: We can estimate the 
magnitude of the hyperoxia-BOLD response for the baseline state where we have more 
complete information about the state from the measurement of M with hypercapnia. Using the 
expression for M in the first modeling section, the hyperoxia-BOLD effect for the baseline state 
is: 
56D" 6HIJ'K(J = >G E;=! [6] 
When interpreting this expression, it is important to remember that the value of M consistent 
with our data depends on the value of # we assume in calculating it. When # is larger, the value 
of M is smaller. As a result, the dependence of Eq. [6] on # is weaker than it at first appears to 
be. For our data, with #=1.0, $=0.2, the product M#=0.180, and with #=1.3 the product 
M#=0.176. Taking the #=1 value, and assuming w/C0=0.12 as estimated above, the estimated 
hyperoxia-BOLD effect for the baseline state is then 0.022. Taking #=1.3, the estimated 
hyperoxia-BOLD effect for the baseline state is then 0.021. We then used this predicted full 
effect of baseline volume to predict the differences from baseline of the activation and 
undershoot hyperoxia-BOLD responses for the predictions of the Balloon Model. That is, the 
estimates of the fractional blood volume changes needed to explain the BOLD undershoot (the 
values plotted in Figure 1.4A) were scaled with the estimated hyperoxia-BOLD effect for the 
baseline state to estimate what the current experiment would show. These estimates are plotted 
in Figure 1.4B. Figure 1.4C shows the mean experimentally observed differences in the 
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hyperoxia-BOLD responses, clearly showing a qualitatively and quantitatively different pattern 
from the Balloon Model prediction.  
3.2.7 Potential systematic errors in the hyperoxia-BOLD effect due to C0: Our primary 
experimental finding is that the hyperoxia-BOLD effect is reduced in the undershoot state 
compared to the baseline state. By the basic interpretation of the hyperoxia-BOLD effect this is 
consistent with reduced venous blood volume in the undershoot period. Could this result be 
biased by systematic errors in the hyperoxia-BOLD response? The modeling above is based on 
a simple model of the BOLD effect, which in its assumptions leaves out important contributions 
to the BOLD signal, such as intravascular signal changes (Griffeth et al., 2013). Nevertheless, 
more detailed compartmental modeling of the BOLD response including these effects showed 
that the Davis model is reasonably accurate for describing these effects provided that M is 
measured experimentally and not estimated from first principles (Griffeth and Buxton, 2011). 
That is, the model expression above for M applies only to the extravascular signal. In general, 
more detailed modeling of the hyperoxia-BOLD response, as done by Blockley and colleagues 
(Blockley et al., 2015, 2013), is needed to better understand the systematic errors that can 
occur in the hyperoxia-BOLD experiment. With that caveat in mind though, the modeling above 
does suggest some potential errors. From Eq. [5], if #>1, the hyperoxia-BOLD effect for a 
particular state will be larger for the same blood volume when the dHb concentration C0 is 
larger. In our experiment, if there were no blood volume changes at all, this would translate to a 
response pattern opposite to what was observed (Figure 1.3), with the activation hyperoxia-
BOLD response smaller than that of the baseline state because of the reduced C0, and the 
undershoot hyperoxia-BOLD response larger than that of the baseline state because of the 
increased C0. Importantly, for testing the Balloon Model, the prediction is that venous dHb 
concentration is back to the baseline level during the undershoot. In that case, any difference 
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between the baseline and undershoot hyperoxia-BOLD responses should reflect a change in 
the venous blood volume. 
3.2.8 Potential systematic errors in the hyperoxia-BOLD effect due to reduced CBF with 
hyperoxia: We also found a reduction of CBF due to hyperoxia in our experiment. If this led to 
an overall shift of venous dHb concentration across the baseline, activation and undershoot 
states we can again use Eq. [5] to estimate the systematic error produced. If the venous dHb 
concentration is increased by % in each state, Eq. [5] becomes: 
56D" ≈ 9:= ;= + M <B,GE ≈ 9:=GE ∙ ;=<B, 1 + G − 1 M;=  [7] 
when %<<C0. For the limiting case of #=1, the second term depending on C0 goes to one, and 
there is no additional error due to C0 and % effects. Then, the hyperoxia-BOLD response for a 
particular state is simply proportional to the blood volume of that state. Note that for testing the 
Balloon Model, as in the previous section, even if #>1, the prediction is that C0 has returned to 
the baseline value, and then the difference between the hyperoxia-BOLD responses in the 
undershoot and baseline states should still reflect the difference in the respective blood 
volumes. That is, by this model the added effect of an overall change in dHb due to the CBF 
change should not be a confounding factor for testing the prediction of the Balloon Model. Our 
key experimental result is that the hyperoxia-BOLD effect is reduced in the undershoot state 
compared to the baseline state, opposite to the prediction of the Balloon Model and consistent 
with an increase of C0 in the undershoot. Note that if % is not the same in all states, but is 
instead a function of C0, the arguments above related to testing the Balloon Model are not 
substantially changed. To go beyond this basic test, though, and interpret the relative 
magnitudes of the blood volume increase with activation and the blood volume decrease in the 
undershoot, would require careful consideration of the additional effects of C0 and % described 
by Eq. [7].  
 41 
3.2.9 The role of other vascular compartments and the meaning of “deoxygenated CBV”: 
In modeling the BOLD effect, the venous concentration of deoxyhemoglobin plays an important 
role because it is directly related to the O2 extraction fraction, and so ties the BOLD effect to the 
physiological quantities CBF and CMRO2, as described above. In reality, we expect that other 
vascular compartments also contribute to the BOLD effect depending on their volumes and dHb 
concentrations. A way to begin to take into account the complication of multiple vascular 
compartments is to consider an effective dHb-weighted blood volume CBVdHb defined such that 
the venous dHb concentration times this volume accurately approximates the combined effect 
on the BOLD signal of each compartment in the tissue: ;N:OPQ[ST6]V ≈ :W[ST6]W + X:Y[ST6]Y + :V[ST6]V! [8] 
where A, V and C as subscripts refer to the arterial, venous and capillary compartments, and V 
and [dHb] as variables refer to the volume and mean deoxyhemoglobin concentration within 
those compartments. This approximate form retains the central role of the venous dHb 
concentration, and its connection to CBF and CMRO2, while expanding the idea of the blood 
volume to include the effects of other compartments. In this equation we have included an 
additional parameter & to model the fact that a given total dHb in capillaries has less of an effect 
on the BOLD signal than the same total amount of dHb in larger vessels because of motional 
narrowing due to diffusion around the smallest vessels (Buxton, 2013). This limits the 
contribution of capillaries, effectively equivalent to a lower capillary volume than the anatomical 
capillary volume. In the hyperoxia experiment, the dHb concentration in each compartment will 
go down, and the resulting hyperoxia-BOLD effect will have contributions from each of the 
vascular compartments, again with the capillary contribution downgraded by &. In this way, the 
hyperoxia-BOLD effect is expected to sample all the vascular compartments that contain dHb in 
the normoxic state, although the precise contribution of each compartment will depend on 
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exactly how much the dHb concentration is changed in each compartment. In short, although 
our earlier modeling considered only the venous compartment, these arguments suggest that 
the hyperoxia-BOLD experiment is also sensitive to dHb in other blood compartments as well, 
so that the measured blood volume likely reflects more of CBVdHb than just venous blood 
volume.  
 
4. Discussion 
This study helps to establish a foundation for estimating the dynamics of oxygen 
metabolism (CMRO2) in the human brain based on measuring the dynamics of blood flow (CBF) 
and the BOLD response. In principle, this is possible if the dynamics of the deoxygenated blood 
volume (CBVdHb) are assumed to closely follow the dynamics of CBF. If not, the unknown 
dynamics of CBVdHb will always be a major confounding effect for isolating the dynamics of 
CMRO2. The BOLD post-stimulus undershoot is a prime example where significant uncoupling 
of CBVdHb and CBF has been hypothesized. The Balloon Model (Buxton et al., 1998) and the 
delayed compliance Windkessel model (Mandeville et al., 1999) predict that this phenomenon is 
due to elevated venous CBV in the presence of normalized or reduced CBF (Buxton et al., 
1998). For this reason, we took the post-stimulus undershoot as an important test case; 
specifically, is CBVdHb elevated during the undershoot? While there are several methods for 
measuring total CBV, isolating the deoxyhemglobin-weighted fraction is more challenging. 
Previous modeling studies (Blockley et al., 2013) found that the hyperoxia-BOLD response, the 
change between normoxia and hyperoxia in a particular state, is proportional to CBVdHb in that 
state. We measured the activation and undershoot responses to a visual stimulus in both 
normoxia and hyperoxia, and then compared the hyperoxia-BOLD response in the undershoot 
to that in the baseline state. The Balloon Model predicts that this response should be larger in 
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the undershoot period, but our experimental finding was that it is significantly smaller, arguing 
against a slowly recovering blood volume during the undershoot.  
To further inform the interpretation of this result, we used a model of the BOLD effect to 
predict the magnitude of the blood volume change that would be required to explain the BOLD 
undershoot, and then to estimate how that blood volume change would translate to the 
hyperoxia-BOLD effect measured here. The modeling was also used to consider potential 
systematic errors involved in interpreting the hyperoxia-BOLD effect as a pure reflection of 
blood volume. For example, in our experiment we found that hyperoxia administration reduced 
CBF, and our concern was whether this additional effect would confound our test of the Balloon 
Model. The modeling suggests that the hyperoxia experiment is relatively robust for testing the 
prediction of the Balloon Model, because that prediction primarily depends on whether the 
hyperoxia-BOLD response in the undershoot is greater than or less than the hyperoxia-BOLD 
response in the baseline state. However, extending the interpretation to quantitative estimates 
of the volume changes in different states would require more extensive modeling of the 
experiment. 
 
4.1 Origin of the BOLD post-stimulus undershoot 
Our findings show no evidence of elevated CBV during the post-stimulus undershoot, 
and are consistent with previous studies using techniques sensitive to total CBV in humans 
(Frahm et al., 2008; Lu et al., 2004; van Zijl et al., 2012). Our data also are consistent with a 
study using a different method, venous refocusing for volume estimation (VERVE) (Stefanovic 
and Pike, 2005), specifically focused on venous CBV changes in humans. In the latter study, for 
a visual stimulus there was evidence for increased venous CBV during the stimulus, but no 
evidence for increased venous CBV during the post-stimulus period.   
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If slow CBV recovery is not the dominant cause of the post-stimulus undershoot, it is likely to be 
due to some combination of reduced CBF and a slow recovery of CMRO2. In most studies, the 
interpretation of the two possibilities hinges on whether there is a detectable undershoot of CBF. 
If not, then elevated CMRO2 is implicated (Frahm et al., 2008; Hua et al., 2011; Lu et al., 2004; 
van Zijl et al., 2012). Our experimental results indicate that blood volume is decreased during 
the undershoot, which would be consistent with a CBF decrease and coupled blood flow and 
blood volume. We also found a modest but statistically significant undershoot of CBF in 
normoxia, but not during hyperoxia. The difference between these two undershoot signals was 
not statistically significant. In addition, our modeling results suggest that we should be cautious 
about interpreting the relative magnitudes of the hyperoxia-BOLD effect between states as a 
pure reflection of blood volume when the venous oxygenation varies between the states, as 
would be the case during the BOLD undershoot if CBF is reduced or CMRO2 is elevated. For 
these reasons, we cannot conclude anything about the quantitative coupling of blood flow and 
blood volume during the undershoot, except to note that the data are consistent with a reduction 
of both. Previous human studies have found statistically significant undershoots of CBF during 
the BOLD undershoot (Jean J. Chen and Pike, 2009; Griffeth and Buxton, 2011). Recent work 
by Mullinger and colleagues (2017) using simultaneously recorded EEG, BOLD, and CBF 
responses to visual stimuli provided evidence for a CBF undershoot with a decrease in the 
CBF/CMRO2 coupling ratio in the post-stimulus phase compared with the primary stimulus 
phase. 
 
4.2 Blood volume dynamics 
Beyond the phenomenon of the post-stimulus undershoot, the more general question is 
whether a venous component of CBV changes more slowly than CBF. Two animal model 
studies, based on anatomical measurements of venous vessels (Drew et al., 2011) and 
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magnetization transfer (MT)-varied BOLD and contrast-agent fMRI techniques (Kim and Kim, 
2011), found evidence for a slow expansion and recovery of venous CBV with a time constant 
on the order of 40 seconds, so that this effect was only observable with long stimuli. This was 
consistent with other anatomical studies, which found no change in venous CBV for shorter 
stimuli (Devor et al., 2007; Hillman et al., 2007). In a recent study in humans, our group looked 
at continuously varying stimuli with periods ranging from 6.3 seconds to 44 seconds over long 
time periods (~5 minutes), measuring the dynamics of BOLD and CBF (Simon and Buxton, 
2015). Venous CBV was not measured, but the consistency of coupling of CBF and BOLD 
across stimuli could be used to test for the presence of a slow component, which could be due 
to either venous CBV or CMRO2. Interestingly, across different oscillation periods the coupling 
was consistent (no evidence of a slow component), but across the full 5 minutes of the run there 
was evidence of a component an order of magnitude slower to develop than CBF. Taken 
together, these studies suggest that there is a slow component of CBV change that only 
becomes important with very long stimuli. In our current study, the SNR was not sufficient to 
detect the effects of such a slow CBVdHb change during the 1-min stimulation. 
 
4.3 Limitations of the current study 
This study has several limitations, a primary one being that the signal changes involved 
in estimating CBVdHb changes are quite small, so comparing exact magnitudes of change is 
likely to be unreliable with these data. Nevertheless, this is a method that is specifically sensitive 
to deoxygenated CBV, and the sign of the measured changes argues against the undershoot 
being primarily due to elevated venous CBV. The original theoretical treatments of the effects of 
hyperoxia focused on changes due to hyperoxia when the underlying physiology remained 
constant (Blockley et al., 2013). Here we have extended that idea to looking at each segment of 
a dynamic response as a sequence of physiological steady-states. While this is plausible for the 
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long positive response during the stimulus, it is not as clear that this is justified for the 
undershoot period. More detailed modeling is needed to address this assumption. In addition, 
hyperoxia itself can alter both the physical and physiological state. The act of breathing elevated 
O2 can subtly alter magnetic field gradients with an uncertain effect on the MR signal. More 
importantly, hyperoxia can alter the physiological state. In our study, we found a reduction of 
CBF due to hyperoxia. Potentially the use of additional control hardware for gas delivery that 
clamps arterial pO2 and pCO2 values would have prevented the CBF change. We assumed that 
these additional effects of hyperoxia created an unknown artifactual offset of !R2* in moving 
from the normoxic to the hyperoxic condition, and that this was the same across the baseline, 
activation and undershoot states. Our modeling, however, indicates that this effect could vary 
depending on the venous deoxyhemoglobin concentration. Importantly, though, this is not a 
confounding effect for the basic test of the Balloon Model, because the prediction is that venous 
deoxyhemoglobin concentration has returned to the baseline value. In short, the hyperoxia 
method remains a relatively robust test of the Balloon Model, but we should be cautious in 
interpreting the magnitude of the blood volume changes between states from these data. More 
detailed modeling may enable a more detailed interpretation of these data. 
 
5. Conclusions 
We found no evidence of a slower recovery of blood volume during the BOLD post-
stimulus undershoot period, contrary to the prediction of the Balloon Model. Taken together with 
a wide range of studies in humans and animal models, the emerging picture is that slow 
changes in venous blood volume occur only for extended duration stimuli. This has important 
implications for estimating the dynamics of oxygen metabolism from dynamic CBF and BOLD 
measurements, and provides support for two key assumptions: 1) for stimuli of modest duration 
(<1-min), the slow component of blood volume change can be neglected, and 2) the faster 
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blood volume changes track with the CBF change. While more work is needed to fully justify 
these assumptions, this emerging view opens the door for measurements of the dynamics of 
oxygen metabolism in the human brain that are not possible with any other method.  
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Figure 1.1: Experimental design and raw data. (A) Schematic of normoxic, hyperoxic, and 
calibrated BOLD hypercapnic gas experiments with visual stimuli (a 6 Hz flickering 
checkerboard was presented in 1-min ON blocks repeated twice, with 1-min OFF blocks 
between) and functional localizer. CBF and BOLD responses were acquired simultaneously with 
PICORE QUIPSS II (Wong et al., 1998) (TR=2500ms, TI1=700ms, TI2=1750ms, TE=3.3/30ms).  
(B) Top: Average BOLD response (19 subjects) expressed as –R2* over the entire 18-min 
sequence. Bottom: Average CBF response over entire 18-min sequence. CBF values have 
been adjusted to correct for decreased T1 of blood due to hyperoxia beginning at the 11-min 
mark (Bulte et al., 2007). 
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Table 1.1: Summary of average CBF and BOLD values in visual activation window, 
undershoot window, and CO2 administration window. P-values are representative of 
difference from zero.   
 
BOLD changes!
! Fractional change! Standard error! P-value!Activation!
BOLDnormoxia + 0.0257 0.002 < 0.00001!
BOLDhyperoxia + 0.0276 0.002 < 0.00001!
∆BOLDh-n + 0.002 0.001 0.0509!
Undershoot!
BOLDnormoxia - 0.0049 0.0006 < 0.00001!
BOLDhyperoxia - 0.0068 0.0007 < 0.00001!
∆BOLDh-n - 0.002 0.0008 0.0251!
CO2!
BOLDCO2 + 0.0306 0.003 < 0.00001!
CBF changes 
 Fractional change Standard error P-value 
Activation!
CBFnormoxia + 0.603 0.038 < 0.00001!
CBFhyperoxia + 0.608 0.048 < 0.00001 
∆CBFh-n + 0.005 0.002 0.883 
Undershoot 
CBFnormoxia - 0.0421 0.020 0.0414 
CBFhyperoxia - 0.0278 0.023 0.221 
∆CBFh-n + 0.0143 0.0006 0.658 
CO2 
CBFCO2 + 0.262 0.024 < 0.00001 
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Figure 1.2: CBF and BOLD changes. (A) Mean fractional BOLD and CBF (!BOLD, !CBF) 
changes in activation and undershoot periods during normoxia and hyperoxia (19 subjects). 
Error bars reflect standard deviation. Separate axes are depicted for the normoxia (blue dashed 
lines) and hyperoxia (red dashed lines) experiments to demonstrate the shift in baseline BOLD 
and CBF with the application of hyperoxia. The data points for average activation and 
undershoot levels are then plotted on the corresponding gas state’s axes, as indicated by 
matching color. Ellipses show 95% confidence interval around means. (B) Teal data point 
represents flow and BOLD change in the hypercapnia experiment. Ellipses around each data 
point indicate 95% confidence interval. Dashed lines indicate regions of similar relationship 
between BOLD and CBF, and thus CBF and CMRO2 coupling (n = CMRO2/CBF), given the 
possible range of error and M=0.18 (calculated from BOLD/CBF measurements during 5% CO2 
calibration), $=0.2, and #=1. 
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Figure 1.3: CBF, BOLD, and CBVdHb dynamics. (A) The CBF and (B) BOLD time courses 
before, during, and after visual stimulation. Curves shown here represent the average of two 
stimulus blocks from the two gas conditions; dotted lines above x-axes indicate time range over 
which measurements were averaged for the respective windows. Average values and standard 
errors across subjects are presented as circles and error bars on the curves and summarized in 
Table 1.1. CBF increases significantly during the visual stimulus, with no statistical difference in 
CBF between normoxia and hyperoxia, and a significant undershoot in normoxia CBF. BOLD 
increased with the visual stimulus and showed typical post-stimulus undershoot (normoxia). P-
values refer to significance of difference between hyperoxia and normoxia value. (C) Difference 
curve represents ∆BOLDh-n = BOLDhyperoxia - BOLDnormoxia across stimulus window. P-value refers 
to significance of difference from zero. There was a significant difference between BOLD in 
hyperoxia and normoxia during the undershoot period, leading to significantly negative ∆BOLDh-
n and thus negative ∆CBVdHb. 
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Figure 1.4: Volume dynamics from experimental results compared to Balloon Model. Error 
bars reflect standard error across subjects. (A) Balloon Model prediction of volume dynamics 
needed to explain the observed BOLD undershoot as a volume effect (blue). The Davis model 
was used with the observed BOLD and hypercapnia data, with assumed values $=0.1, 0.2, 0.3, 
and #=1 and #=1.3. Activation period volume (red) calculated using observed CBF data and 
Grubb’s power-law relationship, with assumed $=0.1, 0.2, 0.3. (B) Same data as A plotted in 
units of ∆BOLD per calculation described in section 3.2.6. (C) Experimental results from the 
hyperoxia and normoxia experiments, demonstrating the ∆BOLD from normoxia to hyperoxia as 
reflective of the volume in that state.  
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CHAPTER 2: The potential for gas-free measurements of absolute oxygen metabolism during 
both baseline and activation states in the human brain 
 
Abstract 
Quantitative functional magnetic resonance imaging methods make it possible to 
measure cerebral oxygen metabolism (CMRO2) in the human brain, although current methods 
require the subject to breathe special gas mixtures (hypercapnia and hyperoxia). We tested a 
noninvasive suite of methods to measure absolute CMRO2 in both baseline and dynamic 
activation states without the use of special gases: arterial spin labeling (ASL) to measure 
baseline and activation cerebral blood flow (CBF), with concurrent measurement of the blood-
oxygenation level dependent (BOLD) signal as a dynamic change in tissue R2*; VSEAN to 
estimate baseline O2 extraction fraction (OEF) from a measurement of venous blood R2, which 
in combination with the baseline CBF measurement yields an estimate of baseline CMRO2; and 
FLAIR-GESSE to measure tissue R2¢ to estimate the scaling parameter needed for estimating 
the change in CMRO2 in response to a stimulus with the calibrated BOLD method. Results for a 
study sample of 17 subjects (8 female, mean age=25.3 years, range 21-31 years) are 
described. Primary findings were: OEF values measured with the VSEAN method were in good 
agreement with previous PET findings, and estimates of the dynamic change in CMRO2 in 
response to a visual stimulus were in good agreement between the traditional hypercapnia 
calibration and calibration based on R2¢. These results support the potential of gas-free methods 
for quantitative physiological measurements. 
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1. Introduction 
The blood-oxygenation-level dependent (BOLD) signal has been used extensively for 
mapping changes of neural activity noninvasively in the human brain. However, the 
physiological complexity of the BOLD signal makes interpretation of BOLD data challenging, 
particularly in studies of development and disease. Quantitative fMRI methods, designed to 
measure the two physiological variables underlying the BOLD response—cerebral blood flow 
(CBF) and the cerebral metabolic rate of oxygen (CMRO2)—may paint a more complete picture 
of neural physiology than BOLD alone. CMRO2 reflects the energy cost of neural activity and, 
when paired with CBF, may potentially provide information on the activity of specific neural 
populations (Buxton et al., 2014; Uhlirova et al., 2016b, 2016a). In addition, quantitative 
physiological measurements have the potential to expand clinical applications of fMRI. The 
primary goal of technological development in this area is to measure both baseline values and 
activation changes in CBF and CMRO2 using quantitative physiological units. Quantitative and 
noninvasive measurements of CBF using arterial spin labeling (ASL) methods are now well 
established (Alsop et al., 2015).  The ASL technique provides a noisy measurement of CBF in a 
relatively short time (<10s), so ASL measured over an extended run of several minutes to allow 
signal averaging can provide both a baseline CBF measurement as well as changes in CBF to a 
stimulus or ongoing activity (Griffeth and Buxton, 2011; Liu et al., 2019; Perthen et al., 2008). 
In contrast, measuring CMRO2 is challenging with any technique (Buxton, 2010), and the 
goals of measuring baseline and dynamic change are approached with two different classes of 
methods. The fractional change in CMRO2 can be measured with a calibrated BOLD approach 
based on simultaneous dynamic measurements of ASL and BOLD signals (Davis et al., 1998). 
This approach requires an additional calibration experiment to determine a scaling parameter M 
in the model of the BOLD signal. M depends on the amount of deoxyhemoglobin in the baseline 
state of the individual, and directly scales the BOLD signal measured for that individual for given 
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changes in CBF and CMRO2. With this measured value of M, the CBF and BOLD responses to 
neural activation are analyzed with the same model of the BOLD signal to estimate the 
fractional change in CMRO2. In the classic calibrated-BOLD method, M is calculated on a voxel-
wise or region-of-interest (ROI) basis from measured CBF and BOLD responses to a 
hypercapnia challenge (Davis et al., 1998), with the assumption that the elevated CO2 produces 
a change in CBF with no change in CMRO2. Baseline CMRO2 is approached by measuring the 
baseline oxygen extraction fraction (OEF), and several techniques have been proposed based 
on different ways in which the oxygenation of blood affects the MR signal. A current technique 
uses measurements of the BOLD response to breathing a gas with elevated O2, in conjunction 
with the measurements of the response to CO2 (Bulte et al., 2012; Gauthier and Hoge, 2013; 
Merola et al., 2018; Wise et al., 2013).  
The need to make measurements while the subject breathes controlled gas mixtures in 
the multi-gas approach makes quantitative fMRI a complicated procedure that limits wider 
application of these tools beyond research settings. In addition, wearing gas masks or breathing 
higher concentrations of CO2 and O2 would not be possible in some patient populations. To 
eliminate this barrier to entry into clinical applications, and for more widespread application of 
quantitative fMRI methods in basic brain studies, we evaluated two methods for measuring 
baseline and activation changes in CMRO2 that do not require the subject to breathe special 
gas mixtures. The calibration information to estimate M is based on measurement of tissue R2¢, 
essentially the component of transverse magnetization relaxation that can be reversed with a 
spin echo. Recent theoretical work (Blockley et al., 2015; Blockley and Stone, 2016), based on 
earlier seminal work of Haacke and Yablonskiy (Yablonskiy, 1998; Yablonskiy and Haacke, 
1994), showed that R2¢, like M, essentially depends on the total deoxyhemoglobin content of 
tissue. In this study, R2¢ was measured with a modified FLuid Attenuated Inversion Recovery 
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Gradient Echo Sampling of Spin Echo sequence (FLAIR-GESSE) method (Simon et al., 2016). 
The baseline CMRO2 measurement was done with a technique called Velocity-Selective 
Excitation and Arterial Nulling (VSEAN) (Guo and Wong, 2012) that isolates the signal of local 
venous blood and measures its relaxation rate R2. Because R2 depends primarily on the O2 
saturation of hemoglobin, with an appropriate calibration curve this provides a measurement of 
the local O2 extraction fraction (OEF), and together with a baseline CBF measurement with ASL 
provides a measurement of baseline CMRO2. In this study, we evaluated the combination of 
these two gas-free techniques to make absolute baseline and activation CMRO2 measurements 
as an initial step toward more widespread applications of quantitative fMRI methods. 
 
 
2. Methods 
2.1 Subjects 
Twenty-one healthy adults were recruited for the study. Inspired and end-tidal O2 and 
CO2 were monitored for all subjects throughout the run. Of the 21 subjects, two were eliminated 
from the analyses because inspired and end-tidal O2 and CO2 measurements revealed leaks in 
the tubing or non-rebreathing facemask. Two other subjects exhibited no BOLD or flow change 
to the visual stimulus administration, demonstrating that the visual cortex was not well targeted. 
Thus, the study sample included 17 subjects (8 female, mean age=25.3 years, range 21-31 
years). The study was approved by the Human Research Protections Program of the University 
of California, San Diego; written informed consent was obtained from all subjects. Subjects were 
remunerated for their participation. 
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2.2 Gas administration 
Subjects were equipped with a non-rebreathing facemask (Hans Rudolph, KS, USA). 
The inspiratory port of the mask was connected to a large gas-tight balloon (VacuMed, CA, 
USA), pre-filled with a pre-mixed hypercapnia gas mixture of 5% CO2, 21% O2, balance N2 
(Airgas-West, CA, USA). The tubing (VacuMed, CA, USA) was disconnected to allow the 
subject to breathe normal room air in the normocapnic condition. End-tidal and inspired O2 and 
CO2 were monitored using a Perkin Elmer 1100 medical gas spectrometer (Perkin Elmer, 
Waltham, MA).  
 
2.3 Imaging 
2.3.1 BOLD-ASL. A dual-echo spiral PICORE QUIPSS II ASL acquisition (Wong et al., 
1998) was used to acquire simultaneous BOLD and ASL dynamic images on a General Electric 
(GE) Discovery MR750 3.0T scanner. Seven axial slices (5 mm thick/1 mm gap) covering the 
occipital cortex, centered around the calcarine sulcus, were obtained with TR=2500ms, 
TI1=700ms, TI2=1750ms, TE=3.3/30ms, 90° flip angle, FOV 256 mm x 256 mm, and matrix 
64x64. A field map with the same slice prescription was acquired to correct distortions in the 
spiral acquisition due to magnetic field inhomogeneity (Noll et al., 2005). Physiological 
monitoring was performed throughout the scan session using a pulse oximeter for cardiac cycle 
monitoring and respiratory bellows for respiratory dynamics (GE MR750 built-in).  
2.3.2 VSEAN. The baseline CMRO2 measurement was done with Velocity-Selective 
Excitation and Arterial Nulling (VSEAN) (Guo and Wong, 2012), which isolates the signal of 
local venous blood and measures its relaxation rate R2. Because R2 depends primarily on the 
O2 saturation of hemoglobin, this provides a measurement of the local O2 extraction fraction 
(OEF). This method isolates the signal from venous blood by differentiating static spins from 
moving spins, thus selectively isolating only moving spins. An arterial-nulling module then 
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isolates the venous blood signal, measured with multiple T2-preparations of different effective 
TEs (eTEs) (Guo and Wong, 2012). The sole center slice of the BOLD-ASL prescription was 
used as the single 10mm VSEAN slab. Details of the acquisition are as follows: 
Arterial nulling: A slab-selective inversion pulse (arterial inversion slab thickness = 
150mm) inverted a bolus of arterial blood below the imaging plane, with delay time TI=1150ms 
to allow the inverted bolus of arterial blood to arrive at the imaging plane at the null point of the 
arterial blood longitudinal magnetization. The spins of the tissue and venous blood in the 
imaging slice were unperturbed, giving a stronger venous signal.  
Velocity-Selective Excitation (VSE) for flow signal separation: Two VSE pulse modules 
(one BIR4-based pulse train with velocity-sensitive gradient pulses, the second built into the 
image acquisition) excited and separated moving spins without generating signal from static or 
slow flowing spins.  
T2 measurement and oxygenation estimation: T2 preparation module (VSE/T2 prep with 
eTEs 25/50/75ms, built into the first BIR-4 based VSE module) measured T2 (TR/TE = 
3s/28ms). The T2 values were translated to blood oxygen saturation of hemoglobin Y via a T2-Y 
calibration curve. We used the calibration curve from Zhao and colleagues based on a bovine 
blood sample measured in vitro at 3 Tesla (Zhao et al., 2007). The equation for the curve used 
in this analysis is !"#$ %#$ = 	8.3 + 33.6	 ∙ 	 1 − 0 + 71.9	 ∙ 	 (1 − 0)" (Guo and Wong, 2012). 
The OEF was then taken as 1-Y, based on the assumptions that arterial hemoglobin was fully 
saturated with oxygen and dissolved O2 is negligible compared to hemoglobin-bound O2.  
Other pulse sequence parameters: FOV = 256 mm x 256 mm, matrix = 64 x 64, single-
slice spin echo with spatial-spectral excitation, two slice-selective hyperbolic secant refocusing 
pulses, single-shot spiral readout, ve=2 cm/s in slice-selective direction, slice-selective post-
saturation pulses, 81 acquisitions preceded by two dummy scans and including six “cos” 
modulated reference scans (Guo and Wong, 2012). The total scan time was 4:03.  
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2.3.3 FLAIR-GESSE. We measured R2¢ with a FLuid Attenuated Inversion Recovery 
Gradient Echo Sampling of Spin Echo (FLAIR-GESSE) (Simon et al., 2016) technique. FLAIR-
GESSE, which measures a series of gradient echo samples around a spin echo, follows 
Yablonskiy and Haacke’s GESSE method with two main modifications (Simon et al., 2016). 
First, a CSF-nulling FLAIR module is added to minimize CSF contamination of R2¢ 
measurements. Our previous work has found that CSF-nulling improves the stability of R2¢ 
measurements (Simon et al., 2016). Second, the two sides of the echo are sampled with two 
acquisitions; each has a different spin echo time so that the acquired data are at the same 
absolute time after excitation. This helps correct for problems with multiple T2 values within a 
voxel. Since R2¢ is sensitive to large-scale field inhomogeneity in addition to sub-voxel 
inhomogeneity due to deoxyhemoglobin, field offsets are acquired in the FLAIR-GESSE 
acquisition that are then used to calculate the large-scale field inhomogeneity and remove their 
contribution to the R2¢ estimate (Dickson et al., 2010). The center of each slice from the BOLD-
ASL prescription was used, though for FLAIR-GESSE the slices were 2 mm thick, with a gap of 
4 mm. The pulse sequence parameters include two pairs of GESSE image series, one as an 
early spin echo series (63.6 ms after excitation) and one as a late spin echo series (83.6 ms 
after excitation), collected separately. For each spin echo series, 64 samples of each decay 
curve are collected asymmetrically. CSF nulling is chosen for middle slices, with a TR of 3.5 s, 
inversion time TI of 1.16 s, matrix = 64 x 64, and FOV = 256 mm x 256 mm. Each image slice is 
acquired in ascending order with a spacing of 110 ms. Each of the two spin echo series was 
3:58 in duration. R2¢ was calculated by the method described in Simon et al., 2016. 
2.3.4 Calibration and reference scans. A cerebral spinal fluid (CSF) reference scan using 
a single-echo spiral EPI acquisition (TE = 3.3ms, TR = 4000ms) was obtained for CBF 
quantification (Chalela et al., 2000; Liu et al., 2004; Perthen et al., 2008). A minimum contrast 
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scan (eight-shot spiral acquisition, TE=11ms, TR=2000ms) was made to corrected for transmit 
and receiver coil inhomogeneities (Wang et al., 2005). These reference and calibration scans 
used the same prescription as the ASL acquisition. A high resolution T1-weighted anatomical 
scan (FSPGR) was acquired for image registration and segmentation. 
 
2.4 Stimulus paradigm 
The visual stimulus task used to elicit neural activity in the occipital lobe (V1) was a 
black and white flickering radial checkerboard (6 Hz light-dark reversal frequency) with contrast 
and luminance as described in previous work (Simon et al., 2016). The central region was 
maintained at iso-luminant gray with visual angle ~1.5°. The stimulus was presented using 
MATLAB (2014a, The MathWorks, MA, USA) with the Psychophysics Toolbox extensions 
(Brainard, 1997; Pelli, 1997). The subject viewed the stimulus, projected onto a screen, through 
a mirror set atop the head coil.   
 
2.5 Experimental setup 
BOLD and ASL responses were measured during a baseline task and to a visual 
stimulus in normocapnia. A hypercapnia calibration measurement and separate VSEAN and 
FLAIR-GESSE acquisitions in normocapnia were performed with the baseline task. The 
baseline state for all acquisitions performed in this experiment was a 1-back task (Kirchner, 
1958) projected on a cross at the center of the screen. Subjects fixated at this center cross and 
performed the 1-back task that presented single digits sequentially at random in 1-second 
intervals. The subjects were instructed to press a button on a response box each time they 
observed a number repeated sequentially. As this served as the baseline state, the task was 
performed continuously throughout each acquisition, with the ON or OFF states representing 
the presence of a visual stimulus, which was the flickering checkerboard described above filling 
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the visual field surrounding the center cross. Given the 11-minute duration of the BOLD/ASL 
acquisition, the 1-back task was chosen as the baseline rather than a resting state (visual 
fixation on a cross) to hold the subject’s attention throughout the long scan.   
The BOLD/ASL acquisition consisted of an 11-min run, starting at 
normoxia/normocapnia with 3 blocks of 30-sec OFF/30-sec ON visual localizer at the beginning 
to independently determine an activated visual region of interest (ROI). The following 
experimental stimuli consisted of 2 blocks of 1-min OFF/1-min ON visual stimulus. The final 4 
minutes of the BOLD/ASL acquisition was the calibrated BOLD experiment with a 1-min 
baseline period at normoxia/normocapnia, then a 3-min block of 5% CO2 administration 
(normoxic/hypercapnia). A schematic of the run is shown in Figure 2.1.  
The FLAIR-GESSE and VSEAN acquisitions as described above were all acquired at 
the baseline state (1-back task with no visual stimulus). Calibration and reference scans were 
acquired pre- and post-experimental acquisitions. 
 
2.6 Data preprocessing 
2.6.1 Arterial Spin Labeling (ASL) images: Raw ASL images were first corrected using 
the field map acquisition to account for inhomogeneity in the magnetic field (Noll et al., 2005). 
The functional scan was motion corrected and registered to one image in the 11-minute run 
using AFNI software (Cox, 1996). The first four images of the run were discarded to allow the 
signal to reach steady state. Minimum contrast images were used to correct ASL data for coil 
sensitivity inhomogeneity (Wang et al., 2005). Applying surround-subtraction to the raw first-
echo ASL images produced CBF-weighted images with minimal contamination from BOLD (Liu 
and Wong, 2005), and these were converted to physiological units (ml/100ml/min) using CSF as 
a reference (Chalela et al., 2000). A gray matter mask was determined from the absolute CBF 
with a cut-off of twice the mean of the average CBF. For the visual ROI determination in 2.6.3, 
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the gray matter mask was limited to the posterior third of the brain via a binary wedge-shaped 
mask covering the posterior third. 
2.6.2. BOLD R2*-weighted images: BOLD R2*-weighted images were calculated from 
surround averaging of the first and second echo ASL images (Liu and Wong, 2005) to enable 
calculation of R2* for each time point as previously reported (Liu et al., 2019). For each time 
series, after ROI selection (Section 2.6.3), the mean R2* was subtracted to form a time series 
∆R2*(t), which removed systematic effects of drift that scale identically with both echoes; ∆R2* 
was then converted back to a dBOLD signal without the drift effects (Liu et al., 2019).  
2.6.3 Regions of interest (ROIs): Visual ROIs were generated using the ASL and BOLD 
responses to the 3-min visual functional localizer exclusively, then limited to the center slice that 
was used for VSEAN. A general linear model approach, described by Perthen et al. (Perthen et 
al., 2008), was used for ROI selection. The pattern of the stimulus was convolved with a gamma 
density function to produce a stimulus regressor (Boynton et al., 1996). A constant and a linear 
term were used as nuisance regressors. A mask containing only gray matter voxels, as 
determined in 2.6.1, in the posterior third of the brain was used to further restrict the ROI 
selection. Voxels exhibiting both CBF and BOLD activations were detected using an overall 
significance threshold of p=0.05 and minimum cluster size of 2. Thus, the final visual ROI for 
each subject consisted of a single mask of voxels exhibiting independent activation in both CBF 
and BOLD to the visual stimulus, restricted to gray matter in the posterior third of the brain.  
2.6.4. Average CBF and BOLD changes to stimuli. Average CBF and R2* from BOLD 
(Section 2.6.2) time courses for the ROI were calculated for each subject, producing one-
dimensional BOLD and CBF time courses. The resulting time series were normalized to an 
average baseline value, defined as the mean of the 15 seconds of rest before the first normoxia 
visual stimulus (at the 4-min mark), the 15 seconds of rest before the second normoxia visual 
stimulus (at the 6-min mark), and the 15 seconds of rest before the CO2 stimulus onset (at the 8-
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min mark). These normalized values were used for all subsequent analyses. To allow time for 
the subjects’ inspired and end-tidal gas levels to stabilize and equilibrate, data from the first 
minute of the hypercapnia block were not used subsequently. To derive single estimates of CBF 
and BOLD responses for each subject, the two visual stimulus blocks were first averaged. 
 
2.7 Calibrated BOLD and FLAIR-GESSE analysis 
In the classic calibrated-BOLD method (Davis et al., 1998) to measure the fractional 
change in CMRO2 with activation, the BOLD signal is modeled as: 
56789:;< = = ∙ 1 − (1 + 5>6?)@ $ABCDEFG$ABCHI J      [1] 
where the prefix “d” indicates the change in the variable normalized to the baseline value. The 
scaling parameter M is approximately proportional to the total deoxyhemoglobin content of 
tissue, which could vary across brain regions and across subjects. The parameters a and b 
were originally introduced to describe specific physical effects related to the change in venous 
blood volume and nonlinearities of the magnetic susceptibility effects, respectively (Davis et al., 
1998). However, that original derivation left out several factors affecting the BOLD signal, and 
later studies including these factors found that the mathematical form of Eq. [1] is still valid, but 
the parameters a and b are now thought of more as fitting parameters rather than reflecting their 
original physical meanings (Buxton, 2013; Gagnon et al., 2016, 2015; Griffeth and Buxton, 
2011; Merola et al., 2016). The standard approach is to measure CBF and BOLD responses to 
hypercapnia, and analyze the data with Eq. [1] and the assumptions: 1) there is no CMRO2 
change during hypercapnia; and 2) particular values of a and b, typically a=0.2 and b=1.3 
(Chen and Pike, 2009; Griffeth et al., 2013; Mark et al., 2011). With these assumptions, the 
scaling factor M is then calculated from the hypercapnia data. The activation data are then 
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analyzed with the estimated value of M and the same assumed values for a and b to estimate 
the fractional CMRO2 change to the stimulus.  
In the current study, we compared the classic hypercapnia estimate of M with a 
measurement of R2¢. R2¢ is the reversible component of the transverse relaxation rate, where R2¢ 
@ R2* - R2. R2¢ is sensitive to magnetic field inhomogeneities due to 1) deoxygenated blood 
vessels, proportional to voxel baseline deoxyhemoglobin concentration, like M, and 2) large-
scale inhomogeneities of the head. The inhomogeneity correction was done as in Simon et al., 
2016, and the remaining R2¢ value was interpreted as reflecting deoxygenated blood vessels. 
Neglecting some of the complexities of tissue relaxation, we would expect M¢ @ TE • R2¢ 
(Blockley et al., 2015).  
FLAIR-GESSE data were analyzed per Simon, et al. 2016. The raw GESSE data were 
first averaged across the visual ROI before R2 and R2¢ values were fitted to the averaged data. 
Magnetic field inhomogeneities were corrected per Dickson et al. (Dickson et al., 2010). M¢ was 
calculated from R2¢ values through M¢ @ TE • R2¢. Fractional change in CMRO2 (dCMRO2) to the 
visual stimulus for each individual was calculated per Eq. [1] (a=0.2, b=1.3) using the indiviudal 
M¢ value for each subject, as well as with the group mean M¢, to compare estimates of dCMRO2 
using individual M¢ versus group mean M¢. Meanwhile, the hypercapnia response BOLD data 
were also substituted into Eq. [1] to yield an estimate of M for each subject, calculated for 
a=0.2, b=1.3. dCMRO2 to the visual stimulus for each individual was then calculated per Eq. [1], 
(a=0.2, b=1.3) using the indiviudal M value for each subject, as well as with the group mean M, 
to compare estimates of dCMRO2 using individual M versus group mean M. These values were 
compared to those using M¢.  
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2.8 VSEAN and baseline CMRO2 analysis 
VSEAN data were analyzed per Guo et al. 2012. Raw multi-echo data were averaged 
over the visual ROIs first, then used to fit a T2 value representative of the entire ROI. The T2 
was then converted into blood oxygenation (Y) levels via T2-Y calibration curve at 3T (Zhao et 
al., 2007). OEF was calculated from venous oxygenation (OEF = 1 – venous oxygenation). 
Baseline CMRO2 was calculated from >=K7" = >6?	 ∙ 7L?	 ∙ >M7".	       [2] 
The equation to determine total arterial oxygen concentration is: CaO2 = 1.36(Hb)(SaO2/100) + 
0.0031(PaO2), with units as follows: CaO2 in ml/dL, 1.36 ml O2/1 g Hb, Hb in g/dL, SaO2 in %, 
0.0031 g/dl/mmHg, and PaO2 in mmHg (Davenport, 1974). Hemoglobin concentration was 
assumed according to mean healthy ranges set by UC San Diego Health (Fraser and 
Haldeman-Englert, 2017); for females, [Hb] = 14g/dL; males, [Hb]=15.7g/dL. The age of each 
subject was also factored into CaO2 determination through the estimate of PaO2 (Estimated 
normal PaO2 @ 100 mmHg – (0.3) age in years) (Crawford and Adesanya, 2010; Jurado and 
Walker, 1969). CBF is expressed in ml/100ml/min, and CaO2 from this equation is divided by 
100 to give CMRO2 units in ml/100ml/min. CMRO2 in ml/100ml/min is then converted to mM/min 
(1 mL O2 at 310 K, 1 atm = 0.03933 mmol O2) (Davenport, 1974). For reference, 1 mM/min = 
2.54 ml O2/100 ml/min = 2.42 ml O2/100g/min = 100 umol/100 ml/min = 95 umol/100g/min, with 
assumed density of blood = 1.05 g/mL at 310 K (Trudnowski and Rico, 1974). 
 
2.9 Voxel-wise analysis 
To compare the quality of VSEAN and FLAIR-GESSE data on a voxel-wise basis to 
ROI-based analyses, maps of OEF and R2¢ values were made for each voxel in the visual ROI. 
The masks were then further limited to encompass voxels that survived both to create dually-
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restricted (VSEAN and FLAIR-GESSE restricted) masks for the ROI. The median, mean, and 
standard deviation of the voxel-wise OEF and R2¢ estimates were calculated for each subject, 
then averaged across all 17 subjects.  
 
2.10 Data and code availability 
The data that support the findings of this study are available from the corresponding 
author, RBB, upon reasonable request. The data and code sharing adopted by the authors 
comply with requirements by the National Institutes of Health and by the University of California, 
San Diego, and comply with institutional ethics approval.  
 
 
3. Results 
3.1 BOLD/ASL results 
Average CBF and BOLD R2* curves from 17 subjects across the entire 11-min 
acquisition are plotted in Figure 2.2. The average fractional change in CBF and BOLD to the 
visual stimulus and CO2 challenge for each subject are plotted in Figure 2.2A. The average 
responses of the cohort are summarized in Figure 2.2B.  
 
3.2 VSEAN results 
Figure 2.3 summarizes calculations of OEF made using VSEAN. Figure 2.3A-C shows 
individual, visual ROI-limited OEF values plotted against the baseline CBF, absolute ∆CBF to 
CO2 and ∆CBF to visual stimulus of each subject. Figure 2.3D summarizes OEF and CBF 
values of the group as a whole, and separately for males and females. There was no significant 
correlation between baseline OEF and CBF across subjects in the visual ROI. The mean 
baseline CBF value was found to be significantly different between males and females 
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(p=0.007), with mean baseline CBF of 80.3 +/- 8.93 ml/100ml/min for females and 66.0 +/- 10.0 
ml/100ml/min for males. A similar effect was seen in previous work studying regional differences 
in CBF by gender (Esposito et al., 1996; Gur and Gur, 1990; Rodriguez et al., 1988). In the 
current data, the effect size was 1.5, as calculated by Hedges’ g for 2 samples of difference 
sizes.   
 
3.3 FLAIR-GESSE and M calibration results 
Mean measured R2¢ across 17 subjects in the visual ROI was 3.60 s-1, with standard 
deviation of 1.39 s-1, giving a mean value of M¢=0.108 +/- 0.04 (Figure 2.4B). The calibrated 
BOLD analysis of the hypercapnia data yielded an average estimate of M = 0.095 +/- 0.05 
(Figure 2.4B). Figure 2.4A shows a plot of the individual data for M¢ against the value of M 
calculated for a=0.2 and b=1.3. We also compared M and M¢ with OEF for each subject and 
found no statistically significant correlation (see Supplementary Materials for details). dCMRO2 
calculated using individual and group mean M and M¢ are reported in Figure 2.4C. While 
individual and group mean M¢ values yielded similar dCMRO2, individual M from hypercapnia 
yielded significantly smaller mean dCMRO2 than that of the group mean (p=0.049).  
  
3.4 Absolute CMRO2 and CBF measurements 
The measured data provide the essential information needed to make estimates of 
absolute CBF and CMRO2 in the baseline state and absolute change in CBF and CMRO2 to the 
visual stimulus, thus yielding a complete quantitative picture of underlying physiology. These 
relationships are shown in Figure 2.5. The average baseline CMRO2, determined using Eq. [2] 
and OEF=0.44 from VSEAN, was calculated to be 2.58 +/- 0.53 mM/min, equivalent to 
approximately 6.56 ml/100ml/min = 6.24 ml/100g/min = 258 umol/100ml/min = 245.1 
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umol/100g/min (see section 2.8 for conversion). The table in Figure 2.5E shows the mean 
measured absolute change in CMRO2 to the stimulus using M¢ values for each subject 
calculated from R2¢, based on a=0.2 and b=1.3. Because this estimate depends on the estimate 
of the fractional CMRO2 change, it also depends on the assumed value of b. The absolute 
∆CMRO2 to a visual stimulus was estimated to be 0.21 mM/min for b=1.3. Figure 2.5 shows the 
spread of individual measurements for these parameters. Importantly, in Figures 2.5A and 2.5B, 
the x and y axes are not independent measures as the value of baseline CMRO2 is calculated 
from baseline CBF.  
 
3.5 Voxel-wise OEF and R2¢ results 
Median, mean, and standard deviation across voxels within each subject’s GM and 
visual ROI masks were calculated for OEF and R2¢. The average values across all 17 subjects 
are summarized in Table 2.1. The mean and median values are not significantly different from 
the mean OEF and R2¢ calculated from the original ROI-based method (see Supplementary 
Material for details on the voxel-wise comparison).  
 
 
 
4. Discussion 
This work explored the feasibility of making absolute measurements of CMRO2 and CBF 
without requiring the subject to breathe special gases as a first step toward more widespread 
application of quantitative physiological measurements. While arterial spin labeling (ASL) 
techniques, which do not involve gases, have been well developed to measure both baseline 
and fractional change in CBF, CMRO2 measurement is much more challenging and often 
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involves administration of gases with higher concentrations of O2 or CO2. The main barrier to 
measuring baseline CMRO2 is obtaining a measurement of oxygen extraction fraction (OEF), 
while measuring fractional change in CMRO2 to a stimulus requires calibration of the blood-
oxygenation level dependent (BOLD) signal through the factor M.  
The two non-gas techniques tested here present ways to measure those parameters 
noninvasively. Velocity-selective excitation and arterial nulling (VSEAN) is a technique that 
leverages relaxation effects of altered hemoglobin O2-saturation on the transverse relaxation 
rate (R2) of venous blood to determine OEF. Fluid attenuated inversion recovery – gradient echo 
sampling of spin echo (FLAIR-GESSE), on the other hand, presents a method of estimating the 
factor M through measurement of R2¢, which reflects the amount of total deoxyhemoglobin in 
tissue. We applied these methods to a relatively homogeneous cohort of 17 subjects. Because 
of the uniformity of the study population, we expect that the physiological parameters are likely 
to be similar across subjects, and that the variance of the measured values across subjects is 
thus likely to be dominated by the intrinsic variability of the measurement methods. We take this 
conservative approach in interpreting the performance of these methods. Our primary findings 
were: 1) VSEAN yielded a mean value of baseline OEF in the visual ROI of 0.44 ± 0.08, 
matching previously reported measurements of extraction (Ibaraki et al., 2007; Ishii et al., 1996; 
Ito et al., 2004) using positron-emission tomography (PET); and 2) the estimated changes in 
CMRO2 in response to the visual stimulus were similar when calculated from M¢ estimated from 
R2¢ measured with the FLAIR-GESSE method and when calculated from M estimated from the 
hypercapnia response. The ability to obtain a complete quantitative picture of human brain 
activation, with absolute measures of CBF and CMRO2 in both baseline and activation states, 
would be a useful tool for basic studies of brain function and for clinical applications to 
characterize the effects of disease.  
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4.1 Baseline CMRO2 with VSEAN OEF measurement 
The VSEAN method is an extension of the seminal method QUIXOTIC for measuring 
baseline OEF (Bolar et al., 2011), expanding on the basic idea to overcome some limitations of 
the earlier technique. QUIXOTIC uses a velocity-selective (VS) spin labeling technique, 
separating venous blood from arterial blood and static tissue. However, the sequence design 
causes the venous signal to be potentially contaminated by diffusion attenuation and to be 
attenuated by a global inversion pulse. VSEAN addresses these issues by isolating the venous 
blood signal using a separate arterial nulling module and improves upon the signal to noise of 
measuring venous T2 by incorporating a slab-selective inversion pulse rather than a global 
inversion pulse, thus yielding a stronger venous signal in comparison to that of QUIXOTIC.  
Although VSEAN had been tested in a few human subjects previously, this is the first 
study utilizing VSEAN on a larger sample of subjects as part of a complete physiological 
measurement. The accuracy of the measured mean OEF value over multiple subjects 
demonstrate its utility as a noninvasive method of estimating baseline CMRO2. Mean OEF value 
across 17 subjects in visual ROI was 0.443 +/- 0.08. These are similar to previously reported 
OEF values determined using PET. Ishii et al. reported OEF=0.413 +/- 6.1 in the visual cortex; 
Ibaraki et al. reported 0.39 +/- 0.05 in occipital cortex (Ibaraki et al., 2007; Ishii et al., 1996). The 
absolute baseline CMRO2 calculations were 2.58 +/- 0.53 mM/min (approximately 6.56 ml/100 
ml/min) for visual ROI. This is higher than previously reported PET values for baseline CMRO2; 
Ishii et al. reported 4.36 +/- 1.03 ml/100ml/min in visual cortex, while Ibaraki et al. reported 4.3 
+/- 0.7 ml/100ml/min in occipital cortex (Ibaraki et al., 2007; Ishii et al., 1996). This is most likely 
due to a higher baseline CBF in our study due to the active baseline.  Baseline CBF was 
determined to be 72.7 +/- 11.8 ml/100ml/min in visual ROI. This is compared to 66.1 +/- 12.9 in 
visual cortex (Ishii et al., 1996), or 58 +/- 11 ml/100ml/min in occipital cortex (Ibaraki et al., 
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2007), as reported previously. The higher baseline CMRO2 calculated from these experiments 
could thus reflect the higher baseline CBF.   
Interestingly, there was no correlation between baseline OEF and baseline CBF. This 
would be consistent with the idea that a baseline OEF around 40% is in some sense optimal, 
and that across subjects, baseline CBF adjusts to produce this OEF for the CMRO2 demands of 
the individual. Raichle and colleagues have pointed out the consistency of a baseline OEF of 
about 40% in the human brain, although why a value of 40% is optimal is unknown (Raichle et 
al., 2001). Additionally, because of the uniformity of the subject population, we did not expect 
large variations in OEF across the subject pool. We thus could assume that the variance 
observed is reflective of the variance in measurement technique combined with true variance 
across subjects. The variance across subjects in measuring OEF with VSEAN compared to the 
variance using PET measurements was similar, or even better, depending on the study, as 
noted above. VSEAN could thus be a comparable technique to utilize that does not require the 
invasiveness of PET.  
At this point, further development may be necessary to reliably assess if an individual 
patient has had an altered baseline CMRO2 due to disease. There may not be sufficient 
sensitivity unless the change is large. However, VSEAN would be a useful tool in using group 
mean results to determine changes in CMRO2 in pathophysiology. Studies of human 
development, healthy aging, and disease would benefit from being able to assess group 
differences in baseline CMRO2. A subsequent paper will address utility of individual and group 
OEF measurements in detecting CMRO2 change in a single subject after significant alteration 
with drug administration.  
When looking at the spread of baseline CBF between female and male subjects, there 
was a significant difference between the sexes (p=0.007, with an effect size of 1.5). This 
corresponds to a large effect size, the difference between the groups being greater than 1 whole 
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standard deviation. Such a result provides strong evidence for a significant and replicable 
difference between male and female measurements of CBF. While a difference in hematocrit 
between males and females could affect blood T2* and thus produce an artefactual difference in 
the ASL measurements, the data here were collected with a short echo time to minimize such 
an effect.  
VSEAN does present its own challenges. Measurements suffer from low SNR of the 
isolated blood signal for certain voxels, causing a poor fit of T2. Additionally, the measurements 
rely on a T2-Y calibration curve that is based on bovine blood developed by Zhao and 
colleagues (Zhao et al., 2007). While a T2-Y calibration curve has been published using human 
blood samples by Lu and colleagues (Lu et al., 2012), this curve was not used due to a different 
T2-preparation module (hard composite pulses vs. BIR-4 based), a different way of modulating 
eTEs (increasing the number of pulse modules vs. increasing the gap in the module), and its 
limited range. The authors noted that the relevant oxygenation range for venous blood, 0.5-0.75, 
was not tested (Lu et al., 2012); since VSEAN was developed specifically to measure blood 
oxygenation at those lower levels, the calibration curve using human blood was forgone for the 
Zhao curve that has a range of 0.39-1.00 for Hct=0.44.   
 
4.2 ∆CMRO2 from FLAIR-GESSE R2¢-M calibration 
FLAIR-GESSE has similarly not been performed on a large sample of subjects to test 
quantitative estimates of CMRO2. Here, we assumed the ideal relationship M¢ @ TE • R2¢ to 
calculate M¢ values, which were then used to calculate dCMRO2 to a stimulus. The scatter of 
these estimates is shown in Figure 2.5, expressed as an absolute ∆CMRO2. While CMRO2 and 
CBF are not independent measurements, it is interesting to note the difference in slope between 
Figure 2.5A and 2.5B, scatterplots of baseline measurements versus absolute change 
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measurements for ROI. Figure 2.5C and 2.5D show the difference between absolute change 
relative to baseline in CMRO2 and in CBF.  
Empirically, our group estimate of M¢  closely resembled the M calculated from a 
hypercapnia experiment, with a=0.2 and b=1.3. This agreement, however, may be fortuitous 
due to the complexity of interpreting M. M depends on the model parameters used (a and b), 
while R2¢ may depend on the acquisition technique and analysis; neither of these variables are 
inherent properties of tissue or physiology. M does not have a well-defined value that is 
independent of the particular version of the BOLD model (Eq. [1]) that is chosen for analysis. 
This model mainly varies in the choice of a and b, and different choices of these parameters will 
lead to different values of M. In reality, due to diffusion and other BOLD effects not captured by 
R2¢, such as blood volume changes with activation or intravascular signal changes, we expect 
that M and M¢ may differ. Given different values of a and b, the relationship between M and M¢ 
may be characterized as M=c∙M'	, where a conversion factor c can be determined empirically 
from the data. In previous theoretical studies, the value of c was estimated through modeling 
(Blockley et al., 2015). In the current study, we could estimate c as the mean value of M from 
hypercapnia across subjects divided by the mean value of M¢ across subjects.  For example, 
with the acquired data, M measured from hypercapnia and a=0.3, b=1 would be 0.128, and thus 
the value of c to empirically relate M¢ to M would be 1.19.  Furthermore, R2¢ is not a well-defined 
number when signal decay is not mono-exponential, so that the measured value will depend on 
the data acquisition and analysis technique. In short, as our understanding of a and b, and our 
understanding of the sources of R2¢, improves it will be necessary to consider the correction 
factor c in order to make dCMRO2 estimates consistent between hypercapnia and R2¢ calibration 
approaches, and more work will be needed to fully evaluate this relationship.   
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The model dependence of M is part of the general caution needed when interpreting the 
meaning of M. It is a complicated lumped parameter that in practice likely captures a number of 
effects that were not included in the original derivation of Eq [1]. Our approach here was to 
begin to establish an empirical connection between the hypercapnia approach and the newer 
R2¢ approach based on the assumption that M and TE•R2¢ are proportional to each other, and in 
the future, we could use the conversion factor c to quantify this relationship. The key idea is 
then that future experiments would theoretically require only a measurement of R2¢ for each 
subject, which would be used with an established value of c for particular model parameters and 
a particular approach for measuring R2¢ to give a value of M consistent with hypercapnia-
calibration but without needing to perform the CO2 experiment. Note, though, that if the 
hypercapnia method itself is inaccurate (e.g., through the assumption of iso-metabolism with 
CO2 inhalation), then that systematic error will carry into similar errors in the estimates based on 
R2¢. 
Theoretical modeling suggests that c is expected to be larger than one (Blockley et al., 
2015) because TE•R2¢ does not fully capture all of the effects that contribute to the BOLD 
response. Our value of c=1.19 for the visual ROI when a=0.2, b=1 meets these expectations, 
but with b=1.3, the value of c would be less than 1. In part, this may be due to a systematic error 
in the measurement of R2¢ due to the correction of field distortions that are difficult to fully take 
into account (Dickson et al., 2010), as discussed more fully below. Any uncorrected large scale 
field heterogeneity will add to the estimated value of R2¢, and so decrease the estimated value 
of c. As a result, further work is needed to improve the accuracy of the R2¢ measurement, 
particularly near the edges of the brain where field distortions are likely to be the most nonlinear, 
and thus more difficult to correct. In addition, it is important to note that the meaning of R2¢ also 
depends on the experiments used to measure it. For example, estimates of R2¢ using an 
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asymmetric spin echo experiment may differ in a systematic way from the values measured 
here (Blockley et al., 2015). For all of these reasons, the value of c is not only restricted by the 
particular BOLD signal model used, but also by the method used to measure R2¢ and the quality 
of the corrections used for large-scale field inhomogeneities. Nevertheless, this empirical 
approach is a way to move R2¢ measurements forward in the human brain as estimates of 
CMRO2 change that are consistent with hypercapnia-calibrated BOLD measurements. While the 
conversion of R2¢ to M through c depends on the BOLD model used and on the acquisition 
technique, as long as one is consistent in the methods one utilizes, the conversion factor can be 
applied to future experiments. 
The mean and standard deviation of the estimates of dCMRO2 calculated using 
individual M¢ values closely matched changes calculated using the group mean M¢. However, 
the same comparison of dCMRO2 estimates from individual M values was significantly less than 
dCMRO2 from the group mean M. This may be due to the variability in response to CO2 across 
the subject sample. A conservative assumption is that the dCMRO2 should be relatively uniform 
across our sample of young, healthy control subjects, and thus the observed variance is likely a 
reflection of measurement error. It may be that the higher variance of dCMRO2 estimates with 
individual M values is due our method of CO2 administration, and it is possible that real-time 
end-tidal forcing could yield more consistent results on an individual basis. However, dedicated 
equipment to enable end-tidal forcing further restricts the application of quantitative physiology 
methods to dedicated research laboratories, supporting the push to work toward replacing gas-
based techniques with non-gas based techniques. 
Finally, it is important to note that R2¢ measurements, like the OEF measurements with 
VSEAN, may be most useful in fMRI studies of development, aging and disease in which 
different groups are compared. For example, a different mean R2¢ for children and adults in the 
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brain region associated with performing a particular task could indicate that a difference in the 
BOLD response between the two groups should be interpreted with caution; the BOLD 
response difference may reflect a difference in baseline conditions rather than a difference in 
neural activity. As described above, in such a case the CMRO2 change, reflecting the energy 
cost of the underlying neural activity, could be estimated if the value of the correction factor c is 
known for the particular method used to measure R2¢ and the particular BOLD signal model 
assumed. Short of knowing c, though, simply normalizing the BOLD response by the mean R2¢ 
for the group would remove the baseline dependence, and any remaining difference between 
the two groups could be interpreted as due to differences in the CMRO2 and CBF responses to 
the stimuli. If the CBF response is measured, this will enable interpretation of whether the 
CMRO2 response is different in the two groups. 
 
4.3 Voxel-wise versus basic ROI-wise analyses 
Our primary analysis of the data focused on a functionally localized ROI in visual cortex. 
In this approach, all of the raw data for voxels within the ROI were first pooled before calculating 
the physiological variables. That is, fractional CBF and BOLD responses were calculated after 
pooling the raw voxel data, and OEF and R2¢ were calculated after pooling the raw data for 
voxels within the ROI. This approach was used to provide a basic proof of concept of estimating 
absolute physiological parameters for both baseline and activation states. In principle, this 
approach could be extended to voxel-wise analysis, although this will require further 
developmental work. There are two central problems: 1) the VSEAN measurement suffers from 
poor estimation of R2 when the signal to noise ratio is low; and 2) the R2¢ measurement is likely 
to be positively biased in regions where large-scale field correction is incomplete. For this 
reason, not every voxel in the visually activated ROI and GM masks may contain accurate 
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information on OEF and R2¢. As a first step in beginning to extend these measurements to 
individual voxels, we chose limits on the quality of fit of R2 in the VSEAN experiment and on the 
range of R2¢ as markers of data of sufficient quality to make an estimate of the associated 
parameter for that voxel. We then tested how many of the voxels chosen to be in the visual 
cortex ROI based on the activation data also had good quality estimates of OEF and R2¢. While 
a relatively large fraction of ROI voxels had a full set of measurements, there is clearly more 
work needed to improve the robustness of these measurements. Importantly, when we 
performed individual voxel analyses on just these voxels and then averaged over the calculated 
values, the basic physiological parameter estimates were similar to the ROI-approach of first 
pooling the data: the mean or median derived from voxel-wise analysis were not statistically 
different from the mean OEF and R2¢ derived using the basic visual ROI mask. In the future, 
simply using a visual ROI determined from the functional localizer and GM mask from the ASL 
flow data may be enough to make representative estimates of OEF and M.  
 
4.4 Physiological results 
The primary goal of this work was to begin to evaluate methods for making quantitative 
physiological measurements without requiring the subject to breathe special gas mixtures. To 
that end, a homogeneous group of young adult subjects was studied, and we did not expect 
there to be large physiological variation across subjects. We found no statistically significant 
correlations between baseline OEF and baseline CBF, nor between baseline OEF and M or M¢. 
Further work is needed to test these methods in a wider range of subjects where more 
physiological variation could be expected. Looking at sex differences in the measured 
physiological parameters we found baseline CBF to be significantly higher in females compared 
to males by about 22%. One of the potential advantages of a fully quantitative assessment of 
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CBF and CMRO2 in both the baseline and activation states is that we are able to examine 
absolute changes to a stimulus in addition to the more commonly measured fractional changes. 
In comparing absolute baseline values of CBF and CMRO2 and absolute changes in these 
quantities to the stimulus, we found a different slope (Figure 2.5A and 2.5B). This suggests that 
different physiological mechanisms may serve to balance baseline CBF/CMRO2 coupling and 
activation CBF/CMRO2 coupling, although more work is needed to define these mechanisms. 
 
 
5. Conclusions 
The results from this work demonstrate the potential for making absolute CMRO2 
measurements without requiring the subject to breathe special gases. However, work is still 
needed to refine these methods and establish their validity. Each method has its own 
challenges: for VSEAN, low SNR of the isolated blood signal for some voxels, and for FLAIR-
GESSE, excessive field distortion near edges of the brain. Nevertheless, these results support 
the feasibility of painting a more complete picture of brain physiology, in absolute terms, during 
both baseline and activation states, with the potential of providing a deeper probe of neural 
activity. 
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Figure 2.1: Experimental set-up, CBF and R2* data. Top panel shows experimental set-up of 
PICORE QUIPSS II BOLD/ASL acquisition with visual stimuli of a 6 Hz flickering checkerboard 
(“Stimulus”) and 5% CO2 administration. Middle and bottom panels illustrate average CBF and 
BOLD R2* curves across 17 subjects. The CBF is normalized to the baseline CBF, and so is 
dimensionless. The BOLD R2* curve is plotted as –R2* for more visibly intuitive purposes. 
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Figure 2.2: Visual activation and calibrated BOLD results. (A) Scatter plot of fractional CBF 
versus fractional BOLD change to the visual stimulus and CO2 challenge for each subject in the 
visual ROI only. (B) Mean and standard deviation of dBOLD and dCBF to visual stimulus 
experiment in normoxia/normocapnia across seventeen subjects, and mean changes to CO2 
challenge in the baseline state, across all subjects.  
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Figure 2.3: VSEAN results. (A) Independent VSEAN and ASL methods show variation of 
measured baseline OEF and CBF across subjects in the visually stimulated ROI. (B) Variation 
of OEF to absolute ∆CBF to CO2 are plotted for ROI, and (C) variation across subjects versus 
absolute ∆CBF to visual stimulus in the visual ROI. (D) Table of baseline OEF, baseline CBF, 
absolute ∆CBF to CO2, and absolute ∆CBF to visual stimulus in visual ROI. There was no 
correlation between OEF and baseline CBF or to any absolute ∆CBF. Baseline CBF between 
male (blue) and female (red) subjects was significantly different (p=0.007). The effect size of 
this difference as measured by Hedges’ g is 1.5. 
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Figure 2.4: FLAIR-GESSE versus calibrated BOLD results. (A) M from calibrated-BOLD 
experiment with a=0.2, b=1.3, and M¢ from FLAIR-GESSE’s R2¢ for each of 17 subjects in the 
visual ROI. Scatterplot demonstrates range and variance of measurements of M from the two 
methods. (B) Average M¢ was calculated from mean measured R2¢ value across 17 subjects 
using FLAIR-GESSE of 3.60 +/- 1.39 s-1, with TE = 0.03 s. M values were calculated from 
calibrated BOLD CO2 experiment. (C) Fractional dCMRO2 to visual stimulus calculated using 
Eq. [1] and dCBF and dBOLD to the visual stimulus, as well as the M and M¢ values. Two 
calculations were performed, one using each subject’s individual M or M¢ value to calculate 
individual dCMRO2, then averaged across all subjects; the other method utilized the group mean 
M or M¢ to calculate individual dCMRO2, then averaged across the subjects.  
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Figure 2.5: Baseline and absolute changes in CMRO2 and CBF across subjects in visual 
ROI. Absolute calculations of CMRO2 at baseline and to a visual stimulus noninvasively 
determined using OEF and M calibration data acquired from VSEAN and FLAIR-GESSE, with 
a=0.2 and b=1.3. (A) Absolute CBF and CMRO2 in the baseline state (slope=0.0196, r2=0.192, 
p=0.079). (B) Absolute CBF and CMRO2 changes in response to the visual stimulus 
(slope=0.014, r2=0.872, p<0.00001). Note that x- and y-axes are not independent in (A) or (B) 
as CMRO2 estimates are calculated from CBF. (C) Absolute ∆CMRO2 change to visual stimulus 
versus baseline CMRO2. Change in CMRO2, based on fractional change of BOLD and CBF to 
visual stimulus, is calculated independently of baseline CMRO2, which is dependent on baseline 
CBF and an independent VSEAN measurement of OEF. The change in CMRO2 is calculated 
using M¢ from individual R2¢. (D) Absolute ∆CBF change to visual stimulus versus baseline CBF. 
Measurements are independent; baseline CBF is calculated based on the CSF calibration scan, 
while ∆CBF is estimated from ASL data with visual stimulus onset. (E) Mean baseline and 
absolute change estimates for CMRO2 and CBF. 
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Table 2.1: Voxel-wise analysis statistics. The median, mean, and standard deviation of OEF 
and R2¢ were calculated across the dually-restricted ROI mask for each subject; the average of 
those statistics in 17 subjects are tabulated here. The right-most column shows the ROI-based 
mean used in the primary analyses for reference. 
 
OEF Median Mean SD Mean ROI-based (from above) 
ROI 0.418 0.424 0.19 0.443 
     
R2¢ (s-1) Median Mean SD Mean ROI-based (from above) 
ROI 3.65 3.80 1.85 3.60 
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Supplementary Material 
 
 
S1. Voxel-wise VSEAN analysis results 
For VSEAN, on average 87 +/- 8.6% of voxels from the visually activated ROI had an 
OEF value properly fitted, whereas 72 +/- 17% of voxels from the gray matter mask had an OEF 
value (Figure S2.1). There may be voxels in the ROI that do not have reliable OEF calculations 
on an individual basis; these may be present as outliers that skew the mean OEF calculated by 
averaging across the voxels. As a result, the median value of the spread of OEF values across 
the ROI may be a more accurate representation of the ROI. The median, mean, and standard 
deviations were calculated for each individual subject’s ROI. The average of those medians, 
means, and standard deviations across the 17 subjects are summarized in Table 2.1. These 
values can be compared to the basic ROI-wise calculation (Figure 2.3D), for which the mean 
OEF for the visual ROI was 0.443. The results from the voxel-wise calculation of OEF in the 
dually-restricted masks are shown to be lower than that of ROI-wise calculations, but the 
difference is not significant (for Visual ROI: p=0.52 for difference between ROI-wise means and 
voxel-wise means; p=0.37 for difference between ROI-wise means and voxel-wise medians. For 
GM: p=0.54 for difference between ROI-wise means and voxel-wise means; p=0.33 for 
difference between ROI-wise means and voxel-wise medians). 
In addition to noisy voxels potentially skewing the fitting of T2, another source of error 
could be the T2-Y curve used to fit T2 to blood oxygenation saturation. The curve used was 
collected from bovine blood in vitro at 3T (Zhao et al., 2007). The transverse relaxation rates R2 
and R2* for blood samples of varying hematocrit (Hct) levels were measured under conditions 
mimicking physiological state using single spin echo and gradient echo sequences. The curve 
corresponding to a hematocrit level of 0.44 is used in the VSEAN analysis, which is a 
reasonable assumption for both females and males, as a Hct = 0.42 was assumed for females 
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and Hct = 0.47 was assumed for males. Despite the careful setup and considerations of the 
authors, the resulting T2-Y curve could still be influenced by the use of bovine blood with sodium 
citrate, which would differ from human blood, although the authors note that bovine erythrocytes 
are very similar to human erythrocytes in physical properties such as size, shape, and water 
permeability. The authors also point out that measuring R2* in their experimental setup would 
have smaller field inhomogeneities than measuring R2* in tissue, so the results from their 
method should be considered lower than physiological numbers. The VSEAN method could 
thus be benefited in future experiments from a T2-Y calibration curve that is derived from human 
blood samples, in conditions as similar to blood in situ as possible.  
 
S2. Voxel-wise R2¢ analysis results 
FLAIR-GESSE’s limitations are also demonstrated by the voxel-wise analysis. Excessive 
field distortion near the edges and due to macroscopic field inhomogeneities can present a 
problem in adequately correcting the measurements, leading to very high R2¢ measurements 
skewing average data. To look at the spread of R2¢ estimates across ROI and GM, FLAIR-
GESSE data were analyzed on a voxel-by-voxel basis. While the pathway does not inherently 
limit the assignment of R2¢ value to each voxel, a generous restriction of 0 – 10 s-1 was applied 
post-R2¢ voxel-wise calculations, independent of the mean R2¢ value or the spatial spread of R2¢ 
across the slice. These restricted FLAIR-GESSE masks had on average 88 +/- 12% of voxels 
from basic visual ROI and 80 +/- 7% of voxels from the full GM mask (Figure S2.1A). Restricted 
masks were then combined with VSEAN-restricted masks to form the dually-restricted mask a 
described above. The mean R2¢ across the dually-restricted mask was calculated for each 
subject; however, as before, because certain voxels may contain erroneous estimates due to 
field distrotions or inhomogeneities leading to high R2¢ values that would skew the mean, the 
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median of each mask was also calculated (Table 2.1). These values were compared to the 
original, ROI-based mean R2¢ calculated, 3.60 +/- 1.39 s-1 for ROI and 3.37 +/- 0.7 s-1 for GM. 
The results from the voxel-wise calculation of R2¢ in the dually-restricted masks appear to be 
higher than that of ROI-wise calculations, but the difference is not significant (for Visual ROI: 
p=0.65 for difference between ROI-wise means and voxel-wise means; p=0.92 for difference 
between ROI-wise means and voxel-wise medians. For GM: p=0.18 for difference between 
ROI-wise means and voxel-wise means; p=0.83 for difference between ROI-wise means and 
voxel-wise medians). 
 
S3. M, M¢, and other physiological variables 
While there was not a strong correlation between M derived from hypercapnia and M¢ 
from R2¢, the values for each subject were also compared to baseline OEF measurements using 
VSEAN and to baseline CBF measurements from ASL to provide insight into whether the 
variance in each of these measurements across subjects is dominated by real physiological 
variability or technical limitations in acquisition. In Figure S2.2A, baseline OEF is compared to M 
and M¢ ; given a large range of M and OEF values, one could predict that M should correlate 
with OEF due to both variables’ relation to the amount of deoxyhemoglobin available for 
oxygenation. For both M and M¢, no significant correlation was seen in the ROI. Given the 
young, healthy population studied, a wide range of OEF values was not expected; as a result, a 
trend in this group would not be reasonably seen. Figure S2.2B shows baseline CBF compared 
to M and M¢, and again there is no significant correlation seen in the ROI. Thus, in comparing M 
from hypercapnia versus R2¢, we cannot comment on which technique is more sensitive to 
physiological differences across subjects.  
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Supplemental Figure S2.1: Voxel-wise calculation of OEF and R2¢. (A) Percentage of whole 
mask (ROI or GM) voxels that survived VSEAN or FLAIR-GESSE analysis for OEF or R2¢. The 
restricted masks for each comprise voxels that exhibited good fit of T2 for OEF, or were in a 
physiologically relevant range of R2¢ (lower limit of 0, higher limit of 10). For VSEAN, on average 
87 +/- 8.6% of voxels from the visually activated ROI and 72 +/- 17% of voxels from the gray 
matter mask had an OEF properly fitted. For FLAIR-GESSE, 88 +/- 12% of voxels from visual 
ROI and 80 +/- 7% of voxels from GM survived R2¢ restriction. The restricted masks for each 
method were then combined into a dually-restricted mask of voxels that have a measurement 
for both OEF and R2¢. (B) The average total number of voxels in the combined, dually-restricted 
masks for ROI and GM versus the total number of voxels in the full masks for 17 subjects. The 
ROI voxels for the full mask were not significantly different from that of the dually-restricted 
mask (p=0.062) while the GM voxels for the full mask were significantly different from that of the 
dual-restricted mask (p<0.00001). (C,D) Brain masks depict one representative subject. (C) Left 
panel: Red voxels show the dually-restricted GM mask superimposed on the full gray matter 
mask, depicted in charcoal. Center panel: Voxel-wise OEF estimates for the dually-restricted 
GM mask (mapped in color with reference to color bar on the right), superimposed on full gray 
matter mask in charcoal. Right panel: Voxel-wise R2¢ estimates for dually-restricted GM mask 
(mapped in color with reference to color bar on the right), superimposed on full gray matter 
mask in charcoal. (D) Left panel: Mustard voxels show the basic visually-stimulated ROI, with 
dually-restricted ROI superimposed in red. Charcoal voxels depict full gray matter mask. Center 
panel: Voxel-wise OEF estimates for dually-restricted ROI mask (mapped in color with reference 
to color bar on the right), superimposed on full gray matter mask in charcoal. Right panel: Voxel-
wise R2¢ estimates for dually-restricted ROI mask (mapped in color with reference to color bar 
on the right), superimposed on full gray matter mask in charcoal. 
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Supplemental Figure S2.2: OEF0 and CBF0 versus M from hypercapnia and FLAIR-
GESSE. (A) Left: Baseline OEF versus M from hypercapnia. Right: Baseline OEF versus M¢, 
derived from R2¢. (B) Left: Baseline CBF versus M from hypercapnia. Right: Baseline CBF 
versus M¢, derived from R2¢. None of the correlations meet significance. 
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CHAPTER 3: Noninvasive detection of baseline changes in cerebral blood flow  
and oxygen metabolism after caffeine administration 
 
Abstract 
 Gas-free measurements of absolute cerebral metabolism of oxygen (CMRO2) during 
both baseline and activation states have been demonstrated using the suite of techniques that 
include: a multi-echo ASL/BOLD acquisition to measure the Blood-Oxygenation Level 
Dependent (BOLD) signal and cerebral blood flow (CBF); Velocity-Selective Excitation and 
Arterial Nulling (VSEAN) to measure oxygen extraction fraction (OEF), used to calculate 
baseline CMRO2, and FLuid-Attenuated Inversion Recovery – Gradient Echo Sampling of Spin 
Echo (FLAIR-GESSE) to determine the calibration factor R2¢ to interpret dynamic BOLD 
responses to a stimulus in terms of the fractional changes in CMRO2. Here, I begin to apply 
these tools to detecting changes in the baseline state after a known intervention, caffeine 
administration. While the objective of this is not to characterize the effects of caffeine 
specifically, this drug induces a change in state that could be reflected through baseline 
measurements of CBF, OEF, R2¢, and CMRO2. After comparing pre- and post-caffeine values, I 
report that both OEF and R2¢ in gray matter were increased with caffeine administration, as 
predicted; additionally, CBF was found significantly decreased, in strong agreement with 
previous reports. CMRO2, however, did not change significantly after caffeine. These results 
demonstrate the utility of this toolbox of methods in measuring physiological changes at 
baseline after an induced alteration in brain state.  
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1. Introduction 
The ability to noninvasively quantify brain activity is the next frontier in human 
neuroimaging. While functional MRI (fMRI) has come a long way since the advent of the Blood-
Oxygenation Level Dependent (BOLD) signal, this widely used method does not physiologically 
quantify brain activity. Instead of BOLD, other measured parameters such as cerebral blood 
flow (CBF) and cerebral metabolic rate of oxygen (CMRO2) paint a more useful picture in the 
clinical setting. This is particularly necessary in comparing activity before and after an 
intervention, such as drug administration. Fractional changes in BOLD to a stimulus may not 
divulge the entire story that could otherwise be unmasked using baseline measurements; or, the 
intervention itself could be resetting the brain at a different baseline state, rendering fractional 
changes with activation alone uninterpretable.  
Quantification of baseline CBF and CMRO2 could thus provide insight into acute effects 
of a drug. Numerous MRI-based methods have been developed to make estimates of absolute 
CBF and CMRO2. Most successful has been the advent of arterial spin labeling (ASL) and its 
many iterations in measuring CBF. This technique is now widely accepted as a reliable, 
noninvasive technique to estimate flow in the brain. Extensive work has also been done in 
making absolute CMRO2 measurements; however, there has not been the same level of 
consensus on one specific method as with ASL. A two-fold requirement exists for making 
absolute CMRO2 measurements: 1) a method for estimating baseline oxygen extraction fraction 
(OEF) and 2) a calibration for interpreting dynamic BOLD responses to a stimulus in terms of 
the fractional fluctuations of CMRO2. For the first requirement, several MRI methods seek to 
estimate OEF, which, when multiplied by CBF and the arterial oxygen content CaO2, yields 
CMRO2. Some of the tools used today involve gas manipulations, extensions of the Davis model 
and calibrated BOLD (Davis et al., 1998), to estimate venous deoxyhemoglobin concentration 
and thus OEF. Other methods use a quantitative measurement of the susceptibility effect of the 
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venous blood or the relaxation effects of altered hemoglobin O2-saturation on the transverse 
relaxation rate (T2) of venous blood. For the second requirement, a measurement of M in the 
Davis model (Davis et al., 1998) is widely accepted as a technique to calibrate the BOLD 
response, but also requires subjects to breathe a special hypercapnic gas mixture.  
Recent work using a dual-calibrated fMRI technique seeks to meet both requirements to 
make absolute CMRO2 estimates (Bulte et al., 2012; Gauthier et al., 2012; Wise et al., 2013). 
One study applied the dual technique to investigate changes in baseline CBF and CMRO2 after 
administration of a drug—caffeine (Merola et al., 2017). Caffeine has been widely studied, and 
its effects well documented using various fMRI techniques (Cameron et al., 1990; Chen and 
Parrish, 2009; Griffeth et al., 2011; Liu et al., 2004; Perthen et al., 2008; Xu et al., 2015). 
However, dual-calibrated fMRI brings with it the need for respiratory manipulations—specifically, 
the subjects are required to breathe hypercapnic and hyperoxic gas mixtures to produce the 
changes in BOLD necessary to yield an estimate of OEF. This may prove to be cumbersome in 
a clinical setting, if the technique were to be translated from benchside to bedside. As a result, I 
seek to apply non-gas techniques recently developed to make baseline measurements of 
CMRO2 in a pre- and post-treatment state. Here, I similarly use caffeine as a drug intervention 
to induce the change in brain state; however, this is not primarily a study of the effects of 
caffeine, but rather an investigation into the use of this suite of noninvasive tools.  
To estimate baseline CMRO2, I employ velocity-selective excitation and arterial nulling 
(VSEAN, Guo et al. 2012), which was introduced to overcome some limitations of earlier 
techniques measuring the T2 of venous blood (TRUST, QUIXOTIC (Bolar et al., 2011; Lu et al., 
2012)). It provides a more sensitive and noninvasive approach to measure OEF. VSEAN 
isolates the signal from venous blood which, taken along with a T2-venous oxygen saturation 
(Yv) calibration curve, yields estimates of venous oxygenation and consequently OEF. Currently, 
VSEAN is performed on one axial slice per acquisition; in this paper, two different regions are 
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targeted. One is in the caudal aspect of the head, encompassing a portion of the occipital cortex 
that would be visually activated were this a functional exam. The second is more superior in the 
brain, encompassing a portion of the frontal lobe that would be involved in motor function. 
Baseline CBF is measured using a tri-echo pseudo-continuous ASL (pCASL) sequence, which 
simultaneously records BOLD and CBF dynamics. Finally, recent work has proposed that R2¢ 
could be an alternative to hypercapnia for estimating M, to get an estimate of the “baseline 
physiological state” of the individual necessary to later quantify fractional changes in CMRO2 to 
a standard stimulus (Blockley et al., 2015; Simon et al., 2016; Yablonskiy, 1998; Yablonskiy and 
Haacke, 1994). This factor is dependent on the total deoxyhemoglobin in a voxel, and is used to 
quantitatively interpret the BOLD signal in a calibrated BOLD experiment. The physiological 
implications of this will be explored in more depth in a separate publication (Chapter 4), but 
nonetheless it is an important scaling factor and thus vital to interpretation of physiological data. 
Here, this factor is represented by a measurement of R2¢, the component of transverse 
magnetization relaxation that can be reversed with a spin echo, using FLuid-Attenuated 
Inversion Recovery – Gradient Echo Sampling of Spin Echo (FLAIR-GESSE) (Simon et al., 
2016). R2¢ is reflective of the total deoxyhemoglobin in tissue, and thus can be used to calibrate 
the BOLD signal to yield estimates of fractional CMRO2 to a stimulus. This study will focus 
solely on baseline physiological measurements, and thus fractional changes will not be 
analyzed; however, baseline changes in R2¢ before and after an intervention contributes to the 
full picture of neural activation. 
I focus now on the post-intervention baseline changes of CBF, OEF, and R2¢ in caudal 
and superior gray matter (GM) regions. The three noninvasive techniques are applied to a group 
of caffeine-experienced subjects who have abstained from caffeine for a set period. Their 
baseline measurements are made in the context of a resting state task. A motor-visual task will 
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be further analyzed in a later paper. The subjects are then administered a caffeine tablet, and 
imaged again using the same techniques and tasks. This study thus evaluates the noninvasive 
detection of baseline changes before and after a drug intervention as a first step toward clinical 
application of quantitative, physiological MRI. Caffeine enables us to begin testing the 
physiological underpinnings of baseline measurements through R2¢ and VSEAN-derived OEF. 
Based on previous studies (Buxton et al., 2014; Griffeth et al., 2011; Liu et al., 2004; Merola et 
al., 2017; Perthen et al., 2008), I expect acute caffeine administration to reduce CBF but not 
CMRO2, leading to an increase of both OEF and R2¢, given correct interpretation of these 
measurements.       
 
 
2. Methods 
2.1 Subjects 
Ten healthy adults (5 female, mean age=23.5 years, range 21-28) were recruited and 
imaged as subjects for the study. All subjects were habitual caffeine consumers, drinking at 
least the equivalent of 12 ounces of black coffee a day. The session comprised a “pre-caffeine” 
state, in which imaging was performed on the subject prior to administration of a 200mg caffeine 
tablet, as well as a “post-caffeine” state, in which imaging was performed 30 minutes after 
administration of the tablet. In this paper, I focus just on the pre-caffeine and post-caffeine 
baseline physiology experiments within the second session. In addition, I performed combined 
ASL/BOLD acquisitions during performance of a complex task. The functional runs consisted of 
a motor-visual task, but are not described here as this specific study only uses the ASL/BOLD 
data to obtain baseline CBF estimates in the two VSEAN slices during a resting period. The 
functional data itself will be analyzed and presented in more detail in Chapter 4. Subjects were 
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asked to abstain from ingesting caffeine at least 4 hours prior to the start of each of the 
sessions. The study was approved by the University of California, San Diego Human Research 
Protections Program. Written, informed consent was obtained from all subjects; all were 
remunerated for their participation.  
 
2.2 Imaging 
2.2.1 BOLD-ASL: A three-dimensional time of flight (3-D TOF) scan was first acquired to 
determine the optimal tagging plane for the subsequent pseudo-continuous arterial spin labeling 
(pCASL) sequences. The conventional two-slab 3-D TOF sequence was used with TR=20ms, 
TE=3.3ms, flip angle=15°; acquisition bandwidth of 31.25 kHz, 256x128x20 matrix, total 
acquisition time was 1:55. Axial slices were centered at the cervicomedullary junction to image 
the vertebral and internal carotid arteries. A tri-echo spiral pCASL sequence with background 
suppression was used to acquire simultaneous BOLD and ASL images using a General Electric 
(GE) Discovery MR750 3.0T scanner. Twelve axial slices (5 mm thick/1 mm gap) covering the 
occipital cortex and the primary motor cortex were obtained with TR=4.2s, start of tag=3250ms, 
tag duration=1650ms, TE=3.3ms/25ms/46.7ms, bgsti1=1580ms, bgsti2=472ms, FOV=256mm, 
and matrix 64x64. In the resting period, which comprises the data used in this study, the subject 
was asked to fixate on a cross projected on the screen; this was viewed through a mirror set 
atop the headcoil.  
2.2.2 Calibration and reference scans: The following calibration and reference scans 
were acquired with the same slice prescription as that of the BOLD-ASL sequence in each 
state. A field map was obtained to correct distortions in the spiral acquisition due to magnetic 
field inhomogeneity (Noll et al., 2005).  A cerebral spinal fluid (CSF) reference scan was 
acquired for CBF quantification, using a single-echo spiral EPI acquisition (TE=3.3ms, 
TR=4000ms) (Chalela et al., 2000; Perthen et al., 2008). A minimum contrast (min/con) scan 
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(eight-shot spiral acquisition, TE=11ms, TR=2000ms) was made to correct for transmit and 
receiver coil inhomogeneities (Wang et al., 2005). In each session, a high resolution T1-
weighted anatomical scan (FSPGR) was acquired for image registration and segmentation. 
2.2.3 VSEAN: In each of the two states, a measurement of venous oxygenation was 
made using the Velocity-Selective Excitation and Arterial Nulling (VSEAN) (Guo and Wong, 
2012) developed by Guo and Wong and tested in a previous study (Chapter 2). The VSEAN 
sequence is applied on one slice at a time; in each state, VSEAN was used to measure the 
relaxation rate R2 of local venous blood in the two slices from the BOLD-ASL prescription that 
correspond to visual cortex and motor cortex, respectively. As R2 depends on the O2 saturation 
of hemoglobin, such a measurement provides an estimate of local oxygen extraction fraction 
(OEF). This method isolates moving spins from static spins and nulls arterial blood, thus 
selecting only for the venous blood signal, the T2 of which is then measured with multiple T2-
preparations of different effective TEs (Guo and Wong, 2012). Venous oxygenation (Yv) is 
determined from the measured T2 using a T2-Yv calibration curve (Zhao et al., 2007). Detailed 
acquisition parameters are as reported in Chapter 2 and reproduced here for convenience. 
Arterial nulling: A slab-selective inversion pulse (arterial inversion slab thickness = 
150mm) inverted a bolus of arterial blood below the imaging plane, with delay time TI=1150ms 
to allow the inverted bolus of arterial blood to arrive at the imaging plane at the null point of the 
arterial blood longitudinal magnetization. The spins of the tissue and venous blood in the 
imaging slice were unperturbed, giving a stronger venous signal.  
Velocity-Selective Excitation (VSE) for flow signal separation: Two VSE pulse modules 
(one BIR4-based pulse train with velocity-sensitive gradient pulses, the second built into the 
image acquisition) excited and separated moving spins without generating signal from static or 
slow flowing spins.  
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T2 measurement and oxygenation estimation: T2 preparation module (VSE/T2 prep with 
eTEs 25/50/75ms, built into the first BIR-4 based VSE module) measured T2 (TR/TE = 
3s/28ms). The T2 values were translated to blood oxygen saturation of hemoglobin Y via a T2-Yv 
calibration curve. I used the calibration curve from Zhao and colleagues based on a bovine 
blood sample measured in vitro at 3 Tesla (Zhao et al., 2007). The equation for the curve used 
in this analysis is !"#$ %#$ = 	8.3 + 33.6	 ∙ 	 1 − 0 + 71.9	 ∙ 	 (1 − 0)" (Guo and Wong, 2012). 
The OEF was then taken as 1-Yv, based on the assumptions that arterial hemoglobin was fully 
saturated with oxygen and dissolved O2 is negligible compared to hemoglobin-bound O2.  
Other pulse sequence parameters: FOV = 256 mm x 256 mm, single-slice spin echo with 
spatial-spectral excitation, two slice-selective hyperbolic secant refocusing pulses, single-shot 
spiral readout, ve=2 cm/s in slice-selective direction, slice-selective post-saturation pulses, 81 
acquisitions preceded by two dummy scans and including six “cos” modulated reference scans 
(Guo and Wong, 2012). The total scan time for each slice was 4:03.  
2.2.4 FLAIR-GESSE: R2¢ was measured using FLuid Attenuated Inversion Recovery-
Gradient Echo Sampling of Spin Echo (FLAIR-GESSE) (Simon et al., 2016). The prescription 
used for this sequence matched that of the BOLD-ASL acquisition, but with a 2mm thick slab 
and 4 mm gap. Two pairs of GESSE image series were acquired separately, one as an early 
spin echo series (63.6 ms after excitation) and one as a late spin echo series (83.6 ms after 
excitation). Two sampling acquisitions helps correct for problems with multiple T2 within a voxel. 
For each series, 64 samples of each decay curve were collected asymmetrically. CSF nulling 
was applied in a FLAIR module (TR=3.5s, TI=1.16s) to the center slices to minimize CSF 
contamination of R2¢ measurements. Field offsets were acquired that were used to calculate 
large-scale field inhomogeneities and remove their contribution to the R2¢ estimate (Dickson et 
al., 2010). Each spin series lasted 3:58. R2¢ was calculated as described in Simon et al. 2016.  
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2.3 Experimental setup 
The pre-caffeine state and post-caffeine state acquisitions were obtained in one 3-hour 
session. At least thirty minutes elapsed between the time of caffeine administration and the 
beginning of the first functional run in the post-caffeine state to ensure the onset of caffeine 
effects. Again, the subject was instructed to abstain from consuming caffeine at least 4 hours 
prior to the start of each session.  
2.3.1 Pre-caffeine state: The pre-caffeine state represents a non-caffeinated state for the 
subject occurring immediately prior to administration of caffeine. Upon entering the scanner, the 
landmark position of the subject’s head was noted. The anatomical, 3-D TOF, CSF, and min/con 
scans as described above were then collected. The BOLD-ASL sequence described in 2.2.1 
was used to record baseline flow during the resting period. FLAIR-GESSE and VSEAN 
acquisitions were also performed while the subject was at rest, with the same directive to keep 
their eyes open and fixate on a cross. While FLAIR-GESSE had the same 10 slice-centered 
prescription as the BOLD/ASL acquisition, VSEAN was used on two separate slices: one 
targeted the occipital cortex/calcarine sulcus to yield the caudal GM region, one targeting the 
primary motor cortex, both determined anatomically to yield the superior GM region.  
2.3.2 Caffeine administration: The subject was removed from the scanner and brought 
outside of the scan room. A 200mg caffeine tablet was given to the subject, to be ingested with 
a cup of water. The subject was given a short break in preparation for the second half of the 
session. At least thirty minutes elapsed between ingestion of the tablet and start of the BOLD-
ASL acquisition for the post-caffeine state. 
2.3.3 Post-caffeine state: The post-caffeine state represents a caffeinated state for the 
subject, occurring after the pre-caffeine state and subsequent administration of caffeine. The 
subject was landmarked at the same position as in the pre-caffeine state. Anatomical, 3-D TOF, 
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CSF and min/con scans were acquired. The background suppressed pCASL sequence 
described in 2.2.1 was used to measure baseline CBF at rest, using as similar a prescription as 
possible to that of the pre-caffeine state. FLAIR-GESSE was acquired in the two acquisitions as 
described in 2.2.4 at rest; VSEAN was used on the same two slices as in the pre-caffeine state. 
 
2.4 Data preprocessing 
2.4.1 BOLD-ASL images: Field map correction was first performed on raw ASL to 
account for magnetic field inhomogeneities (Noll et al., 2005). The functional scans were motion 
corrected and registered to one image in each of the runs using AFNI software (Cox, 1996). The 
first four images were dropped to allow the signal to have reached a steady state. The ASL data 
was then corrected for coil sensitivity inhomogeneity using the min/con images (Wang et al., 
2005). Surround-subtraction was applied to first-echo ASL images to produce CBF-weighted 
images, then converted to physiological CBF units using the CSF scan as reference (Chalela et 
al., 2000).  
2.4.2. Data upsampling: Given the coarse temporal and spatial resolution of the 
acquisitions, the BOLD and ASL time courses were upsampled from 64x64 matrix size to 
256x256 matrix size by zero-padding in the Fourier domain with the original data centered in k-
space, then reconstructing the image again through an inverse Fourier transform. A gray matter 
mask was created using a specific threshold for CBF (35 ml/100ml/min for baseline, caffeine-
free CBF, and 20 ml/100ml/min for post-caffeine CBF). The lower threshold for the post-caffeine 
data was chosen to produce approximately the same number of voxels in the mask as the pre-
caffeine study, to compensate for the expected CBF lowering effect of caffeine. The data and 
masks were also smoothed using a Gaussian smoothing kernel with a full width at half 
maximum of 8 voxels at the upsampled resolution (2 voxels in terms of the original 64x64 
resolution); the smoothed data were used for subsequent analyses. 
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2.4.3 Gray matter mask selection: The gray matter masks for the slices targeted in the 
VSEAN acquisition were isolated. The superior GM slice was taken as a whole, while the caudal 
GM region was taken as the caudal one-third of that lower slice, to censor artifacts caused by 
bony structures in the rostral head. These regions will henceforth be referred to as superior GM 
and caudal GM, respectively. 
2.4.4 Baseline CBF estimate: The masks were applied to the CBF dynamics across the 
entire time series. Subsequent measurements of the various baseline parameters were 
determined by averaging over the data from the baseline resting period, during which the 
subject fixated on a cross on the screen for 2.5 minutes. Baseline CBF was calculated by taking 
the average CBF value over this resting period for each voxel in the respective region, then 
averaged across those voxels. The same analysis was done for both pre- and post-caffeine 
states. 
 
2.5 FLAIR-GESSE analysis 
FLAIR-GESSE data were analyzed per Simon, et al. 2016. The raw GESSE data were 
first upsampled to the same 256x256 matrix size as the BOLD/ASL data. R2¢ values were fitted 
to the raw data for each voxel; the median of the caudal or superior GM regions were taken 
from voxels in the respective masks.  
 
2.6 VSEAN and baseline CMRO2 analysis 
VSEAN data were analyzed per Guo et al. 2012. Raw multi-echo data were averaged 
over the individual masks first, then used to fit a T2 value representative of the entire region. The 
T2 was then converted into venous blood oxygenation (Yv) levels via T2-Yv calibration curve at 
3T (Zhao et al., 2007). OEF was calculated from venous oxygenation (OEF = 1 – venous 
oxygenation). Baseline CMRO2 was calculated from 
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5678" = 59:	 ∙ 8;:	 ∙ 5<8".	       [1] 
The equation to determine total arterial oxygen concentration is: CaO2 = 1.36(Hb)(SaO2/100) + 
0.0031(PaO2), with units as follows: CaO2 in ml/dL, 1.36 ml O2/1 g Hb, Hb in g/dL, SaO2 in %, 
0.0031 g/dl/mmHg, and PaO2 in mmHg (Davenport, 1974). Hemoglobin concentration was 
assumed according to mean healthy ranges set by UC San Diego Health (Fraser and 
Haldeman-Englert, 2017); for females, [Hb] = 14g/dL; males, [Hb]=15.7g/dL. The age of each 
subject was also factored into CaO2 determination through the estimate of PaO2 (Estimated 
normal PaO2 @ 100 mmHg – (0.3) age in years) (Crawford and Adesanya, 2010; Jurado and 
Walker, 1969). CBF is expressed in ml/100ml/min, and CaO2 from this equation is divided by 
100 to give CMRO2 units in ml/100ml/min. CMRO2 in ml/100ml/min can be converted to mM/min 
(1 mL O2 at 310 K, 1 atm = 0.03933 mmol O2) (Davenport, 1974). For reference, 1 mM/min = 
2.54 ml O2/100 ml/min = 2.42 ml O2/100g/min = 100 umol/100 ml/min = 95 umol/100g/min, with 
assumed density of blood = 1.05 g/mL at 310 K (Trudnowski and Rico, 1974). 
 
2.7 Pre- and post-caffeine comparisons 
After determining the mean and standard deviation across subjects in the pre-caffeine 
and post-caffeine states for CBF, OEF, and R2¢, the pre- and post-caffeine means were 
compared using a 1-tailed matched pairs T-test with the null hypothesis that post-caffeine value 
– pre-caffeine value = 0. Intersubject variation was also compared pre- and post-caffeine using 
the coefficient of variation (CV), defined as the ratio of the sample standard deviation to the 
sample mean. This allows for comparison of intersubject variability in the context of samples 
with widely different means, as could be expected given the caffeine intervention. The 
relationship between pre- and post-caffeine variance was tested using a F-test of equality of 
variances.   
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Post-caffeine and pre-caffeine values for each individual subject were also plotted 
against each other in a scatterplot. The Pearson’s correlation coefficient r was calculated to 
determine the strength of a linear association between the two variables. A p-value was 
calculated for each r coefficient. For plots that exhibited significant correlation (p<0.05), the 
slope of the regression line was tested to determine significant difference from 1, where a 
slope=1 would imply that the relationship between post-caffeine and pre-caffeine values stayed 
constant throughout the sample. This test of significance was performed via a T-test using the 
standard error of the slope from the linear regression.  
To examine the relationship between the change in a measurement from pre- to post-
caffeine states to the initial (pre-caffeine) value of the measurement, Oldham’s method was 
employed (Oldham, 1962). Oldham’s method presents a solution to the statistical faux pas of 
correlating change with baseline. This practice is problematic due to mathematical coupling and 
regression to the mean of the initial and change values (Tu and Gilthorpe, 2007). Two methods 
have been proposed to rectify this issue: Blomqvist’s formula, to correct for measurement errors 
in initial values, and Oldham’s method, to test change and average. Blomqvist’s formula was 
foregone in this analysis due to a lack of proper measurement error estimation in our 
experiments (Blomqvist, 1977). Oldham’s method does not address the problem of 
measurement error, but rather proposes the plotting of change against the average of the initial 
and post-treatment values instead of simply the initial value. This is essentially a test of 
differences in the variances of two repeated measurements, in which the two variances may be 
correlated (Oldham, 1962). If there is no correlation found between change and average value, 
this would reflect that there is no difference in the variance at the initial state and the variance in 
the post-treatment state, and thus that the post-treatment effect does not depend on the initial 
value. However, if there is a variable treatment effect of the intervention, this will result in a 
change of variances between the initial and post-treatment measurements, and would be 
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demonstrated in a significant correlation between the change and average values (either a 
positive or negative correlation depending on a greater or smaller treatment effect with greater 
initial state measurement). Thus, Oldham’s method was applied to determine if the effect of 
caffeine on CBF, OEF, R2¢ or CMRO2 was dependent on the initial baseline value of those 
parameters.  
Baseline OEF and baseline CBF values were also compared in a scatterplot for pre- and 
post-caffeine values on an individual subject basis. Although the derived values of CMRO2 and 
CBF are not statistically independent, because the measured CBF value is used to calculate 
CMRO2, CMRO2 was compared to CBF in a scatterplot for pre- and post-caffeine values to paint 
a physiological picture of brain activity before and after the caffeine intervention.  
 
2.8 Data and code availability 
The data that support the findings of this study are available from the corresponding 
author, RBB, upon reasonable request. The data and code sharing adopted by the authors 
comply with requirements by the National Institutes of Health and by the University of California, 
San Diego, and comply with institutional ethics approval. 
 
 
3. Results 
 
3.1 Baseline measurements  
Across subjects, on the upsampled data, the caudal GM mask contained on average 
3877 +/- 671 voxels pre-caffeine, and 4375 +/- 665 voxels post-caffeine on the upsampled 
images; the superior GM mask contained on average 9107 +/- 1051 voxels pre-caffeine, and 
9254 +/- 819 voxels post-caffeine. The baseline measurements in the two states for these 
regions, as well as the percent change from pre- to post-caffeine, are summarized in Table 3.1.  
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The results are notable for a significant decrease in baseline CBF in both GM regions, 
with p<0.001 (Figure 3.1A, Table 3.1) and significant increase in OEF for both regions with 
p<0.05 (Figure 3.1B, Table 3.1). For R2¢, the increase from pre- to post-caffeine was significant 
in superior GM (p<0.05) only, although the trend of increase in R2¢ post-caffeine was seen in 
caudal GM (Figure 3.1C, Table 3.1).   
Baseline CMRO2 was calculated using baseline OEF and CBF measurements for each 
region. There was no significant change in CMRO2 from pre- to post-caffeine in either caudal or 
superior GM (Figure 3.1D, Table 3.1). 
 
3.2 Changes with caffeine  
Of the four parameters—CBF, OEF, R2¢, and CMRO2—CBF and R2¢ both showed a 
significant correlation between pre- and post-caffeine in the two regions. For CBF, the 
correlation coefficient between the two states was r=0.70 (p<0.05) for caudal GM and r=0.93 
(p<0.001) for superior GM (Figure 3.2A). Pre- and post-caffeine R2¢ correlation resulted in 
r=0.73 (p<0.01) for caudal GM and r=0.77 (p<0.01) for superior GM.  
 Using Oldham’s method of testing for correlation of the magnitude of change following 
the intervention on the initial value, there was a significant correlation seen in OEF (r=0.92, 
p<0.001) (Figure 3.3B) and CMRO2 (r=0.86, p<0.01) for superior GM (Figure 3.3D).  
There was no significant relationship between baseline OEF and baseline CBF in either 
the pre-caffeine or post-caffeine state for caudal or superior GM (Figure 3.4). There was also no 
correlation seen between ∆OEF to ∆CBF to caffeine in either region.  
CMRO2 and CBF scatterplots demonstrated a significant correlation (r=0.72, p<0.05) 
between baseline CBF and baseline CMRO2 in the pre-caffeine state for superior GM only. 
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However, CMRO2 estimate is dependent on CBF, and thus the two axes in these scatterplots 
are not independent measurements. 
 
 
4. Discussion 
This study sought to measure baseline activity, before and after an intervention, of  
caudal gray matter, which would include occipital or visually activated brain areas, and superior 
gray matter encompassing regions responsible for motor activity. The baseline measurements 
were acquired with a suite of tools that noninvasively quantify brain state: BOLD/ASL to 
measure cerebral blood flow (CBF), VSEAN to measure oxygen extraction fraction (OEF), and 
FLAIR-GESSE to measure R2¢.   
 
4.1 Caffeine effects on cerebral blood flow 
Caffeine has been extensively studied in previous literature and exhibits strong, reliable 
changes in brain physiology that were similarly detected in this study. Over 10 subjects, the 
average decrease in CBF pre- to post-caffeine of around 20-25% (Figure 3.1A, Table 3.1) is 
consistent with the general range of previous reports of baseline CBF drop (Cameron et al., 
1990; Chen and Parrish, 2009; Griffeth et al., 2011; Liu et al., 2004; Perthen et al., 2008; Xu et 
al., 2015).  
Interestingly, our results are supportive of the idea that caffeine induces an absolute 
decrease in flow rather than a consistent fractional decrease across subjects; that is, the effect 
of caffeine on flow appears to be fixed at a constant absolute value, irrespective of initial 
baseline CBF level. This is shown in Figure 3.2A by a significant correlation between pre- and 
post-caffeine CBF, but the slope of the regression line is not shown to be significantly different 
from slope=1 (p=0.14 for caudal GM; p=0.30 for superior GM). I would expect to see a 
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significant correlation between pre- and post-caffeine CBF with a regression line slope that is 
significantly different from 1 if fractional change in CBF were dependent on baseline CBF. This 
idea is further supported by the results of Oldham’s method of looking at dependency of change 
in CBF on initial (pre-caffeine) CBF. In Figure 3.3A, there is no significant correlation between 
change in CBF on the average of pre- and post-caffeine CBF. Given the theory behind 
Oldham’s method, this indicates there is no relationship between the change in CBF and initial 
(pre-caffeine) CBF. Also of note is the lack of caffeine effect on intersubject variability. The 
variability amongst subjects in the two states was calculated using the coefficient of variation 
(CV); these CVs were compared using an F-test of equality of variances. The CBF CV in pre- 
and post-caffeine were not significantly different (p=0.39 for caudal GM, p=0.40 for superior 
GM).  
The finding of a relatively fixed absolute change in CBF across subjects in response to 
caffeine, despite a significant variation of baseline flow, is a pattern that was also reported in a 
previous study (Whittaker et al., 2016) in response to a different intervention, hypercapnia. A 
separate study looking at motor CBF activations before and after administration of 
acetazolamide (Brown et al., 2003) was consistent with activation-induced CBF changes being 
additive to the altered baseline CBF. This lends support to underlying physiology causing a fixed 
drop in baseline CBF to this intervention (caffeine), perhaps to counter the more variable effects 
of the intervention on OEF, as discussed next (4.2).  
 
4.2 Caffeine effects on OEF 
Our results demonstrate a significant increase in OEF measured using VSEAN in the 
caudal GM of 23% and in superior GM of around 18% (Figure 3.1, Table 3.1). This is similar to 
or slightly greater than previously reported increases in OEF with caffeine measured with dual 
calibrated BOLD (∆OEF = +15.6% (Merola et al., 2017)) and with TRUST MRI (∆OEF = +18.6% 
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(Xu et al., 2015)). Additionally, there was a significant difference in the CV of pre-caffeine OEF 
versus that of post-caffeine OEF for superior GM (p=0.032), but not in caudal GM (p=0.31). 
Greater variability post-caffeine suggests that the change in OEF behavior to caffeine is more 
variable across subjects. This is unsurprising, as I would expect variable effect of a drug on 
people.  
There was no significant correlation between pre-caffeine and post-caffeine OEF in 
either caudal or superior GM, but in looking at the relationship between the change in OEF and 
initial value (Figure 3.3B), there was a significant correlation between ∆OEF and the average of 
pre- and post-caffeine OEF in superior GM, suggesting that OEF was increased depending on 
the baseline OEF, whereas the CBF was reduced by a fixed amount across subjects. There was 
also no relationship found between ∆OEF and ∆CBF (Figure 3.4B, D). The different responses 
in OEF and CBF could be a physiological balance between the two forces to ensure little to no 
change in CMRO2 after the intervention, as discussed next.  
 
4.3 Caffeine effects on CMRO2 
Taken together, the effects of caffeine on CBF and OEF inform the effect of caffeine on 
CMRO2. I saw a significant decrease in CBF, and significant increase in OEF. These opposing 
forces cancel out each other’s effect, leading to no mean change in CMRO2 across the 10 
subjects (Figure 3.1D, Table 3.1). ∆CBF is fixed, and the variance pre- and post-treatment stay 
the same (no significant change in CV); ∆OEF appears to be dependent on the pre-treatment 
value, and its variance post-caffeine increases significantly. This leads to an increase in 
variance post-caffeine in CMRO2 (p=0.046), and a seeming dependence of ∆CMRO2 on the 
initial CMRO2 value (Figure 3.3D). Subjects with lower CMRO2 pre-caffeine tended to decrease 
in CMRO2 post-caffeine, while those with a higher baseline rate pre-caffeine tended to either 
stay the same or increase in CMRO2 post-caffeine. As a result, the mean stayed about the 
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same but the variance was increased post-caffeine. This physiology is intriguing, although the 
underlying processes are unknown and would need to be further explored.  
The finding that CMRO2 does not change from pre- to post-caffeine treatment agrees 
with previous reports using calibrated BOLD (Perthen et al., 2008) and TRUST MRI (Xu et al., 
2015), and contrasts with findings of an increase of CMRO2 using calibrated BOLD (Griffeth et 
al., 2011) and of a decrease of CMRO2 using dual-calibrated fMRI (Merola et al., 2017). 
However, these studies vary in not only the method used to calculate OEF or CMRO2, but also 
the region of the brain that is averaged over. These confounding factors could lead to the 
ostensible variability in caffeine effect on CMRO2.  
 
4.4 Caffeine effects on R2¢ 
As mentioned before, to make absolute measurements of dynamic data, such as 
physiological responses to a stimulus, both the baseline CMRO2 (4.3) and a calibration for the 
BOLD response must be performed. This calibration is usually through the factor M and 
obtained through the hypercapnia experiments applying the Davis model, or more recently, 
dual-calibrated fMRI techniques. However, in this study, I sought to replace these gas methods 
with a non-gas measurement of R2¢, which can be a substitute for M. Although this chapter does 
not delve into dynamic data, it is important to measure the baseline state through R2¢ to paint a 
complete physiological picture that can be applied in the setting of dynamic data. R2¢ thus is 
important in calibration of fractional CMRO2 change to a stimulus, vital in a separate analysis of 
BOLD and CBF functional data (Chapter 4). R2¢ as determined through FLAIR-GESSE showed 
a significant increase post-caffeine (Figure 3.1C, Table 3.1) in superior GM. Additionally, a 
significant correlation was seen between pre- and post-caffeine R2¢ measurement (p<0.01, 
Figure 3.2C). The slope of the regression line was not found to be significantly different from 1 
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(p=0.078). There was no dependence of ∆R2¢ on the initial pre-caffeine value (Figure 3.3C). 
Taken together, these results could indicate that there is a fixed effect of caffeine on R2¢ that is 
independent of the initial state. 
 
4.5 Baseline CBF and CMRO2 
While I cannot draw any statistical conclusions from the interaction of CBF and CMRO2 
due to the dependence of CMRO2 on CBF (Eq. [1]), Figure 3.5 gives us an idea of the baseline 
picture attainable from this suite of non-gas techniques. 
 
 
5. Conclusions 
The overall goal of our work is to establish a foundation for quantitatively assessing 
CMRO2 in baseline and altered brain states, using MRI methods that do not require the subject 
to breathe special gas mixtures. For an extended change in brain state, as in the current study 
with caffeine, the change in CMRO2 can be derived with separate measurements of OEF in the 
two states. I investigated OEF as measured with the VSEAN method. To measure more 
dynamic changes in CMRO2, such as in response to task performance or stimulus, a calibrated 
BOLD approach, based on dynamic measurement of BOLD and ASL signals, can provide an 
estimate of the fractional fluctuations of CMRO2, and in combination with the baseline OEF and 
CBF measurements these dynamic CMRO2 changes can be expressed as absolute changes. 
For the calibrated BOLD experiment, a measurement sensitive to the deoxyhemoglobin content 
in the baseline state—the parameter M in the Davis model—is needed. The parameter R2¢ has 
been proposed as a method for estimating M, and would provide an alternative to the current 
hypercapnia calibration. The current study was designed to test the biological plausibility of 
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these two experimental parameters important for characterizing the baseline physiological state: 
R2¢ derived from a FLAIR-GESSE experiment and OEF derived from a VSEAN experiment. The 
use of caffeine as an intervention was motivated by previous findings that CBF is reduced with 
much less of a change in CMRO2. For this basic set of physiological changes, I would expect 
OEF to increase, and if R2¢ reflects baseline deoxyhemoglobin, I would expect R2¢ to increase as 
well. I found these changes as predicted, supporting the use of these experimental metrics to 
follow the underlying physiological changes. 
In addition to these basic tests of the behavior of R2¢ and OEF, I characterized the CBF 
and CMRO2 changes with caffeine. Interestingly, the change in CBF is better characterized as a 
fixed drop in absolute baseline CBF across subjects, rather than a fixed percentage change. In 
other words, the absolute change in CBF was not related to the baseline CBF, perhaps due to a 
wider range of effects leading to variable baseline values, but a more uniform mechanism for 
acute caffeine effects. I found no significant change in CMRO2 across subjects, although an 
analysis of the relationship between the degree of change and the baseline value suggests an 
interestingly complex picture. The observed changes are consistent with subjects having a 
lower baseline CMRO2 tending to have decreased CMRO2 post-caffeine, while those with a 
higher baseline CMRO2 tended to have even higher CMRO2 post-caffeine. As a result, the 
variance of CMRO2 across subjects increased post-caffeine. Note that this type of trend is the 
opposite of what I expect for regression to the mean. Further work is needed to test whether this 
effect is robust, and to determine what this tells us about the underlying physiology. 
In this study, I focused on the baseline measurements, and a more complete analysis 
including the dynamic measurements, and the full use of the measured R2¢ values to determine 
task-induced CMRO2 changes, will be presented in a subsequent report (Chapter 4).  
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Table 3.1: Pre- and post-caffeine results. Asterisks indicate significant difference from zero. 
*** p<0.001; ** p<0.01; * p<0.05. 
 
Caudal GM 
 
CBF 
(ml/100ml/min) OEF R2¢ (s-1) 
CMRO2 
(ml/100ml/min) 
Pre-caffeine 66.21 0.36 3.91 4.80 
Standard deviation 7.69 0.06 0.42 0.78 
CV (%) 11.62 16.14 10.64 16.36 
     Post-caffeine 49.22 0.43 3.96 4.27 
Standard deviation 6.97 0.10 0.49 1.11 
CV (%) 14.15 22.73 12.27 26.04 
     ∆ Post – Pre -16.99*** +0.07* +0.05 -0.52 
Standard deviation 5.76 0.12 0.34 1.55 
% Change from 
pre-caffeine -25.66*** +19.44* +1.28 -10.83 
 Superior GM 
 
CBF 
(ml/100ml/min) OEF R2¢ (s-1) 
CMRO2 
(ml/100ml/min) 
Pre-caffeine 46.73 0.35 3.59 3.32 
Standard deviation 5.50 0.03 0.33 0.30 
CV (%) 11.76 7.70 9.18 9.13 
     Post-caffeine 36.48 0.42 3.73 3.09 
Standard deviation 5.13 0.12 0.27 0.92 
CV (%) 14.07 28.63 7.25 29.90 
     ∆ Post – Pre   -10.25*** 0.07* 0.14* -0.23 
Standard deviation 2.07 0.11 0.21 0.79 
% Change from 
pre-caffeine -21.93*** +20.0* +3.90* -6.93 
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Figure 3.1: Baseline values pre- and post-caffeine. Mean values across 10 subjects of (A) 
CBF, (B) OEF, (C) R2¢,  and (D) CMRO2 in the pre- and post-caffeine states. Baseline CBF 
exhibited a significant decreased after administration of caffeine (*** p<0.001) in both the caudal 
and superior GM slice, while OEF exhibited a significant increase after administration of caffeine 
(* p<0.05) in the two regions. R2¢ exhibited a significant increase after caffeine (* p<0.05) in only 
the superior GM; no significant change was detected in baseline CMRO2.  
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Figure 3.2: Pre- and post-caffeine relationships. The scatter of individual pre- and post-
caffeine values (A) CBF, (B) OEF, (C) R2¢, and (D) CMRO2 in the caudal and superior GM 
areas. There was a significant correlation between baseline CBF before and after caffeine 
administration in both regions, with correlation coefficient r and p values as indicated on the 
plots. There was also a significant correlation found between pre- and post-caffeine R2¢ values 
in both regions, again with r and p values as shown.  
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Figure 3.3: Change as a function of initial value using Oldham’s method. Units of 
physiological variables are as indicated in Figure 3.1. Change in (A) CBF, (B) OEF, (C) R2¢, and 
(D) CMRO2 plotted as a function of the average of the pre- and post-caffeine values as a test of 
the relationship of change and initial value. There was a significant correlation found between 
the two values for OEF in GM and CMRO2 in superior GM, with r and p values as indicated on 
the plots.  
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Figure 3.4: Baseline OEF versus CBF in caudal and superior GM. Units of physiological 
variables are as indicated in Figure 3.1. (A) Baseline OEF plotted as a function of baseline CBF 
in both pre- (blue) and post-caffeine (purple) states in caudal GM. There was no significant 
correlation found. (C) Baseline OEF plotted as a function of baseline CBF in both pre- (blue) 
and post-caffeine (purple) states in superior GM. There was no significant correlation found. In 
caudal GM (B) and superior GM (D), ∆OEF (post-caff OEF – pre-caff OEF) versus ∆CBF. No 
significant correlation was found. Open circles on each plot indicate mean value.  
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Figure 3.5: Baseline CMRO2 versus CBF in caudal and superior GM. Note that the axes in 
these plots are not independent, so correlations should be interpreted with caution. Units of 
physiological variables are as indicated in Figure 3.1. (A) Baseline CMRO2 versus baseline CBF 
in pre- (blue) and post-caffeine (purple) states for caudal GM. There was no significant 
correlation. (C) Baseline CMRO2 versus baseline CBF in pre- (blue) and post-caffeine (purple) 
states for superior GM. There was a significant correlation between CMRO2 and CBF in the pre-
caffeine data, with r=0.72 (p<0.05). In caudal GM (B) and superior GM (D), ∆CMRO2 (post-caff 
CMRO2 – pre-caff CMRO2) versus ∆CBF. No correlation was found in either region. Open 
circles on each plot indicate mean value.   
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CHAPTER 4: Physiological fMRI noninvasively quantifies changes in brain state 
 
Abstract 
 The utility of a toolbox of three noninvasive, non-gas methods—simultaneous 
BOLD/ASL, VSEAN, and FLAIR-GESSE—has been shown in quantifying baseline changes in 
an individual after a brain state-altering intervention (Chapter 3). The Blood-Oxygenation Level 
Dependent (BOLD) signal and a method of arterial spin labeling (ASL) yield fractional changes 
in BOLD to a stimulus, while ASL gives a measurement of baseline cerebral blood flow (CBF) 
and fractional change of CBF to a stimulus. Velocity-Selective Excitation and Arterial Nulling 
(VSEAN) is used to measure oxygen extraction fraction (OEF), which is then used to calculate 
baseline CMRO2, while FLuid-Attenuated Inversion Recovery – Gradient Echo Sampling of Spin 
Echo (FLAIR-GESSE) yields the calibration factor R2¢ to interpret dynamic BOLD responses to a 
stimulus in terms of the fractional changes in CMRO2. When applied before and after an 
intervention, with a functional stimulus “stress test” to determine if specific regions of the brain 
alter their behavior after the intervention, this toolbox paints a complete physiological picture. 
Here, I utilize the tools before and after caffeine administration (the change in brain state) with a 
motor-visual task (the stimulus “stress test”) to determine which parameters, or combination of 
parameters, would best differentiate between the two brain states. I report that to reliably 
distinguish the two states requires measurements both pre-and post-caffeine, and while scaled 
fractional BOLD change to the stimulus, baseline CBF, and the coupling ratio l of fractional 
CMRO2/fractional CBF were most sensitive to caffeine, only baseline CBF and l were also 
specific to the intervention.  These results demonstrate that physiological fMRI has the potential 
to specifically and sensitively quantify changes in brain state.  
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1. Introduction 
 The complexity of interpreting the Blood-Oxygenation Level Dependent (BOLD) 
response in functional magnetic resonance imaging (fMRI) has led to a deeper look at 
measuring physiological parameters that better reflect underlying neural activity. Cerebral blood 
flow (CBF) and cerebral metabolism of oxygen (CMRO2) are two such parameters that, when 
quantified, can serve to more accurately reflect the status of an individual’s brain, or even detect 
when there is a change in brain state. While arterial spin labeling (ASL) has become a staple 
technique to measure CBF in both the research and clinical settings, the measurement of 
CMRO2 has not found such stability. This is partially due to the cumbersome nature of many of 
the techniques used to measure metabolism, as well as the two-fold nature of measuring 
cerebral blood flow in a baseline state, such as a person at rest, to an activated state, such as 
when the person is performing a task or responding to a stimulus. In Chapter 3, I demonstrated 
successful measurement of baseline CBF and CMRO2 before and after an intervention, thus 
establishing that this suite of tools could be useful in detecting changes in brain state at rest. 
The next step in evaluating these tools would be in comparing the multiple parameters acquired 
in combination with a task or stimulus and determining which of these is best at distinguishing 
the two distinct brain states, which in this case reflects the period before and after drug 
administration. What is a “different” brain state? An alteration in state would be reflected in the 
change in baseline physiological measurements—baseline CBF, oxygen extraction fraction 
(OEF), CMRO2, or R2¢ which reflects the amount of deoxyhemoglobin present at baseline—or in 
the fractional change in these parameters to a stimulus or task, specifically fractional change in 
CBF (dCBF), BOLD (dBOLD), or CMRO2 (dCMRO2), or in the coupling ratio l, which is the 
relationship between the fractional change in CMRO2 and the fractional change in CBF. Here, I 
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use caffeine as the intervention that changes the state of the brain, and those two distinct states 
are thus “pre-caffeine” and “post-caffeine.” 
This study seeks to evaluate the sensitivity of this suite of quantitative physiological 
measurements consisting of three noninvasive techniques: pseudo-continuous ASL with 
background suppression (pCASL), FLuid-Attenuated Inversion Recovery – Gradient Echo 
Sampling of Spin Echo (FLAIR-GESSE), and Velocity-Selective Excitation and Arterial Nulling 
(VSEAN). The background-suppressed pCASL is used to acquire BOLD and ASL signals 
simultaneously, which is used to measure baseline CBF, dCBF and dBOLD (here “d” is used to 
denote a fractional change); FLAIR-GESSE is used to measure a baseline value of R2¢ to 
calibrate the BOLD signal, which in combination with dBOLD and dCBF, provides an estimate of 
dCMRO2; and lastly VSEAN is used to measure baseline OEF, which in combination with the 
baseline CBF measurement provides a measurement of baseline CMRO2. The sensitivity of the 
techniques to the change from pre- to post-caffeine depends on the noise in the experimental 
methods as well as physiological aspects of the effects of caffeine. I am interested in identifying 
which changes in physiology are detected with the best sensitivity and specificity. While the 
results of Chapter 3 showed a change in several baseline parameters across gray matter, here I 
also use a motor-visual task-stimulus that is analogous to a “stress test” to see if the brain 
regions responsible for motor and visual function alter their response to these stimuli after 
caffeine administration. Can I identify the effects of caffeine as a change of brain state, with 
these methods? Which measurements or combination of measurements are the most sensitive? 
 Painting the full picture of baseline and activated physiology is important for future 
clinical applications of these tools in individual subjects. While this study uses caffeine to induce 
the change in brain state, I do not seek to specifically characterize the effects of caffeine; rather, 
it is simply an intervention with a well-known effect on certain physiological parameters such as 
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baseline CBF that is used as a test case. Future applications of these techniques may show that 
other drugs alter baseline or activation physiology in a different manner, and thus a combination 
of different measured parameters may be best used for distinguishing when an individual has 
undergone the intervention.  
 
 
2. Methods 
2.1 Subjects 
 Ten healthy adults (5 female, mean age=23.5 years, range 21-28), were voluntarily 
recruited and examined in this study. All subjects were habitual caffeine consumers, drinking at 
least the equivalent of 12 ounces of black coffee a day (Chapter 3). Each attended one 3-hour 
scan session, which included a “pre-caffeine” state, in which the subject had abstained from 
consuming caffeine for at least 4 hours prior; administration of a 200-mg caffeine tablet; and a 
“post-caffeine” state, in which subjects were scanned after ingesting the tablet. The study was 
approved by the University of California, San Diego Human Research Protections Program. 
Written, informed consent was obtained from all subjects; all were remunerated for their 
participation. 
 
2.2 Imaging 
 Imaging was done in three basic modalities: 1) BOLD-ASL was acquired using a tri-echo 
spiral pseudo-continuous arterial spin labeling (pCASL) sequence with background suppression; 
2) T2 estimates were made using Velocity-Selective Excitation and Arterial Nulling (VSEAN) 
(Guo and Wong, 2012); 3) and R2¢ measurements were made using FLuid-Attenuated Inversion 
Recovery – Gradient Echo Sampling of Spin Echo (FLAIR-GESSE) (Simon et al., 2016). All 
three techniques were utilized before and after caffeine administration. pCASL was performed in 
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resting state, as well as with a block-design task/stimulus, while VSEAN and FLAIR-GESSE 
were acquired solely in the resting state.  
 2.2.1 BOLD-ASL: Imaging parameters are as described in Chapter 3. Briefly, on a 
General Electric (GE) Discovery MR750 3.0T machine, a three-dimensional time of flight scan 
(3-D TOF) was first acquired in preparation for optimal pCASL tagging of blood. The tri-echo 
pCASL sequence with background suppression was used to simultaneously acquire BOLD and 
ASL images. Twelve axial slices (5 mm thick/1 mm gap) encompassing occipital and primary 
motor cortices were obtained with TR=4.2s, start of tag=3250ms, tag duration=1650ms, 
TE=3.3ms/25ms/46.7ms, bgsti1=1580ms, bgsti2=472ms, FOV=256mm, and matrix 64x64. 
Calibration and reference scans, including anatomical, minimum contrast, and CSF sequences, 
are as described in Chapter 3, Section 2.2.2. 
 2.2.2 VSEAN: Venous oxygenation was estimated from T2 measured using VSEAN (Guo 
and Wong, 2012). Imaging is performed on one slice at a time; a total of two axial slices were 
targeted with this technique. The first included primary visual areas in the occipital cortex, 
specifically the anatomical regions near the calcarine sulcus that would be strongly activated by 
a visual stimulus. The second was superior to the first, cutting through the motor region involved 
in right hand movement. Venous oxygenation (Yv) was estimated from T2 using a T2-Yv 
calibration curve (Zhao et al., 2007). Detailed acquisition parameters are as described in 
Chapter 3, Section 2.2.3. 
 2.2.3 FLAIR-GESSE: R2¢ was measured using FLAIR-GESSE in all twelve slices 
prescribed in the pCASL acquisition (2.2.1), with 2mm thick slab/4mm gap (Simon et al., 2016). 
Detailed acquisition parameters are as described in Chapter 3, Section 2.2.4, and Simon et al., 
2016.   
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2.3 Functional stimulus paradigm 
The functional stimulus was used solely with the pCASL BOLD-ASL acquisition. The 
subject viewed the functional stimulus, projected onto a screen, through a mirror set on the 
head coil. There were two major components to the paradigm: resting periods (resting state) 
and a motor-visual task. The resting state had the subject resting quietly and fixating on a cross 
at the center of the field of view. The motor-visual task, delivered in a block design, involved a 
red circle at the center of the field of view that pulsed on for 250ms and off for 250ms. Every 
time the red circle pulsed on, the subject was to press a specific button on a 4-button box with 
their right hand. The pattern of button-pressing was as follows: 1-3-2-4 or index-ring-middle-
pinky. The subject was to press the buttons in that order to the timing of the red circle. 
Surrounding the red circle was a ring that extended to the edge of the subject’s field of view that 
consisted of a flickering checkerboard. The subjects were instructed to ignore the flickering 
checkerboard and focus on the red circle and performing the button-presses in the correct 
pattern. The motor-visual task was displayed continuously for 33.6 seconds at a time, then 
switched to a rest period for 33.6 seconds. This was repeated 2 times for a total of 3 blocks of 
motor-visual stimuli.  
The timing of the stimulus paradigm was as follows: baseline resting period (2 min 56.4 
secs or 42 TRs); a signal announcing the beginning of the motor-task (8.4 secs or 2 TRs); 
motor-visual sequence (33.6 secs or 8 TRs); resting period (33.6 secs or 8 TRs); motor-visual 
sequence (33.6 secs or 8 TRs); resting period (33.6 secs or 8 TRs); motor-visual sequence 
(33.6 secs or 8 TRs); resting period (33.6 secs or 8 TRs). In the pre-caffeine state, two task runs 
were acquired, with the second run immediately following completion of the first run, whereas in 
the post-caffeine state, one task run was completed.  
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2.4 Experimental setup 
 Pre-caffeine and post-caffeine acquisitions were obtained on the same day, in one 3-
hour session. Subjects abstained from consuming caffeine at least 4-hour prior to the start of 
their appointment. At the start, the subject was trained on task performance outside the 
scanner, with a short trial run to familiarize the subject with the tasks.  
 2.4.1 Pre-caffeine state: The pre-caffeine state represents a non-caffeinated, caffeine-
abstinent state for the veteran coffee drinker. It is the time immediately preceding administration 
of the caffeine tablet. The subject was landmarked in the scanner and positioning was noted. 
Anatomical, 3-D TOF, CSF, and minimum contrast scans were collected. Then, the BOLD-ASL 
pCASL sequence as described above was used to record BOLD and CBF responses for the 
entirety of the functional motor-visual stimulus paradigm, which included a resting state prelude. 
This was repeated once. The pCASL acquisitions were followed by the GESSE acquisitions with 
the subject at rest, then VSEAN in the inferior slice, and lastly VSEAN targeting the superior 
slice, both with the subject at rest.  
 2.4.2 Caffeine administration: Caffeine was administered outside the scan room after the 
subject was removed from the scanner. A 200 mg caffeine tablet was ingested with water. The 
subject took a short break before the second half of the session commenced. At least thirty 
minutes elapsed between caffeine ingestion and start of the post-caffeine pCASL acquisition.  
 2.4.3 Post-caffeine state: The post-caffeine state represents the caffeinated, post-
caffeine ingestion time for the subject. Subject positioning was estimated to be as close as 
possible to pre-caffeine. The scanning circumstances of the pre-caffeine state were mimicked. 
Anatomical, 3-D TOF, CSF, and minimum contrast scans were acquired again. Similarly, 
pCASL was used to acquire BOLD-ASL during resting state and performance of the functional 
task, using the closest feasible prescription as in the pre-caffeine state. FLAIR-GESSE 
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acquisition followed with the subject at rest, and the session ended with the two VSEAN 
acquisitions targeting the same slices as in the pre-caffeine state, with the subject at rest.  
 
2.5 Data preprocessing 
 2.5.1 BOLD-ASL images: Field map correction was first performed on raw ASL data to 
account for magnetic field inhomogeneities (Noll et al., 2005). The functional scans were motion 
corrected and registered to one image in each of the runs using AFNI software (Cox, 1996). The 
first four images were dropped to allow the signal to have reached a steady state. The ASL data 
was then corrected for coil sensitivity inhomogeneity using the min/con images (Wang et al., 
2005). Surround-subtraction was applied to first-echo ASL images to produce CBF-weighted 
images, then converted to physiological CBF units using the CSF scan as reference (Chalela et 
al., 2000). Surround-averaging was applied to the first- and second-echo images; these values 
were used to calculate BOLD R2*-weighted images. For each time series, after ROI selection 
(2.5.3), the mean R2* was subtracted to form ∆R2*(t) time series, which were then converted 
back to dBOLD signal without systematic effects of drift (Liu et al., 2019). 
 2.5.2 Data upsampling: Given the coarse temporal and spatial resolution of the 
acquisitions, the BOLD and ASL time courses were upsampled from 64x64 matrix size to 
256x256 matrix size by zero-padding in the Fourier domain with the original data centered in k-
space, then reconstructing the image again through an inverse Fourier transform.  
 2.5.3 Gray matter mask selection: Gray matter masks were created using a specific 
threshold for CBF (35 ml/100ml/min for baseline, caffeine-free CBF, and 20 ml/100ml/min for 
post-caffeine CBF). The lower threshold for the post-caffeine data was chosen to produce 
approximately the same number of voxels in the mask as the pre-caffeine study, to compensate 
for the expected CBF lowering effect of caffeine. The data and masks were also smoothed 
using a Gaussian smoothing kernel with a full width at half maximum of 8 voxels in the 
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upsampled images (2 voxels in the originally acquired images); the smoothed data were used 
for subsequent analyses. The gray matter masks for the slices targeted in the VSEAN 
acquisition were isolated. The superior GM slice was taken as a whole, while the caudal GM 
region was taken as the caudal one-third of that lower slice, to censor artifacts caused by bony 
structures in the rostral head. 
 2.5.4 ROI selection: Voxel-wise correlation of the CBF dynamics across time with the 
stimulus paradigm was done on voxels within the gray matter masks in the two slices. For the 
caudal slice, the visual ROI was determined from voxels in the occipital lobe that had a 
correlation coefficient of r > 0.3. For the superior slice, the motor ROI was determined from 
voxels in the left primary motor cortex that had a correlation coefficient r > 0.3. The ROIs thus 
reflect a gray matter region that demonstrated an increase in CBF in the three motor-visual 
blocks of the stimulus. Separate functional ROIs were taken for each of the two states, so that 
the ROIs are comparable functionally across pre-caffeine and post-caffeine situations. I chose 
this approach of functional alignment rather than anatomical alignment so all numbers derived 
from the ROI’s are in the native space of the acquisition in each state. Our concern was that the 
interpolation involved in anatomical alignment of these relatively coarse images would introduce 
bias in some of the calculated physiological responses. Additionally, a functional alignment may 
be more appropriate in the context of future clinical imaging involving changing neuroanatomy 
(i.e. patients with brain tumors that get removed, or patients who receive radiation treatment that 
causes edema). A potential statistical concern is associated with whether using ROIs selected 
from the CBF data will then bias the measured fractional change in CBF to that stimulus. I 
expect that the ultimate impact of doing so is to skew the fractional change in CBF to the 
stimulus higher, since regions that exhibit this change are selectively picked. To combat this, I 
look only at the change in fractional CBF and BOLD from pre-caffeine to post-caffeine. 
Additionally, though, because the mask based on CBF is determined separately in each state, a 
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bias could be introduced if a fixed CBF threshold is used when there is a global change in CBF, 
as I expect with caffeine. To avoid this bias, I limit the ROIs to be the same size in both states, 
by adjusting the threshold level in the post-caffeine data until the mask has the same number of 
voxels as the pre-caffeine mask. Thus, correlation of CBF data with the stimulus paradigm 
yielded comparable motor and visual ROI regions for each subject in both the pre-caffeine and 
post-caffeine states of approximately similar size and anatomical region; these ROIs are 
henceforth the only regions analyzed. 
 2.5.5 Baseline CBF estimate. Baseline CBF for each subject was estimated by 
averaging over the baseline CBF dynamics in the resting period (total time of 2.5 minutes, 
starting 37.8 seconds from the beginning of the sequence). This was performed for each ROI in 
the pre- and post-caffeine data.  
2.5.6 Fractional change in CBF to task/stimulus. The fractional change in CBF (dCBF) to 
the task/stimulus was calculated by averaging the latter 21 seconds of each of the 3 stimuli 
blocks, to allow for a brief transition (12.6 seconds or 3 TRs) from stimulus onset, to give one 
average value. The baseline CBF was taken as the average of the following windows: the 29.4 
seconds before the start of the first stimulus, the 29.4 seconds before the start of the second 
stimulus, the 29.4 seconds before the start of the third stimulus, and 29.4 seconds after the end 
of the last stimulus, skipping one 4.2 second window (1 TR). That is, one TR was skipped for 
the window after each of the stimuli ended to allow the transition back to baseline. The fractional 
change in CBF to the task/stimulus was then calculated by taking the difference of the baseline 
and stimulus values and dividing by the baseline value.  
2.5.7 Fractional change in BOLD to task/stimulus. The fractional change in BOLD 
(dBOLD) to the task/stimulus was calculated by averaging over the same windows as described 
in 2.5.6. Since the signal is already expressed as a fractional BOLD change after being 
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converted from dR2*, the fractional change in BOLD to the task/stimulus was taken as the 
difference between the baseline value and the activated value.  
 
2.6 FLAIR-GESSE and fractional CMRO2 analysis 
 FLAIR-GESSE data were analyzed per Simon, et al. 2016. The raw GESSE data were 
first upsampled to the same 256x256 matrix size as the BOLD/ASL data. R2¢ values were fitted 
to the raw data for each voxel; the median of the ROIs was taken from voxels in the respective 
masks. 
 Fractional CMRO2 (dCMRO2) was calculated using the fractional BOLD (dBOLD) and 
CBF (dCBF) change to the stimulus as calculated in 2.5. Taking ! = (1 + &'()) and +	 = 	 (1 +	&'-./0), the BOLD model used to calculate dCMRO2 was &(/12 = - 1 − !456+6 , as 
previously described (Liu et al., 2019), based on the Davis model (Davis et al., 1998), with a = 
0.2 and b = 1.3. The baseline parameter M¢ @ M was derived from -¢ = .0¢ ∙ 89, with TE=0.025.  
 
2.7 VSEAN and baseline CMRO2 analysis 
VSEAN data were analyzed per Guo et al. 2012. Raw multi-echo data were averaged 
over the individual ROI masks first, then used to fit a T2 value representative of the entire region. 
The T2 was then converted into venous blood oxygenation (Yv) levels via T2-Yv calibration curve 
at 3T (Zhao et al., 2007). OEF was calculated from venous oxygenation (OEF = 1 – venous 
oxygenation). Baseline CMRO2 was calculated from '-./0 = '()	 ∙ /9)	 ∙ ':/0.	       [1] 
given OEF calculated using VSEAN and CBF from the resting state in 2.5.5. The equation to 
determine total arterial oxygen concentration is: CaO2 = 1.36(Hb)(SaO2/100) + 0.0031(PaO2), 
with units as follows: CaO2 in ml/dL, 1.36 ml O2/1 g Hb, Hb in g/dL, SaO2 in %, 0.0031 
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g/dl/mmHg, and PaO2 in mmHg (Davenport, 1974). Hemoglobin concentration was assumed 
according to mean healthy ranges set by UC San Diego Health (Fraser and Haldeman-Englert, 
2017); for females, [Hb] = 14g/dL; males, [Hb]=15.7g/dL. The age of each subject was also 
factored into CaO2 determination through the estimate of PaO2 (Estimated normal PaO2 @ 100 
mmHg – (0.3) age in years) (Crawford and Adesanya, 2010; Jurado and Walker, 1969). CBF is 
expressed in ml/100ml/min, and CaO2 from this equation is divided by 100 to give CMRO2 units 
in ml/100ml/min. 
 
2.8 Pre- to post-caffeine change 
 The above analyses were performed for the respective acquisitions in both pre- and 
post-caffeine states. This led to four sets of eight values for each subject: 1) Baseline CBF, 2) 
baseline OEF, 3) baseline R2¢, 4) baseline CMRO2, 5) fractional BOLD change (dBOLD) to 
task/stimulus, 6) fractional CBF (dCBF) change to task/stimulus, 7) fractional CMRO2 change 
(dCMRO2), 8) coupling ratio l ( dCMRO2/dCBF) to task/stimulus for 4 conditions: 1) pre-caffeine 
motor ROI, 2) pre-caffeine visual ROI, 3) post-caffeine motor ROI, 4) pre-caffeine visual ROI. 
For each ROI, the pre-caffeine value was subtracted from the post-caffeine value to calculate 
the difference (∆) in each parameter due to caffeine. The mean and standard deviation of each 
∆ was calculated.  
 The pre- and post-caffeine means were compared using a matched pairs T-test with the 
null hypothesis that post-caffeine – pre-caffeine = 0; in other words, ∆=0. This allowed us to 
compare the parameters to determine which could be best at predicting which state the subject 
is in. For the changes from pre- to post-caffeine, 1-tailed testing was used for parameters that 
have been established to show uni-directional change after caffeine administration (baseline 
CBF and l). Other parameters were tested using 2-tailed matched pairs T-tests. All the 
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individual subject data were plotted as scatterplots comparing two variables, with ellipses 
indicating the 95% confidence interval drawn around the mean. The parameters that were able 
to distinguish the two states were determined by the presence of a 95% confidence interval that 
did not pass through the x and y axes, which would indicate ∆=0.  
 While these comparisons were useful in distinguishing the two states of pre- and post-
caffeine, the specificity of the trio of measurements that resulted in significant state separation 
was determined by comparing the pre-caffeine state with a repeated pre-caffeine acquisition. 
The means for the 2 pre-caffeine states were compared using a 2-tailed matched pairs T-test 
with the null hypothesis that the difference equaled 0. Individual subject data were plotted as 
scatterplots, with ellipses indicating the 95% confidence interval drawn around the mean.  
 After determining the key parameters for distinguishing pre- versus post-caffeine using 
the difference in each parameter from state to state, the values themselves were plotted for 
each state with ellipses indicating 2 standard deviations, or 95% of the sample to demonstrate 
the spread of the data, and as an initial test of the ability of that metric to distinguish the two 
states in individual subjects. 
 Primary physiological data (baseline CBF, baseline CMRO2, dCBF, and dCMRO2 to the 
stimuli/tasks) were summarized in bar plots.  
 
2.9 Data and code availability 
The data that support the findings of this study are available from the corresponding 
author, RBB, upon reasonable request. The data and code sharing adopted by the authors 
comply with requirements by the National Institutes of Health and by the University of California, 
San Diego, and comply with institutional ethics approval. 
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3. Results 
 The mean results of the measured parameters are summarized in Table 4.1. The 
average motor ROI size pre-caffeine was 181 +/- 76 voxels, and average motor ROI post-
caffeine was 155 +/- 101 voxels. The average visual ROI size pre-caffeine was 250 +/- 105 
voxels, and the average visual ROI size post-cafffeine was 272 +/- 125 voxels. The difference in 
each from pre- to post-caffeine was calculated and tested for significance from 0, with significant 
differences highlighted with asterisks in Table 4.1.   
 
3.1 Baseline measurements 
 Baseline CBF in the pre-caffeine state was found to be significantly higher than baseline 
CBF in the post-caffeine state in both the visual ROI (p<0.001) and motor ROI (p<0.001). 
However, pre-caffeine baseline CMRO2 was not significantly different from post-caffeine 
baseline CMRO2 in either the visual or motor ROI. Baseline R2¢ in the motor ROI was 
significantly higher in the post-caffeine state compared to pre-caffeine. The changes in baseline 
parameters from pre- to post-caffeine (∆) were plotted against each other to visualize the gross 
changes in each variable (Figure 4.1D-F).  
 
3.2 Functional measurements: fractional changes to stimuli/task 
 Fractional change in CBF (dCBF) to the stimulus was not found to be significantly 
different pre- to post-caffeine. Fractional change in BOLD (dBOLD) to the stimulus was 
significantly lower post-caffeine compared to pre-caffeine in both the visual ROI (p<0.001) and 
motor ROI (p<0.01). However, fractional change in CMRO2 was not significantly different pre- to 
post-caffeine, although the trend appears to be a higher dCMRO2 post-caffeine (Figure 4.1B,C). 
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The trio of functional measurements were plotted against each other to visualize the gross 
changes in each variable (Figure 4.1A-C).  
 
3.3 Separation of pre- and post-caffeine measurements 
 Functional and baseline measurements were plotted in Figure 4.2. From here, it was 
evident that dBOLD and ∆ baseline CBF were most discriminatory in separating the pre- and 
post-caffeine states (Figure 4.2B), while R2¢ was effective in the motor ROI (Figure 4.2D).  
 Important to note is the interpretation of the BOLD signal; specifically, the BOLD 
response is modulated by M through R2¢, a scaling parameter reflecting baseline 
deoxyhemglobin, as well as by the coupling of dCMRO2 and dCBF (l = dCMRO2/dCBF) (Ances 
et al., 2008; Griffeth et al., 2011). R2¢ scales the BOLD response to the stimulus; as a result, an 
important relationship to examine is the scaled dBOLD response, or dBOLD/R2¢ (Figure 4.3A). 
This empirically best segregates all the motor ROI individual data to the lower left quadrant, 
indicating that all subjects demonstrated a lower scaled BOLD response and lower baseline 
CBF post-caffeine. The physiological responses of dCBF and dCMRO2 through the coupling l = 
dCMRO2/dCBF also demonstrated a significant change post-caffeine; for both motor and visual 
ROI, l was increased post-caffeine (Figure 4.3C).  
  Specificity of these three parameters (scaled dBOLD/R2¢, l, and baseline CBF) in 
detecting a change in brain state from pre- to post-caffeine was tested by examining these 
relationships in a second set of pre-caffeine acquisitions. While FLAIR-GESSE and VSEAN 
were only acquired once pre-caffeine, the functional stimulus acquisition was performed twice 
pre-caffeine. The first pre-caffeine run was used in comparing between pre- and post-caffeine, 
as its acquisition circumstances were most similar to those post-caffeine (timing after entrance 
into the scanner, no habituation likely). Pre- to pre-caffeine differeces are demonstrated in 
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Figure 4.2 B and D. While no significant change in l or baseline CBF was seen, as would be 
expected, surprisingly dBOLD/R2¢ appeared to be significantly different between the two pre-
caffeine states (Figure 4.3B).  
 The spread of the individual pre- and post-caffeine data were also plotted in Figure 4.4, 
with ellipses indicating 2 standard deviations drawn around the mean. These ellipses would 
surround 95% of the population.  The spread of data for pre- to pre-caffeine data are shown in 
Supplementary Materials. The significant overlap in range of the two distinct populations—pre- 
and post-caffeine—show that a single measurement in an unknown state is not enough to 
identify the state itself; instead, taking two separate measurements and quantifying the 
difference is more demonstrative of whether a change in state has occurred.  
 
 
4. Discussion 
This study demonstrates the feasibiltiy of separating two different brain states using this 
suite of physiological measurements through noninvasive modalities. Here, I used caffeine, a 
much studied drug, to induce a change in brain state. I collected information on eight 
parameters—1) Baseline CBF, 2) baseline OEF, 3) baseline R2¢, 4) baseline CMRO2, 5) 
fractional BOLD change (dBOLD) to task/stimulus, 6) fractional CBF change (dCBF) to 
task/stimulus, 7) fractional CMRO2 change (dCMRO2), 8) coupling ratio l (dCMRO2/dCBF) to 
task/stimulus—in two different regions, visual and motor ROIs, using a combined motor-visual 
task. BOLD and CBF were imaged using a tri-echo pCASL sequence, while baseline OEF to 
calculate CMRO2 was measured using VSEAN and R2¢ to calibrate the BOLD response to 
calculate dCMRO2 was measured using FLAIR-GESSE.  
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Our results pinpoint scaled dBOLD (dBOLD/R2¢), baseline CBF, and coupling ratio l 
(dCMRO2/dCBF) as the most sensitive parameters for separating pre-caffeine from post-caffeine 
states. While neither baseline CMRO2 nor OEF change to post-caffeine was significant, the 
VSEAN-enabled measurement of OEF allowed us to make the baseline CMRO2 calculation to 
compare the two states and determine that baseline CMRO2 did not change significantly. 
Additionally, in this particular example of caffeine, the methods that were most useful were 
BOLD/ASL and FLAIR-GESSE, but that may not be the case with other drugs or interventions. It 
is thus important to retain the full suite of tools, yielding measurements for all parameters, in 
order to paint a full picture of what is changing with the change in brain state.  
While I did not see any significant change between repeated pre-caffeine studies in l or 
baseline CBF, as would be expected, dBOLD to the stimuli was significanly different. A change 
in the BOLD response for two different rounds of stimulation could be due to an altered neural 
response to the stimulus, or slight differences in the ROI used, or minor subject movement. An 
earlier study of the reproducibility of activation metrics from our group (Leontiev and Buxton, 
2007) found that the repeated responses to the same stimulus were more variable than the 
CMRO2/CBF coupling ratio. Here I found a similar effect, in that the CBF and CMRO2 responses 
individually did not reach significance in distinguishing the pre- and post-caffeine states, 
probably due to the variability of the response amplitude to repeated stimuli, but the coupling 
ratio l was a good metric for distinguishing the states. In short, specific responses (BOLD, CBF 
or CMRO2) may simply be more variable across different repeated stimulations than the 
relationships between these responses, such as the coupling parameter l.  
 The relationship of dCBF and dCMRO2 has long been explored in its variability across 
different brain regions and under different conditions (Ances et al., 2008; Chiarelli et al., 2007; 
Griffeth et al., 2011; Liang et al., 2013). Changes in CMRO2 may provide a more relevant 
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picture of neural activity than changes in BOLD signal, since oxygen metabolism may reflect the 
underlying neuronal energy requirements, such as supporting ATP production for 
neurotransmitter release and restoring ion gradients (Lin et al., 2010). The energy demand 
appears to be met predominantly by oxidative metabolism, although glucose metabolism may 
shift toward nonoxidative metabolism during activation. For caffeine specifically, I expect 
increased caffeine to reduce the effects of adenosine by blocking adenosine receptors. 
Adenosine potentially has two effects that could affect CMRO2 and CBF: an inhibitory effect on 
neural activity, which could tend to reduce CMRO2; and a vasodilatory effect on blood vessels, 
which would tend to increase CBF. The observed reduced baseline CBF in this study and a 
number of previous studies is thus consistent with caffeine blocking adenosine effects on the 
blood vessels. The idea of increased dCMRO2 relative to dCBF elicited by the same stimulus 
could be due to the brain being set at a more “excitable” state after caffeine administration, 
increasing neural excitability (Griffeth et al., 2011). Our results corroborate results seen 
previously of an increase in l (or a decrease in n = 1/l) with caffeine (Chen and Parrish, 2009; 
Griffeth et al., 2011). In terms of baseline CMRO2 effects of caffeine, previous studies have 
reported no significant change in CMRO2 (Xu et al., 2015) or increased CMRO2 (Griffeth et al., 
2011). In our results, I did not detect a significant change in baseline CMRO2 across subjects, 
although I found evidence for an unexpected effect: a large increase in the variance of baseline 
CMRO2 post-caffeine compared to pre-caffeine (Chapter 3). This effect needs further study, but 
this finding does suggest that the physiological picture of the caffeine effect on baseline CMRO2 
may be more complicated than the effects on CBF and the activation coupling ratio.  
 Importantly, this study was not conducted to explore the effects of caffeine. Rather, 
caffeine was an example of a type of intervention that could be given to a subject or patient to 
induce a change; the ability to reproducibly quantify that change is potentially important in 
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understanding any of the following relevant questions: What is the intervention’s effect on the 
brain’s physiology? Does the dose of the drug affect neuronal activity as measured through 
metabolism? Perhaps most tellingly from our data: Can I detect that there has been an 
intervention administered through these physiological measurements? For any given drug, any 
mix of the data collected in this study could help elaborate the story, and as a result, it is crucial 
to be able to apply the full suite of methods. For example, while OEF may not have contributed 
directly to the differentiation of the two different states, it made it possible to conclude that 
baseline CMRO2 was significantly changed by caffeine. It may be a vital factor in discriminating 
a different drug-induced state from baseline when CMRO2 is more directly affected. Similarly, 
dBOLD appeared to be excellent at separating the two conditions, and yet lacked specificity in 
its discrimination when it appeared to also separate one pre-caffeine trial from a repeated pre-
caffeine trial.  
 The study thus proposes that comparing the measurements in two states can begin to 
distinguish and quantify those conditions. However, it’s important to note that simply performing 
one set of measurements is currently not enough to determine what state is at hand. This is due 
to a high variability and range of these parameters amongst individuals, as evidenced in Figure 
4.4. This high variability, in combination with the specific drug’s range of effect on the 
parameters, leads to significant overlap between the absolute values of each state. As a result, 
the contrast of two separate measurements in the two states is needed to make this distinction.  
 
 
5. Conclusions 
 The suite of tools I tested here have the potential to provide quantitative information on 
both baseline CBF and CMRO2, and on the changes of these physiological parameters with a 
stimulus or task, without requiring the subject to breathe special gas mixtures. As an initial 
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evaluation of this suite of tools I tested the sensitivity of these metrics to detect a change in 
brain state due to ingestion of caffeine. The full suite of measurements showed that while 
baseline CMRO2 was not affected by the caffeine, baseline CBF was reduced and the 
CMRO2/CBF dynamic coupling ratio l in response to a standard stimulus was increased. The 
CBF decrease with caffeine was found in 10 of 10 subjects in both motor and visual ROI’s and 
the increase of l was found in 9 of 10 subjects, supporting the potential of these methods to 
make meaningful measurements in individual subjects. To reliably distinguish the two brain 
states, though, required measurements pre-and post-caffeine. The intrinsic variability of these 
metrics across subjects meant that a single set of measurements (e.g., just post-caffeine) still 
strongly overlapped with the spread of pre-caffeine values across subjects. These results set 
the grounds for future clinical applications; their non-gas nature serves to ease introduction into 
measuring changes in a patient population that may not tolerate breathing special gases. To our 
knowledge, this is the first demonstration of distinct quantification of absolute CBF and CMRO2 
in specific ROIs before and after drug administration with non-gas methods, laying the 
groundwork for investigation into other brain regions and interventions to come.  
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Table 4.1: Average ROI changes to caffeine. *** p<0.001; ** p<0.01; * p<0.05. 
Visual ROI 
 
Baseline 
CBF 
(ml/100ml/min) 
Baseline 
OEF 
Baseline R2¢ 
(sec-1) 
Baseline 
CMRO2 
(ml/100ml/min) 
dCBF to 
stimulus 
dBOLD to 
stimulus 
dCMRO2 to 
stimulus 
l 
(dCMRO2 / 
dCBF) 
Pre-caffeine 
Mean 73.56 0.33 4.18 4.77 0.23 0.013 0.071 0.28 
Std. dev. 11.45 0.12 0.59 1.58 0.082 0.0058 0.061 0.22 
CV (%) 15.56 35.25 14.20 33.10 35.23 43.56 85.4 80.3 
Post-caffeine 
Mean 53.96 0.37 4.26 3.88 0.21 0.0091 0.10 0.47 
Std. dev. 13.38 0.21 1.07 2.08 0.089 0.0061 0.047 0.17 
CV (%) 24.79 56.25 25.05 53.70 41.64 67.12 46.7 37.0 
∆ (Post-pre) 
Mean -19.60*** +0.045 +0.072 -0.89 -0.017 -0.0043*** +0.030 +0.16* 
Std. dev. 10.09 0.21 1.13 2.07 0.09 0.0025 0.09 0.27 
% ∆  -26.6*** +13.6 +1.72 -18.7 -7.39 -33.1*** +42.3 +57.1* 
Motor ROI 
 
Baseline 
CBF 
(ml/100ml/min) 
Baseline 
OEF 
Baseline R2¢ 
(sec-1) 
Baseline 
CMRO2 
(ml/100ml/min) 
dCBF to 
stimulus 
dBOLD to 
stimulus 
dCMRO2 to 
stimulus 
l 
(dCMRO2 / 
dCBF) 
Pre-caffeine 
Mean 45.09 0.37 3.57 3.29 0.24 0.011 0.080 0.32 
Std. dev. 6.79 0.13 0.69 1.11 0.039 0.0035 0.047 0.15 
CV (%) 15.07 34.77 19.40 33.72 16.34 30.66 59.6 47.8 
Post-caffeine 
Mean 37.22 0.41 4.29 3.13 0.21 0.0083 0.11 0.47 
Std. dev. 6.55 0.18 0.51 1.63 0.081 0.0029 0.063 0.17 
CV (%) 17.59 44.90 11.94 52.08 38.16 34.85 59.8 35.5 
∆ (Post-pre) 
Mean -7.87*** +0.041 +0.71** -0.16 -0.028 -0.0032** +0.026 +0.15*** 
Std. dev. 5.28 0.16 0.75 1.52 0.077 0.0027 0.060 0.12 
% ∆  -17.5*** +10.8 +19.9** -4.9 -11.7 -29.1** +32.5 +46.9*** 
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Figure 4.1: Functional and baseline changes to caffeine in motor and visual ROIs. (A-C) 
Caffeine-induced change (post-caffeine minus pre-caffeine) to fractional changes to the visual 
or motor stimulus in the respective ROIs. Ellipses represent 95% confidence interval; error bars 
represent standard error. (D-F) Caffeine-induced change to baseline measurements in the 
visual or motor ROIs. Ellipses represent 95% confidence interval; error bars represent standard 
error.  
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Figure 4.2: Comparative changes to caffeine in motor and visual ROIs. The intermix of 
fractional changes to the stimuli versus baseline values, with ∆ = post-caffeine – pre-caffeine. 
Ellipses indicate 95% confidence interval; error bars indicate standard error.  
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Figure 4.3: Separation of pre- and post-caffeine states. (A) and (C) depict the major 
parameters distinguishing the two different conditions, pre- and post-caffeine. (B) and (D) depict 
the corresponding comparisons between two pre-caffeine experiments. The results in (B) 
demonstrate that dBOLD is not discriminating in its ability to indicate two different states; rather, 
l (dCMRO2/dCBF) is more specific to separating the two conditions. Ellipses indicate 95% 
confidence intervals, error bars indicate standard error.   
 
 156 
 
Figure 4.4: Individual data in pre- and post-caffeine states. The scatter of individual 
measurements for the plotted parameters, with ellipses indicating 2 standard deviations from the 
mean (95% of the population), and error bars indicating standard deviation. For both the motor 
ROI (A and C) and visual ROI (B and D), there is significant overlap between the two states, 
demonstrating intersubject variability and thus the inability of any one set of measurements to 
designate the correct state.  
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Figure 4.5: Physiological summary of changes to an intervention. The suite of tools 
described in this study allow for complete quantification of physiological parameters in the 
baseline state, as well as changes to a stimulus. These measurements reveal the ability to 
discriminate between two distinct brain states, in this case before and after caffeine 
administration. Those physiological parameters include (A) baseline CBF and CMRO2, (B) 
fractional dCBF and dCMRO2 to a stimulus, and (C) the coupling of dCMRO2/dCBF, or l. While 
this study showed a significant change in baseline CBF and coupling ratio l from one state to 
the other, future applications of these methods may demonstrate other distinguishing 
differences. *** p<0.001, * p<0.05. Colors and cross-hatching legend in panel (A) indicate ROI 
and state. 
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CONCLUSIONS and FUTURE DIRECTIONS 
 
Conclusions 
The human brain at work: What does it look like? How can we tell it is working? Can we 
open a window to peer into the primary motor cortex as someone taps their fingers? The 
previous body of work has shown that we have come a long way since the development of the 
blood oxygenation level dependent (BOLD) signal and the beginnings of functional magnetic 
resonance imaging (fMRI). While research using BOLD has burgeoned, with many fields 
utilizing the signal to study different neural processes, BOLD fMRI to quantify brain activity has 
not found a strong foothold in the clinical world. The goal of my PhD research was to establish 
the foundations for physiological, quantitative fMRI that can readily bridge the gap between 
benchside and bedside applications. Specifically, the main goals were to noninvasively quantify 
physiological parameters—absolute and fractional cerebral blood flow (CBF) and cerebral 
metabolism of oxygen (CMRO2)—in different states of the human brain.  
While arterial spin labeling (ASL) techniques are well established as a technique for 
measuring baseline and fractional change in CBF in both research and clinical settings, 
measuring oxygen metabolism is much more challenging, and thus was a primary obstacle to 
tackle in my studies. Theoretically, baseline CMRO2 could be attained through a measurement 
of baseline oxygen extraction fraction (OEF) that can be combined with a measurement of 
baseline CBF and arterial oxygen content (CaO2). Fractional CMRO2 change to a stimulus, on 
the other hand, must be tackled through a model of dynamic BOLD and CBF responses to the 
stimulus. This model involves a calibration factor that reflects the baseline deoxyhemoglobin 
content. Thus, the path to CMRO2 quantification involves two separate approaches to 
characterize baseline and fractional change.  
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Aim 1: Physiology 
Before diving into the multiple techniques to calculate CMRO2, a primary physiological 
mystery must first be solved regarding cerebral blood volume (CBV) changes that accompany 
changes in CBF, so that future application of the BOLD model can incorporate this relationship 
correctly to yield proper estimates of CMRO2. Chapter 1 set out to answer this physiological 
question: Do the dynamics of blood volume changes present a significant obstacle to measuring 
metabolism? I found, using the BOLD post-stimulus undershoot as a test-case for possibly 
varying relationship between CBF and CBV, that CBV does follow CBF, and that the effect of 
volume is weak with stimulation and takes a long time to develop (Liu et al., 2019). Thus, 
subsequent application of this relationship with short stimuli lengths (< 1 min.) can assume that 
the volume dynamics are reflected by flow dynamics.      
  
Aim 2: Methodology 
 To measure baseline CMRO2 or fractional change in CMRO2, separate techniques 
already exist that require subjects to breathe a mix of special gases. However, because my goal 
was to produce a suite of tools that would be amenable to clinical application that necessarily 
involves patient populations for whom special gases may be contraindicated, I sought to 
incorporate a suite of non-gas tools to perform these measurements. In Chapter 2, I tested two 
recently developed methods, Velocity-Selective Excitation and Arterial Nulling (VSEAN) (Guo 
and Wong, 2012) and FLuid-Attenuated Inversion Recovery – Gradient Echo Sampling of Spin 
Echo (FLAIR-GESSE) (Simon et al., 2016), by analyzing their results against previously 
reported values and calibrating against a hypercapnia calibrated BOLD experiment. My results 
demonstrated that VSEAN produced estimates of OEF very similar to literature values using 
positron emission tomography (PET) imaging, while R2¢ from FLAIR-GESSE could replace M 
values from calibrated BOLD, potentially through a calibration factor. This supported the use of 
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these non-invasive techniques in obtaining CMRO2 measurements from subjects in a variety of 
applications. 
 
Aim 3: Applications 
 In Chapters 3 and 4, I utilized the suite of tools—VSEAN, FLAIR-GESSE, and a multi-
echo ASL/BOLD acquisition—to make meaningful quantitative measurements in individual 
subjects. In Chapter 3, these techniques were applied to a simple experiment: characterizing 
the baseline state for a subject at rest before and after drug administration. The drug used was 
caffeine, and CBF, OEF, and R2¢ were measured using the toolbox of non-invasive methods. 
The results showed that both OEF and R2¢ were increased with caffeine in gray matter, while 
CBF was significantly decreased. CMRO2 did not change after caffeine. This basic picture 
demonstrated the applicability of these tools to detecting a change in brain state.  
In Chapter 4, I introduced a more complex stimulus into the equation. Given the 
intervention (administering a drug) and a “stress test” stimulus (motor-visual task and stimulus), 
which of the eight parameters acquired using the toolbox would best distinguish the pre-caffeine 
state from the post-caffeine state? The answer in this case appeared to be baseline CBF and l, 
the ratio of fractional CMRO2 change to fractional CBF change with the stimulus 
(dCMRO2/dCBF). These results revealed the utility of the toolbox in painting a full physiological 
picture in different states, as well as the need to acquire all parameters in future studies to best 
determine which measurements can distinguish one state from another. This last chapter thus 
fulfills my original goal of establishing the foundation for physiological, quantitative fMRI in 
different states of the human brain. Henceforth, the clinical applications of these tools can be 
readily explored. 
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Future Directions 
 
Network dynamics 
Coherent patterns of activity in the brain based on correlations in BOLD signal 
fluctuations across different brain regions, otherwise known as neural network dynamics, is a 
major focus of current research (Barkhof et al., 2014; Fox and Raichle, 2007). Network analysis 
can potentially provide information on normal and pathologic brain function for the study of 
disease processes, and may prove crucial in evaluating clinical therapies (Fox and Greicius, 
2010). This suite of fMRI tools will be applied to the quantification of network dynamics and 
interactions in each of three task states: resting, motor task, and vigilance task. My approach 
makes possible new metrics based on absolute physiological measures, and could potentially 
reveal underlying neural activity based on the degree of neurovascular coupling. These data 
have already been collected, and will be analyzed shortly soon in collaboration with Dr. Frank 
Haist. 
 
Cognitive function 
Much of my work to this point focused on motor and visual stimuli. To bridge the 
benchside-bedside gap of using the new techniques, I seek to expand this work beyond these 
systems. My goal is to establish a foundation for clinical applications of these tools by testing 
their ability to reliably characterize CBF and CMRO2 both for the baseline state and for the 
changes associated with cognitive tasks. This may extend the application of these tools to sub-
cortical areas of the brain—and also form a bridge between the new studies and my previous 
studies in visual cortex—using a task that has been well validated in our lab, a complex motor 
task probing the basal ganglia with simultaneous visual stimulus (Ances et al., 2008). Results 
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from this study will determine reproducibility and population variability of the metrics measured 
with these quantitative tools. Specifically, I seek to answer the following questions:  
1. Are the metrics of CBF and CMRO2 (baseline values and task/stimulus response 
values) measured in the basal ganglia and visual cortex reproducible within an 
individual in repeated studies?  
2. How does the test/retest variability compare with the variability across subjects?  
 
To probe this, I will acquire sets of data on the same young, healthy subjects at two 
different time-points and evaluate individual reproducibility of the physiological metrics and 
population variance. Importantly, as a foundation for future clinical applications in individual 
subjects, I will characterize the balance of variance due to the methods themselves and true 
population variability by testing post-processing options to improve signal to noise ratio (SNR), 
with analyses ranging from single voxel to region of interest (ROI) measures. 
My work resulted in the development of an alternate approach to measuring absolute 
CBF and CMRO2 in both the baseline state and in response to a standard stimulus, in both the 
visual and cognitive systems. Upon establishing this, I will move onto a more complex, 
previously untested but highly cognitively important region in terms of clinical impact: 
hippocampal activity during a memory encoding task. As my future career goals are in the field 
of radiation oncology, I am most interested in understanding cognitive deficits related to cancer 
treatment, mainly due to radiotherapy of the brain and chemotherapy (Greene-Schloesser et al., 
2012; Monje et al., 2007; Peiffer et al., 2013). Because one of the primary sequelae of post-
radiation therapy is a decline is memory abilities, I am most interested in probing the 
hippocampus, a region closely associated with memory. The new methods I have developed 
are potentially powerful tools for this application, as cancer treatment could have several effects 
on the brain: changing baseline state, altering the way neurons respond to a stimulus, or 
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causing vascular damage (Greene-Schloesser et al., 2012; Greene-Schloesser and Robbins, 
2012; Yamada, 2016). Are these tools able to quantify hippocampal activation with a memory 
task?  Imaging hippocampal function is technically challenging and thus will be an important test 
of the new methodology. I anticipate that this will require more work up front to optimize the 
methods.  
 
Other clinical and basic science applications 
A review of the clinical and basic science literature reveals that there are many cases 
where one can anticipate that physiological parameters such as baseline and/or fractional 
changes in metabolism or blood flow could differ in significant ways between individuals (e.g., 
healthy and unhealthy individuals) or across time within individuals (e.g., lifespan development). 
My findings suggest that in such cases traditional BOLD-based fMRI may provide inaccurate 
comparisons of neural activity. Below are some example cases where my approach using 
quantitative physiological fMRI may prove useful in understanding fundamental basic science 
questions in addition to clinically relevant information.  
Human development. Quantitative, physiological fMRI can be used to understand 
development differences in neural responsiveness across multiple networks (Haist and Anzures, 
2017). These tools can be used to measure baseline differences in physiology at different 
stages of child development, and contrast these parameters, as well as fractional changes to a 
stimulus, with findings in adults. The parameters can also be compared with structural brain 
anatomy to determine if certain aspects of structure, such as cortical thickness or gray matter 
volume, are associated with activation parameters. I plan to explore these issues in my ongoing 
collaboration with Dr. Frank Haist.  
Alzheimer’s Disease. The tools described here can also be applied to the study of 
dementia and Alzheimer’s Disease (AD). CBF has been established as a biomarker of 
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preclinical AD (Hays et al., 2016); can measurements of CMRO2 support even more sensitive 
and specific identification of individuals at risk for AD, or for predicting cognitive decline? 
Radiation oncology. BOLD fMRI has been utilized in the field of radiation oncology for 
identifying regions of a tumor that require higher dose (van der Heide et al., 2012), while ASL 
has been applied to differentiate benign from malignant meningiomas (Qiao et al., 2017). Our 
toolbox of methods here could be further incorporated to answer other questions of radiation 
sensitivity and tumor character, or differentiate tumor cell types. Additionally, our methods can 
be used to understand effects of radiation on underlying physiology and track progression of 
radiation side effects on non-targeted regions in the brain.  
 
Final thoughts 
 One can see that the applications of these tools are varied and broad; I look forward to 
the next step of not only fine-tuning the acquisitions for various research applications, such as in 
studying network dynamics and cognitive regions, but also the multiple clinical applications of 
such measurements. With this work, we begin to slowly unfog the frosted window into the 
workings of the human brain. 
 
 
 
  
 169 
References 
Ances, B.M., Leontiev, O., Perthen, J.E., Liang, C., Lansing, A.E., Buxton, R.B., 2008. Regional 
differences in the coupling of cerebral blood flow and oxygen metabolism changes in 
response to activation: Implications for BOLD-fMRI. Neuroimage 39, 1510–1521. 
https://doi.org/10.1016/j.neuroimage.2007.11.015 
 
Barkhof, F., Haller, S., Rombouts, S. a R.B., 2014. Resting-State Functional MR Imaging: A 
New Window to the Brain. Radiology 272, 29–49. https://doi.org/10.1148/radiol.14132388 
 
Fox, M.D., Greicius, M., 2010. Clinical applications of resting state functional connectivity. Front. 
Syst. Neurosci. 4, 19. https://doi.org/10.3389/fnsys.2010.00019 
 
Fox, M.D., Raichle, M.E., 2007. Spontaneous fluctuations in brain activity observed with 
functional magnetic resonance imaging. Nat. Rev. Neurosci. 8, 700–711. 
https://doi.org/10.1038/nrn2201 
 
Greene-Schloesser, D., Robbins, M.E., 2012. Radiation-induced cognitive impairment--from 
bench to bedside. Neuro. Oncol. 14 Suppl 4, iv37-44. 
https://doi.org/10.1093/neuonc/nos196 
 
Greene-Schloesser, D., Robbins, M.E., Peiffer, A.M., Shaw, E.G., Wheeler, K.T., Chan, M.D., 
2012. Radiation-induced brain injury: A review. Front. Oncol. 2, 1–18. 
https://doi.org/10.3389/fonc.2012.00073 
 
Guo, J., Wong, E.C., 2012. Venous oxygenation mapping using velocity-selective excitation and 
arterial nulling. Magn. Reson. Med. 68, 1458–1471. https://doi.org/10.1002/mrm.24145 
 
Haist, F., Anzures, G., 2017. Functional development of the brain’s face-processing system. 
Wiley Interdiscip. Rev. Cogn. Sci. https://doi.org/10.1002/wcs.1423 
 
Hays, C.C., Zlatar, Z.Z., Wierenga, C.E., 2016. The Utility of Cerebral Blood Flow as a 
Biomarker of Preclinical Alzheimer’s Disease. Cell. Mol. Neurobiol. 
https://doi.org/10.1007/s10571-015-0261-z 
 
Liu, E.Y., Haist, F., Dubowitz, D.J., Buxton, R.B., 2019. Cerebral blood volume changes during 
the BOLD post-stimulus undershoot measured with a combined normoxia/hyperoxia 
method. Neuroimage 185, 154–163. https://doi.org/10.1016/j.neuroimage.2018.10.032 
 
Monje, M.L., Vogel, H., Masek, M., Ligon, K.L., Fisher, P.G., Palmer, T.D., 2007. Impaired 
human hippocampal neurogenesis after treatment for central nervous system 
malignancies. Ann. Neurol. 62, 515–520. https://doi.org/10.1002/ana.21214 
 
Peiffer, A.M., Leyrer, C.M., Greene-Schloesser, D.M., Shing, E., Kearns, W.T., Hinson, W.H., 
Tatter, S.B., Ip, E.H., Rapp, S.R., Robbins, M.E., Shaw, E.G., Chan, M.D., 2013. 
Neuroanatomical target theory as a predictive model for radiation-induced cognitive 
decline. Neurology 80, 747–53. https://doi.org/10.1212/WNL.0b013e318283bb0a 
 
Qiao, X.J., Kim, H.G., Wang, D.J.J., Salamon, N., Linetsky, M., Sepahdari, A., Ellingson, B.M., 
Pope, W.B., 2017. Application of arterial spin labeling perfusion MRI to differentiate benign 
from malignant intracranial meningiomas. Eur. J. Radiol. 
 170 
https://doi.org/10.1016/j.ejrad.2017.10.005 
 
Simon, A.B., Dubowitz, D.J., Blockley, N.P., Buxton, R.B., 2016. A novel Bayesian approach to 
accounting for uncertainty in fMRI-derived estimates of cerebral oxygen metabolism 
fluctuations. Neuroimage 129, 198–213. https://doi.org/10.1016/j.neuroimage.2016.01.001 
 
van der Heide, U.A., Houweling, A.C., Groenendaal, G., Beets-Tan, R.G.H., Lambin, P., 2012. 
Functional MRI for radiotherapy dose painting. Magn. Reson. Imaging. 
https://doi.org/10.1016/j.mri.2012.04.010 
 
Yamada, M.K., 2016. A link between vascular damage and cognitive deficits after whole-brain 
radiation therapy for cancer: A clue to other types of dementia? Drug Discov. Ther. 10, 79–
81. https://doi.org/10.5582/ddt.2016.01004 
 
